{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "9467fde4",
   "metadata": {},
   "source": [
    "# Claude Sonnet 4\n",
    "---\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "37622a32",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Imports\n",
    "import os\n",
    "import sys\n",
    "import pandas as pd\n",
    "import ipywidgets as widgets\n",
    "from IPython.display import display\n",
    "\n",
    "sys.path.append(r\"C:\\Users\\janbe\\Documents\\GitHub Repos\\pulse\")\n",
    "from src.eval.llm_analyzer import LLMAnalyzer\n",
    "from src.eval.pulse_score import PULSEScoreCalculator"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "682aca7b",
   "metadata": {},
   "source": [
    "## Analysis of different prompting approaches\n",
    "---"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "4dfa4491",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['hybrid_reasoning_agent_preprocessor', 'sarvari_2024_aggregation_preprocessor', 'zhu_2024b_zero_shot_preprocessor']\n",
      "==================================================\n",
      "\n",
      "Prompting Approach hybrid_reasoning_agent_preprocessor\n",
      "Extracting metadata from files:\n",
      "Model Name: ClaudeSonnet4, Task: aki, Dataset: eicu, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: aki, Dataset: hirid, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: aki, Dataset: miiv, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: eicu, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: hirid, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: miiv, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: sepsis, Dataset: eicu, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: sepsis, Dataset: hirid, Timestamp: 20250711_173050\n",
      "Model Name: ClaudeSonnet4, Task: sepsis, Dataset: miiv, Timestamp: 20250711_173050\n",
      "\n",
      "\n",
      "--- Approach Summary ---\n",
      "- Number of Samples: 5529\n",
      "- Number of Requests: 23879\n",
      "- Total Input Tokens: 17512767\n",
      "- Total Output Tokens: 13041513\n",
      "- Total Thinking Tokens: 0\n",
      "- Average Thinking Tokens: 0.00\n",
      "- Total Cost (USD): $248.16\n",
      "\n",
      "Preparing data for ClaudeSonnet4 PULSE score calculation...\n",
      "Model Type: LLM\n",
      "✓ No invalid predictions detected\n",
      "✅ Data format is correct for PULSE calculation!\n",
      "\n",
      "Data distribution by task:\n",
      "\n",
      "AKI:\n",
      "  Total samples: 2950\n",
      "  Positive labels: 693\n",
      "  Valid predictions: 2950\n",
      "  Positive predictions: 212.0\n",
      "  Probability range: [0.020, 1.000]\n",
      "  Probability mean: 0.171\n",
      "\n",
      "MORTALITY:\n",
      "  Total samples: 300\n",
      "  Positive labels: 30\n",
      "  Valid predictions: 300\n",
      "  Positive predictions: 8.0\n",
      "  Probability range: [0.020, 1.000]\n",
      "  Probability mean: 0.093\n",
      "\n",
      "SEPSIS:\n",
      "  Total samples: 2279\n",
      "  Positive labels: 116\n",
      "  Valid predictions: 2279\n",
      "  Positive predictions: 12.0\n",
      "  Probability range: [0.020, 0.850]\n",
      "  Probability mean: 0.070\n",
      "\n",
      "Data types and unique values:\n",
      "  Target Label: int64, values: [0 1]\n",
      "  Predicted Diagnosis: object, values: ['not-aki' 'aki' 'not-mortality' 'mortality' 'not-sepsis']\n",
      "  Predicted Probability: float64, values: [0.12 0.08 0.1  0.35 0.25]\n",
      "\n",
      "Data source information:\n",
      "  • Predictions from explicit prediction column\n",
      "  • Total samples: 5529\n",
      "  • Tasks: aki, mortality, sepsis\n",
      "  • Datasets: eicu, hirid, miiv\n",
      "Calculating PULSE scores...\n",
      "✅ PULSE scores calculated successfully for ClaudeSonnet4!\n",
      "PULSE SCORE DETAILED REPORT\n",
      "Model Type: LLM\n",
      "Weights: AUPRC=0.33, AUROC=0.33, MCC=0.34\n",
      "\n",
      "OVERALL SCORES\n",
      "--------------------------------------------------\n",
      "              Metric      Value\n",
      "0      overall_score  57.312331\n",
      "1        overall_aki  64.333231\n",
      "2       overall_eicu  59.158192\n",
      "3  overall_mortality  63.638688\n",
      "4      overall_hirid  59.315677\n",
      "5     overall_sepsis  43.965076\n",
      "6       overall_miiv  53.463125\n",
      "\n",
      "TASK DATASET SCORES\n",
      "--------------------------------------------------\n",
      "                 pulse_score     auprc     auroc       mcc       ccf\n",
      "aki_eicu           68.186777  0.601629  0.761455  0.684234  0.999136\n",
      "aki_hirid          58.195297  0.406194  0.798578  0.548218  0.996548\n",
      "aki_miiv           66.617618  0.573717  0.791142  0.636320  0.999136\n",
      "mortality_eicu     66.463247  0.448769  0.781874  0.760354  1.000000\n",
      "mortality_hirid    65.853515  0.450918  0.819203  0.708763  0.997600\n",
      "mortality_miiv     58.599301  0.448660  0.851799  0.473623  0.992900\n",
      "sepsis_eicu        42.824553  0.096580  0.685982  0.500000  1.000000\n",
      "sepsis_hirid       53.898219  0.244959  0.799207  0.572408  0.999608\n",
      "sepsis_miiv        35.172455  0.028069  0.522611  0.500000  1.000000\n",
      "==================================================\n",
      "\n",
      "Prompting Approach sarvari_2024_aggregation_preprocessor\n",
      "Extracting metadata from files:\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: eicu, Timestamp: 20250722_130446\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: hirid, Timestamp: 20250722_130446\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: miiv, Timestamp: 20250722_130446\n",
      "\n",
      "\n",
      "--- Approach Summary ---\n",
      "- Number of Samples: 300\n",
      "- Number of Requests: 300\n",
      "- Total Input Tokens: 588706\n",
      "- Total Output Tokens: 217737\n",
      "- Total Thinking Tokens: 0\n",
      "- Average Thinking Tokens: 0.00\n",
      "- Total Cost (USD): $5.03\n",
      "\n",
      "Preparing data for ClaudeSonnet4 PULSE score calculation...\n",
      "Model Type: LLM\n",
      "✓ No invalid predictions detected\n",
      "✅ Data format is correct for PULSE calculation!\n",
      "\n",
      "Data distribution by task:\n",
      "\n",
      "MORTALITY:\n",
      "  Total samples: 300\n",
      "  Positive labels: 30\n",
      "  Valid predictions: 300\n",
      "  Positive predictions: 254.0\n",
      "  Probability range: [0.250, 0.950]\n",
      "  Probability mean: 0.718\n",
      "\n",
      "Data types and unique values:\n",
      "  Target Label: int64, values: [0 1]\n",
      "  Predicted Diagnosis: object, values: ['mortality' 'not-mortality']\n",
      "  Predicted Probability: float64, values: [0.72 0.25 0.78 0.85 0.3 ]\n",
      "\n",
      "Data source information:\n",
      "  • Predictions from explicit prediction column\n",
      "  • Total samples: 300\n",
      "  • Tasks: mortality\n",
      "  • Datasets: eicu, hirid, miiv\n",
      "Calculating PULSE scores...\n",
      "✅ PULSE scores calculated successfully for ClaudeSonnet4!\n",
      "PULSE SCORE DETAILED REPORT\n",
      "Model Type: LLM\n",
      "Weights: AUPRC=0.33, AUROC=0.33, MCC=0.34\n",
      "\n",
      "OVERALL SCORES\n",
      "--------------------------------------------------\n",
      "              Metric      Value\n",
      "0      overall_score  54.432908\n",
      "1  overall_mortality  54.432908\n",
      "2       overall_eicu  59.381142\n",
      "\n",
      "TASK DATASET SCORES\n",
      "--------------------------------------------------\n",
      "                 pulse_score     auprc     auroc       mcc  ccf\n",
      "mortality_eicu     59.381142  0.457762  0.758065  0.566437  1.0\n",
      "mortality_hirid    47.439954  0.271933  0.624617  0.525112  1.0\n",
      "mortality_miiv     56.477628  0.363602  0.759470  0.571067  1.0\n",
      "==================================================\n",
      "\n",
      "Prompting Approach zhu_2024b_zero_shot_preprocessor\n",
      "Extracting metadata from files:\n",
      "Model Name: ClaudeSonnet4, Task: aki, Dataset: eicu, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: aki, Dataset: hirid, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: aki, Dataset: miiv, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: eicu, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: hirid, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: mortality, Dataset: miiv, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: sepsis, Dataset: eicu, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: sepsis, Dataset: hirid, Timestamp: 20250709_125732\n",
      "Model Name: ClaudeSonnet4, Task: sepsis, Dataset: miiv, Timestamp: 20250709_125732\n",
      "\n",
      "\n",
      "--- Approach Summary ---\n",
      "- Number of Samples: 6189\n",
      "- Number of Requests: 6189\n",
      "- Total Input Tokens: 24430757\n",
      "- Total Output Tokens: 6346975\n",
      "- Total Thinking Tokens: 0\n",
      "- Average Thinking Tokens: 0.00\n",
      "- Total Cost (USD): $168.50\n",
      "\n",
      "Preparing data for ClaudeSonnet4 PULSE score calculation...\n",
      "Model Type: LLM\n",
      "✓ No invalid predictions detected\n",
      "✅ Data format is correct for PULSE calculation!\n",
      "\n",
      "Data distribution by task:\n",
      "\n",
      "AKI:\n",
      "  Total samples: 2950\n",
      "  Positive labels: 693\n",
      "  Valid predictions: 2950\n",
      "  Positive predictions: 404.0\n",
      "  Probability range: [0.020, 0.980]\n",
      "  Probability mean: 0.229\n",
      "\n",
      "MORTALITY:\n",
      "  Total samples: 300\n",
      "  Positive labels: 30\n",
      "  Valid predictions: 300\n",
      "  Positive predictions: 248.0\n",
      "  Probability range: [0.250, 0.880]\n",
      "  Probability mean: 0.696\n",
      "\n",
      "SEPSIS:\n",
      "  Total samples: 2939\n",
      "  Positive labels: 145\n",
      "  Valid predictions: 2939\n",
      "  Positive predictions: 2644.0\n",
      "  Probability range: [0.230, 0.950]\n",
      "  Probability mean: 0.756\n",
      "\n",
      "Data types and unique values:\n",
      "  Target Label: int64, values: [0 1]\n",
      "  Predicted Diagnosis: object, values: ['not-aki' 'aki' 'mortality' 'not-mortality' 'sepsis']\n",
      "  Predicted Probability: float64, values: [0.25 0.15 0.92 0.95 0.35]\n",
      "\n",
      "Data source information:\n",
      "  • Predictions from explicit prediction column\n",
      "  • Total samples: 6189\n",
      "  • Tasks: aki, mortality, sepsis\n",
      "  • Datasets: eicu, hirid, miiv\n",
      "Calculating PULSE scores...\n",
      "✅ PULSE scores calculated successfully for ClaudeSonnet4!\n",
      "PULSE SCORE DETAILED REPORT\n",
      "Model Type: LLM\n",
      "Weights: AUPRC=0.33, AUROC=0.33, MCC=0.34\n",
      "\n",
      "OVERALL SCORES\n",
      "--------------------------------------------------\n",
      "              Metric      Value\n",
      "0      overall_score  49.166347\n",
      "1        overall_aki  54.825711\n",
      "2       overall_eicu  47.841237\n",
      "3  overall_mortality  54.177374\n",
      "4      overall_hirid  48.192043\n",
      "5     overall_sepsis  38.495956\n",
      "6       overall_miiv  51.465761\n",
      "\n",
      "TASK DATASET SCORES\n",
      "--------------------------------------------------\n",
      "                 pulse_score     auprc     auroc       mcc       ccf\n",
      "aki_eicu           59.702244  0.471441  0.663879  0.657149  0.998222\n",
      "aki_hirid          48.769313  0.262412  0.618847  0.579373  0.999776\n",
      "aki_miiv           56.005575  0.424622  0.615998  0.637594  0.999766\n",
      "mortality_eicu     45.218665  0.095806  0.687404  0.572852  0.997700\n",
      "mortality_hirid    49.343938  0.335575  0.613892  0.530913  0.999200\n",
      "mortality_miiv     67.969519  0.584008  0.848958  0.612290  0.998000\n",
      "sepsis_eicu        38.602802  0.061128  0.556213  0.536192  1.000000\n",
      "sepsis_hirid       46.462877  0.201828  0.673847  0.516635  1.000000\n",
      "sepsis_miiv        30.422189  0.019255  0.388207  0.499292  1.000000\n"
     ]
    },
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "hybrid_reasoning_agent_preprocessor",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "sarvari_2024_aggregation_preprocessor",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "zhu_2024b_zero_shot_preprocessor",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "af606328-34a3-4237-b093-183b1555c408",
       "rows": [
        [
         "input_cost",
         "52.538301000000004",
         "1.766118",
         "73.292271"
        ],
        [
         "output_cost",
         "195.62269500000002",
         "3.266055",
         "95.20462500000001"
        ],
        [
         "thinking_cost",
         "0.0",
         "0.0",
         "0.0"
        ],
        [
         "total_cost",
         "248.16099600000004",
         "5.032173",
         "168.49689600000002"
        ]
       ],
       "shape": {
        "columns": 3,
        "rows": 4
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>hybrid_reasoning_agent_preprocessor</th>\n",
       "      <th>sarvari_2024_aggregation_preprocessor</th>\n",
       "      <th>zhu_2024b_zero_shot_preprocessor</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>input_cost</th>\n",
       "      <td>52.538301</td>\n",
       "      <td>1.766118</td>\n",
       "      <td>73.292271</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>output_cost</th>\n",
       "      <td>195.622695</td>\n",
       "      <td>3.266055</td>\n",
       "      <td>95.204625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>thinking_cost</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_cost</th>\n",
       "      <td>248.160996</td>\n",
       "      <td>5.032173</td>\n",
       "      <td>168.496896</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "               hybrid_reasoning_agent_preprocessor  \\\n",
       "input_cost                               52.538301   \n",
       "output_cost                             195.622695   \n",
       "thinking_cost                             0.000000   \n",
       "total_cost                              248.160996   \n",
       "\n",
       "               sarvari_2024_aggregation_preprocessor  \\\n",
       "input_cost                                  1.766118   \n",
       "output_cost                                 3.266055   \n",
       "thinking_cost                               0.000000   \n",
       "total_cost                                  5.032173   \n",
       "\n",
       "               zhu_2024b_zero_shot_preprocessor  \n",
       "input_cost                            73.292271  \n",
       "output_cost                           95.204625  \n",
       "thinking_cost                          0.000000  \n",
       "total_cost                           168.496896  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Best prompt approach: hybrid_reasoning_agent_preprocessor with PULSE score: 57.31233135653227\n",
      "Saved 21 result entries to C:\\Users\\janbe\\Documents\\GitHub Repos\\pulse\\output_to_keep\\results_benchmark\\results_output\\jsons\\claudesonnet4_results.json\n"
     ]
    }
   ],
   "source": [
    "model_id = \"claudesonnet4\"\n",
    "base_output_dir = (\n",
    "    r\"C:\\Users\\janbe\\Documents\\GitHub Repos\\pulse\\output_to_keep\\results_benchmark\"\n",
    ")\n",
    "model_output_dir = os.path.join(base_output_dir, \"llms\", model_id)\n",
    "results_output_dir = os.path.join(base_output_dir, r\"results_output\")\n",
    "\n",
    "\n",
    "prompt_approaches = os.listdir(model_output_dir)\n",
    "print(prompt_approaches)\n",
    "\n",
    "# Try to load results_dict from json before calculating\n",
    "results_loaded = False\n",
    "results_output_jsons = os.path.join(results_output_dir, \"jsons\")\n",
    "results_json_path = f\"{model_id}_results.json\"\n",
    "\n",
    "if not results_loaded:\n",
    "    best_prompt_approach = None\n",
    "\n",
    "    results_dict = {}\n",
    "    mdata_dict = {}\n",
    "    cost_df = pd.DataFrame()\n",
    "\n",
    "    for prompt_approach in prompt_approaches:\n",
    "\n",
    "        if not os.path.isdir(os.path.join(model_output_dir, prompt_approach)):\n",
    "            continue\n",
    "\n",
    "        print(\"=\" * 50)\n",
    "        print(f\"\\nPrompting Approach {prompt_approach}\")\n",
    "\n",
    "        cat_files = LLMAnalyzer.categorize_files(\n",
    "            [os.path.join(model_output_dir, prompt_approach)],\n",
    "            verbose=False,\n",
    "        )\n",
    "\n",
    "        df_mdata = LLMAnalyzer.load_metadata(cat_files[\"metadata_files\"], verbose=True)\n",
    "        summary = LLMAnalyzer.print_approach_summary(\n",
    "            df_mdata, input_token_cost=3, output_token_cost=15\n",
    "        )\n",
    "\n",
    "        # Filter for final prediction step if agent is used\n",
    "\n",
    "        if \"Step Name\" in df_mdata.columns:\n",
    "\n",
    "            df_mdata = df_mdata[\n",
    "                df_mdata[\"Step Name\"] == \"final_prediction\"\n",
    "            ].reset_index(drop=True)\n",
    "\n",
    "        ps = PULSEScoreCalculator()\n",
    "\n",
    "        pulse_score = ps.calculate_pulse_score_from_raw_data(\n",
    "            df=df_mdata,\n",
    "        )\n",
    "        pulse_score[\"model_id\"] = model_id\n",
    "        pulse_score[\"prompting_id\"] = prompt_approach\n",
    "\n",
    "        pulse_score_temp = pulse_score[\"overall\"][\"overall_score\"]\n",
    "\n",
    "        results_dict[prompt_approach] = pulse_score\n",
    "        mdata_dict[prompt_approach] = df_mdata\n",
    "        cost_df[prompt_approach] = [\n",
    "            summary[\"input_cost\"].sum(),\n",
    "            summary[\"output_cost\"].sum(),\n",
    "            summary[\"thinking_cost\"].sum(),\n",
    "            summary[\"total_cost\"].sum(), # Reasoning Tokens included in output cost\n",
    "        ]\n",
    "        cost_df.index = [\"input_cost\", \"output_cost\", \"thinking_cost\", \"total_cost\"]\n",
    "\n",
    "        if best_prompt_approach is None or pulse_score_temp > best_prompt_approach[1]:\n",
    "\n",
    "            best_prompt_approach = (prompt_approach, pulse_score_temp)\n",
    "\n",
    "    display(cost_df)\n",
    "\n",
    "    print(\n",
    "        f\"\\nBest prompt approach: {best_prompt_approach[0]} with PULSE score: {best_prompt_approach[1]}\"\n",
    "    )\n",
    "\n",
    "    # Save results as json. Uses pulse-result format\n",
    "    json_output_path = os.path.join(results_output_jsons, f\"{model_id}_results.json\")\n",
    "    LLMAnalyzer.save_results_dict_as_json(\n",
    "        results_dict, json_output_path\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "31ffe63c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "Input Prompt",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Target Label",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "Predicted Probability",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Predicted Diagnosis",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Predicted Explanation",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Tokenization Time",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "Inference Time",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "Input Tokens",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "Output Tokens",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "Thinking Tokens",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "Thinking Output",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "model_name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "task",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "dataset",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "timestamp",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "24f1014c-00e0-4636-8aee-281e66a3f18f",
       "rows": [
        [
         "0",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 0, age: 71.0, sex: Male, weight: 89.8, height: 182.9\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=22.000, max=26.000, mean=24.240\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=18.000, max=23.000, mean=20.200\nCalcium (unit: mg/dL): min=9.300, max=10.000, mean=9.608\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=106.000, max=108.000, mean=106.880\nCreatinine (unit: mg/dL): min=0.890, max=1.050, mean=0.960\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=48.000, max=64.500, mean=54.220\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=104.000, max=177.500, mean=129.020\nHemoglobin (unit: g/dL): min=11.300, max=14.000, mean=12.488\nHeart Rate (unit: bpm): min=108.000, max=118.500, mean=111.740\ninr (unit: ): min=1.200, max=1.300, mean=1.204\nPotassium (unit: mmol/L): min=4.400, max=4.800, mean=4.576\nLactate (unit: mmol/L): min=1.400, max=1.400, mean=1.400\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=62.500, max=77.500, mean=68.780\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=30.400, max=31.400, mean=30.960\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.400, max=33.400, mean=32.960\nMean Corpuscular Volume (MCV) (unit: fL): min=93.900, max=94.000, mean=93.956\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.300, max=2.300, mean=1.860\nSodium (unit: mmol/L): min=135.000, max=137.000, mean=135.880\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=92.000, max=99.000, mean=96.520\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.500, max=2.900, mean=2.676\nPlatelets (unit: 1000/µL): min=184.000, max=323.000, mean=245.160\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=31.800, max=103.800, mean=75.720\nRespiratory Rate (unit: breaths/min): min=5.000, max=24.000, mean=17.560\nSystolic Blood Pressure (unit: mmHg): min=91.000, max=115.500, mean=104.460\nTemperature (unit: °C): min=37.211, max=37.789, mean=37.555\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=40.000, max=190.000, mean=84.600\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=9.500, max=22.500, mean=15.220",
         "0",
         "0.72",
         "mortality",
         "Septic shock presentation: severe inflammation (CRP 76.25 mg/L), hypotension (MAP 68.78 mmHg), tachycardia (HR 111.74 bpm), left shift with bands 8%, lymphopenia 9%, coagulopathy (PTT up to 103.8 sec), hypoalbuminemia 2.8 g/dL, and oliguria (minimum 40 mL/h). Requiring oxygen support (FiO2 40%).",
         "0",
         "0",
         "1962",
         "844",
         "0",
         "Let me analyze this patient's data systematically to assess mortality risk:\n\n**Age and Demographics:**\n- 71-year-old male, which is already a risk factor\n\n**Critical indicators to look for:**\n1. Lactate levels - 1.400 mmol/L (normal is <2, so this is normal)\n2. CRP - 76.250 mg/L (very elevated, normal <3 mg/L) - indicates significant inflammation/infection\n3. Blood pressure - MAP 62.5-77.5 mmHg (mean 68.78) - this is low, hypotensive\n4. Heart rate - 108-118.5 bpm (mean 111.74) - tachycardic\n5. WBC - 9.5-22.5 (mean 15.22) - elevated, indicates infection/inflammation\n6. Band neutrophils - 8% (elevated, normal <3%) - left shift indicating infection\n7. Neutrophils - 80.7% (elevated)\n8. Lymphocytes - 9% (low, normal 20-40%) - lymphopenia\n9. FiO2 - 40% (requiring supplemental oxygen)\n10. Oxygen saturation - 92-99% (mean 96.52%) - lower end concerning\n11. Temperature - 37.2-37.8?C (mean 37.6?C) - mild fever\n12. PTT - 31.8-103.8 sec (mean 75.72) - very prolonged, indicates coagulopathy\n13. Albumin - 2.8 g/dL (low, normal 3.4-5.4) - hypoalbuminemia\n14. Urine output - 40-190 mL/h (mean 84.6) - the minimum of 40 mL/h is concerning for oliguria\n\n**Concerning findings:**\n- Sepsis picture: high CRP (76.25), elevated WBC with left shift (bands 8%), lymphopenia (9%), fever\n\n\n- Multiple organ systems showing compromise: cardiovascular instability, potential renal dysfunction, and inflammatory response\n\nI'm seeing a complex clinical picture of systemic inflammation with multiple organ involvement. The patient's hemodynamic parameters reveal significant physiological stress. Despite normal lactate, the constellation of findings suggests a serious inflammatory process with potential progression to multi-organ dysfunction. The combination of low blood pressure, elevated heart rate, coagulation abnormalities, and reduced urine output indicates a critical clinical state requiring aggressive intervention and close monitoring.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "1",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 1, age: 55.0, sex: Female, weight: 89.3, height: 175.3\nAlbumin (unit: g/dL): min=2.800, max=3.400, mean=3.328\nAlkaline Phosphatase (unit: U/L): min=78.000, max=98.000, mean=95.600\nAlanine Aminotransferase (ALT) (unit: U/L): min=18.000, max=28.000, mean=19.200\nAspartate Aminotransferase (AST) (unit: U/L): min=27.000, max=34.000, mean=27.840\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=29.000, mean=28.280\nTotal Bilirubin (unit: mg/dL): min=0.100, max=0.700, mean=0.280\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=10.000, max=21.000, mean=11.320\nCalcium (unit: mg/dL): min=8.200, max=8.200, mean=8.200\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=108.000, mean=107.640\nCreatinine (unit: mg/dL): min=0.780, max=1.080, mean=0.816\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=40.000, max=110.000, mean=73.920\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=109.000, max=175.000, mean=131.840\nHemoglobin (unit: g/dL): min=10.300, max=10.400, mean=10.388\nHeart Rate (unit: bpm): min=56.500, max=75.500, mean=66.500\ninr (unit: ): min=1.000, max=1.300, mean=1.036\nPotassium (unit: mmol/L): min=4.000, max=4.600, mean=4.528\nLactate (unit: mmol/L): min=0.900, max=1.900, mean=1.020\nLymphocytes (unit: %): min=9.000, max=16.100, mean=15.248\nMean Arterial Pressure (MAP) (unit: mmHg): min=59.000, max=121.000, mean=87.040\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.300, max=29.900, mean=28.492\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.300, max=33.000, mean=32.384\nMean Corpuscular Volume (MCV) (unit: fL): min=87.800, max=90.000, mean=88.064\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=139.000, max=141.000, mean=140.760\nNeutrophils (unit: %): min=77.400, max=80.700, mean=77.796\nOxygen Saturation (unit: %): min=86.000, max=97.000, mean=93.740\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.400, mean=3.388\nPlatelets (unit: 1000/µL): min=182.000, max=205.000, mean=202.240\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=33.400, max=35.500, mean=33.820\nRespiratory Rate (unit: breaths/min): min=10.000, max=17.500, mean=14.560\nSystolic Blood Pressure (unit: mmHg): min=101.000, max=167.000, mean=128.300\nTemperature (unit: °C): min=36.500, max=37.394, mean=36.866\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=1900.000, mean=306.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=18.500, mean=17.600",
         "0",
         "0.25",
         "not-mortality",
         "Mixed clinical picture: severe inflammation (CRP 76.25 mg/L, WBC 17.6 with 8% bands) and mild respiratory compromise (O2 sat minimum 86%, FiO2 40%), but preserved organ function with normal creatinine (0.816 mg/dL), adequate urine output (mean 306 mL/h), low-normal lactate (mean 1.02 mmol/L), and stable hemodynamics (MAP mean 87 mmHg).",
         "0",
         "0",
         "1963",
         "1088",
         "0",
         "Let me analyze this patient data systematically to determine mortality risk.\n\nLooking at the key indicators:\n\n**Vital Signs:**\n- Age: 55, Female, BMI around 29.0 (89.3kg, 175.3cm)\n- Heart rate: 56.5-75.5 bpm (mean 66.5) - normal range\n- Blood pressure: Systolic 101-167 (mean 128), Diastolic 40-110 (mean 73.9), MAP 59-121 (mean 87) - some concerning low diastolic readings (40 mmHg is quite low)\n- Temperature: 36.5-37.394?C (mean 36.866) - normal to slightly elevated\n- Respiratory rate: 10-17.5 (mean 14.56) - normal\n\n**Oxygenation:**\n- FiO2: 40% - indicates supplemental oxygen requirement\n- Oxygen saturation: 86-97% (mean 93.74%) - concerning low values, especially minimum of 86%\n- PaO2: 101 mmHg - adequate\n- PaCO2: 40 mmHg - normal\n- pH: 7.36 - slightly acidic but within normal range\n\n**Laboratory values:**\n- Lactate: 0.9-1.9 mmol/L (mean 1.02) - slightly elevated but not critically high\n- WBC: 11-18.5 (mean 17.6) - elevated, indicating infection/inflammation\n- CRP: 76.25 mg/L - very elevated, indicating significant inflammation\n- Band neutrophils: 8% - indicates left shift/infection\n- Neutrophils: 77.4-80.7% - elevated\n- Lymphocytes: 9-16.1% - low (lymphopenia)\n\n**Organ function:**\n- Creatinine: 0.78-1.08 mg/dL (mean 0.816) - normal\n\n\n- BUN and liver enzymes appear stable, with albumin slightly low. Troponin T suggests potential cardiac involvement, warranting careful monitoring of cardiac markers and overall inflammatory response.\n\nKey clinical observations reveal significant systemic challenges:\n- Marked inflammatory state with extremely elevated CRP\n- Substantial infection evidenced by high WBC and left shift\n- Respiratory compromise indicated by low oxygen saturation and increased oxygen support\n- Hemodynamic instability with critically low diastolic blood pressure\n- Mild anemia and lymphopenia further complicating patient's clinical picture\n\nComprehensive assessment suggests a complex, multi-system inflammatory process requiring aggressive intervention and close clinical surveillance.\n\nDespite serious inflammatory markers, organ systems demonstrate remarkable resilience. Kidney and liver functions remain stable, urine output maintains adequacy, and lactate levels do not indicate profound metabolic derangement.\n\nMortality risk appears moderate - serious infection present, but without catastrophic multi-organ failure. Patient requires intensive monitoring and targeted therapeutic strategies.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "2",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 10, age: 50.0, sex: Female, weight: 59.0, height: 157.5\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=22.000, max=23.000, mean=22.800\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=27.000, mean=22.200\nCalcium (unit: mg/dL): min=8.200, max=8.900, mean=8.340\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=113.000, mean=106.600\nCreatinine (unit: mg/dL): min=1.080, max=1.220, mean=1.108\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=56.000, max=74.000, mean=65.560\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=136.000, max=166.000, mean=142.000\nHemoglobin (unit: g/dL): min=10.300, max=10.800, mean=10.620\nHeart Rate (unit: bpm): min=73.000, max=107.000, mean=85.940\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.600, max=4.000, mean=3.920\nLactate (unit: mmol/L): min=0.700, max=1.900, mean=0.748\nLymphocytes (unit: %): min=7.300, max=9.000, mean=7.572\nMean Arterial Pressure (MAP) (unit: mmHg): min=75.000, max=87.000, mean=82.000\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=31.500, mean=31.116\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.000, mean=33.000\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=95.400, mean=94.088\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=139.000, max=145.000, mean=140.200\nNeutrophils (unit: %): min=80.700, max=89.100, mean=87.756\nOxygen Saturation (unit: %): min=85.500, max=93.000, mean=89.700\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.200, max=3.300, mean=3.280\nPlatelets (unit: 1000/µL): min=84.000, max=182.000, mean=105.280\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=20.000, max=27.000, mean=22.480\nSystolic Blood Pressure (unit: mmHg): min=100.000, max=131.000, mean=109.400\nTemperature (unit: °C): min=36.817, max=38.000, mean=37.183\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=25.000, max=300.000, mean=146.400\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=9.200, max=11.000, mean=10.576",
         "0",
         "0.78",
         "mortality",
         "Sepsis with multi-organ dysfunction: CRP 76.25 mg/L (severe inflammation), neutrophilia 87.8% with 8% bands (left shift), lymphopenia 7.6%, hypoxemia (O2 sat 85.5-93%), acute kidney injury (creatinine 1.08-1.22 mg/dL, oliguria min 25 mL/h), thrombocytopenia (platelets 84-182), and coagulopathy (INR 1.3).",
         "0",
         "0",
         "1962",
         "678",
         "0",
         "Let me analyze this patient data systematically for mortality risk indicators:\n\nKey concerning findings:\n1. CRP is elevated at 76.25 mg/L - this indicates significant inflammation/infection\n2. Band neutrophils at 8% - this suggests a left shift in white cells (infection/sepsis)\n3. Neutrophils very high at 80.7-89.1% (mean 87.756%) - significant neutrophilia\n4. Lymphocytes very low at 7.3-9% (mean 7.572%) - lymphopenia suggests immune suppression\n5. Oxygen saturation concerning at 85.5-93% (mean 89.7%) - hypoxemia\n6. Urine output variable from 25-300 mL/h (mean 146.4) - the minimum of 25 mL/h is very concerning for oliguria\n7. Creatinine elevated at 1.08-1.22 mg/dL - acute kidney injury\n8. BUN elevated at 21-27 mg/dL \n9. Hemoglobin low at 10.3-10.8 g/dL - anemia\n10. Platelets low at 84-182 (mean 105.28) - thrombocytopenia\n11. Temperature range 36.8-38?C suggests fever\n12. INR elevated at 1.3 - coagulopathy\n13. Albumin low at 2.8 g/dL - hypoalbuminemia\n\nPositive findings:\n- FiO2 only 40% (not extremely high)\n- Lactate relatively normal at 0.7-1.9 mmol/L\n- Blood pressure stable (MAP 75-87)\n- pH normal at 7.36\n\nThis patient shows signs of sepsis with multi-organ involvement:\n- Infection markers (high CRP, neutrophilia with left shift, fever)\n\n\n- Respiratory compromise (low oxygen saturation)\n- Renal dysfunction with reduced urine output\n- Potential coagulation and inflammatory cascades triggering systemic complications\n\nI'm seeing critical interconnected pathological processes that dramatically elevate mortality risk. The systemic inflammatory response is compromising multiple organ systems simultaneously - respiratory, renal, and hematologic. Each dysfunction amplifies the patient's vulnerability, creating a potentially fatal cascade of physiological breakdown.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "3",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 11, age: 50.0, sex: Male, weight: 80.0, height: 170.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-7.000, max=-7.000, mean=-7.000\nBicarbonate (unit: mmol/L): min=19.000, max=20.000, mean=19.400\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=16.000, max=16.000, mean=16.000\nCalcium (unit: mg/dL): min=7.900, max=9.000, mean=8.340\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=111.000, max=112.000, mean=111.600\nCreatinine (unit: mg/dL): min=1.040, max=1.080, mean=1.064\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=47.000, max=69.500, mean=58.060\nFibrinogen (unit: mg/dL): min=234.000, max=234.000, mean=234.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=45.000, mean=40.400\nGlucose (unit: mg/dL): min=100.000, max=174.000, mean=129.880\nHemoglobin (unit: g/dL): min=10.300, max=12.400, mean=11.208\nHeart Rate (unit: bpm): min=80.000, max=102.000, mean=89.340\ninr (unit: ): min=1.100, max=1.200, mean=1.160\nPotassium (unit: mmol/L): min=4.000, max=5.100, mean=4.440\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=62.000, max=84.000, mean=72.120\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.400, max=29.700, mean=29.564\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.500, max=32.800, mean=32.752\nMean Corpuscular Volume (MCV) (unit: fL): min=89.900, max=90.500, mean=90.196\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.000, mean=1.940\nSodium (unit: mmol/L): min=137.000, max=138.000, mean=137.600\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=93.000, max=100.000, mean=97.020\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=34.000, max=34.000, mean=34.000\npH Level (unit: /): min=7.340, max=7.340, mean=7.340\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=81.000, max=101.000, mean=89.920\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=131.000, max=131.000, mean=131.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=30.700, max=30.700, mean=30.700\nRespiratory Rate (unit: breaths/min): min=11.000, max=24.000, mean=16.800\nSystolic Blood Pressure (unit: mmHg): min=87.000, max=138.000, mean=107.440\nTemperature (unit: °C): min=36.289, max=38.894, mean=37.734\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=30.000, max=425.000, mean=113.400\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=7.100, max=8.600, mean=7.516",
         "0",
         "0.85",
         "mortality",
         "Critical sepsis with multi-organ dysfunction: CRP severely elevated at 76.250 mg/L, metabolic acidosis (base excess -7.000 mmol/L, bicarbonate 19.000-20.000 mmol/L), cardiac injury (troponin T 0.140 ng/mL), thrombocytopenia (platelets 81.000-101.000), immunosuppression (lymphocytes 9%), hypocalcemia (7.900 mg/dL), hypotension episodes (MAP minimum 62.000 mmHg), and oliguria (minimum urine output 30.000 mL/h).",
         "0",
         "0",
         "1962",
         "841",
         "0",
         "Let me analyze this patient data systematically to identify any concerning abnormal values that might indicate mortality risk:\n\nKey abnormal findings:\n\n1. **Base Excess: -7.000 mmol/L** (normal range is typically -3 to +3) - This indicates metabolic acidosis\n2. **Bicarbonate: 19.000-20.000 mmol/L** (normal 22-28) - Low, consistent with acidosis\n3. **Band Neutrophils: 8.000%** (normal <3%) - This is elevated, suggesting infection/sepsis\n4. **Calcium: 7.900-9.000 mg/dL** (normal 8.5-10.5) - Hypocalcemia\n5. **C-Reactive Protein: 76.250 mg/L** (normal <3.0) - Very high, indicating severe inflammation/infection\n6. **Diastolic BP: 47.000-69.500 mmHg** - Some readings quite low\n7. **FiO2: 40-45%** - Patient requires supplemental oxygen\n8. **Lactate: 1.900 mmol/L** (normal <2.0) - Borderline elevated\n9. **Lymphocytes: 9.000%** (normal 20-40%) - Very low, immunosuppression\n10. **MAP: 62.000-84.000 mmHg** - Some readings low (normal >65)\n11. **Neutrophils: 80.700%** (normal 50-70%) - Elevated\n12. **pH: 7.340** (normal 7.35-7.45) - Slightly acidic\n13. **PaCO2: 34.000 mmHg** (normal 35-45) - Low, compensating for acidosis\n14. **Platelets: 81.000-101.000** (normal 150-450) - Thrombocytopenia\n\n\n15. **Temperature: max 38.894?C** - Fever\n16. **Troponin T: 0.140 ng/mL** (normal <0.04) - Elevated, cardiac injury\n17. **Urine output: min 30.000 mL/h** - Oliguria at times\n\nAdditional critical observations emerge: the patient exhibits fever and reduced urine output, further complicating the clinical picture. Elevated troponin suggests potential myocardial damage, while intermittent oliguria indicates possible renal compromise. These findings compound the existing concerns of systemic inflammation, metabolic derangement, and potential organ dysfunction.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "4",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 12, age: 59.0, sex: Female, weight: 134.0, height: 170.2\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=25.000, mean=24.680\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=25.000, mean=24.360\nCalcium (unit: mg/dL): min=8.200, max=9.200, mean=9.040\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=100.000, max=105.000, mean=100.800\nCreatinine (unit: mg/dL): min=1.080, max=1.250, mean=1.223\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=57.000, max=103.000, mean=74.760\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=111.000, max=136.000, mean=115.000\nHemoglobin (unit: g/dL): min=10.300, max=12.500, mean=12.148\nHeart Rate (unit: bpm): min=65.000, max=131.500, mean=102.560\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.300, mean=4.252\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=24.000, mean=21.600\nMean Arterial Pressure (MAP) (unit: mmHg): min=71.000, max=111.000, mean=89.540\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.800, max=29.900, mean=28.976\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.300, mean=33.252\nMean Corpuscular Volume (MCV) (unit: fL): min=86.400, max=90.000, mean=86.976\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=136.000, max=139.000, mean=136.480\nNeutrophils (unit: %): min=65.000, max=80.700, mean=67.512\nOxygen Saturation (unit: %): min=94.000, max=97.000, mean=96.160\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=182.000, max=295.000, mean=276.920\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=19.000, max=20.000, mean=19.200\nSystolic Blood Pressure (unit: mmHg): min=96.000, max=142.000, mean=121.920\nTemperature (unit: °C): min=36.578, max=36.890, mean=36.674\nTroponin T (unit: ng/mL): min=0.010, max=0.140, mean=0.031\nUrine Output (unit: mL/h): min=100.000, max=500.000, mean=310.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=12.200, mean=12.008",
         "0",
         "0.3",
         "not-mortality",
         "Moderate risk profile: elevated inflammatory markers (CRP 76.25 mg/L, WBC 12.0, band neutrophils 8%) and kidney dysfunction (creatinine 1.25 mg/dL), but lactate normal at 1.9 mmol/L, adequate urine output 310 mL/h, modest oxygen support (FiO2 40%), and stable pH 7.36 indicate manageable condition.",
         "0",
         "0",
         "1962",
         "696",
         "0",
         "Let me analyze this patient data carefully to assess the probability of mortality.\n\nKey concerning findings:\n1. CRP is elevated at 76.250 mg/L (normal is typically <3 mg/L) - suggests significant inflammation/infection\n2. BUN is elevated at 21-25 mg/dL (normal is typically 6-24 mg/dL) - borderline high\n3. Creatinine is elevated at 1.080-1.250 mg/dL (normal for women is typically 0.6-1.1 mg/dL) - suggests kidney dysfunction\n4. WBC count is elevated at 11.0-12.2 (normal is typically 4.5-11.0) - suggests infection/inflammation\n5. Band neutrophils at 8% (normal is typically <6%) - suggests bacterial infection\n6. INR is elevated at 1.3 (normal is typically <1.1) - suggests coagulation dysfunction\n7. Heart rate shows wide range (65-131.5 bpm) with mean 102.56 - suggests possible instability\n8. Blood pressure shows wide range - diastolic 57-103, systolic 96-142\n9. Albumin is low at 2.8 g/dL (normal is typically 3.5-5.0 g/dL) - suggests poor nutritional status or liver dysfunction\n\nPositive findings:\n1. Lactate is normal at 1.9 mmol/L (normal is <2.0 mmol/L)\n2. FiO2 is only 40% - not requiring high oxygen support\n3. Oxygen saturation is adequate at 94-97%\n4. pH is normal at 7.36\n5. Urine output is adequate at 100-500 mL/h (mean 310 mL/h)\n6. Temperature is normal\n7. Troponin T is low at 0.01-0.14 ng/mL\n \nThe clinical picture reveals a complex medical scenario with multiple inflammatory markers and mild organ dysfunction. Despite several concerning indicators, the patient's compensatory mechanisms appear partially intact. I assess the mortality risk as moderate, approximately 30%, reflecting the nuanced interplay between pathological signs and preserved physiological resilience.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "5",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 13, age: 51.0, sex: Male, weight: 86.6, height: 176.5\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=30.000, mean=26.360\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=6.000, max=21.000, mean=13.800\nCalcium (unit: mg/dL): min=8.200, max=8.900, mean=8.536\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=97.000, max=105.000, mean=101.160\nCreatinine (unit: mg/dL): min=0.550, max=1.080, mean=0.826\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=68.000, max=105.000, mean=93.360\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=80.000, max=138.000, mean=87.000\nHemoglobin (unit: g/dL): min=10.300, max=14.600, mean=12.364\nHeart Rate (unit: bpm): min=70.500, max=100.000, mean=82.540\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.500, max=4.000, mean=3.760\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=19.400, mean=13.992\nMean Arterial Pressure (MAP) (unit: mmHg): min=92.000, max=134.000, mean=113.980\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=33.900, mean=31.820\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.800, mean=33.384\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=100.200, mean=94.896\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.800, max=1.900, mean=1.804\nSodium (unit: mmol/L): min=135.000, max=139.000, mean=137.080\nNeutrophils (unit: %): min=63.100, max=80.700, mean=72.252\nOxygen Saturation (unit: %): min=95.000, max=100.000, mean=97.840\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.900, max=3.300, mean=2.916\nPlatelets (unit: 1000/µL): min=116.000, max=182.000, mean=150.320\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=13.000, max=22.000, mean=16.540\nSystolic Blood Pressure (unit: mmHg): min=120.000, max=164.000, mean=143.360\nTemperature (unit: °C): min=36.683, max=37.289, mean=36.843\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=600.000, mean=422.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=6.800, max=11.000, mean=8.984",
         "0",
         "0.25",
         "not-mortality",
         "Moderate illness with signs of infection: CRP elevated at 76.25 mg/L and band neutrophils 8%, but stable hemodynamics with MAP 92-134 mmHg, adequate oxygenation on FiO2 40%, normal lactate 1.9 mmol/L, and good urine output 100-600 mL/h indicating preserved organ perfusion.",
         "0",
         "0",
         "1962",
         "826",
         "0",
         "I need to analyze this ICU patient data to determine probability of mortality. Let me go through the key parameters that are often associated with poor outcomes:\n\n1. Age: 51 years old - middle age, not extreme\n2. Vital signs:\n   - Heart rate: 70.5-100 bpm (mean 82.5) - relatively stable range\n   - Blood pressure: Systolic 120-164 (mean 143), Diastolic 68-105 (mean 93) - elevated but not critically so\n   - MAP: 92-134 (mean 114) - adequate\n   - Temperature: 36.7-37.3?C - slightly elevated but not severe fever\n   - Respiratory rate: 13-22 (mean 16.5) - normal range\n\n3. Oxygenation/Ventilation:\n   - FiO2: 40% - mild oxygen requirement, not critically high\n   - Oxygen saturation: 95-100% (mean 97.8%) - good\n   - pH: 7.36 - slightly acidic but within acceptable range\n   - PaCO2: 40 mmHg - normal\n   - PaO2: 101 mmHg - good\n\n4. Lab values of concern:\n   - Lactate: 1.9 mmol/L - slightly elevated (normal <2.0), suggests mild hypoperfusion but not severe\n   - CRP: 76.25 mg/L - significantly elevated, indicates significant inflammation/infection\n   - Albumin: 2.8 g/dL - low (normal 3.4-5.4), suggests poor nutrition or liver dysfunction\n   - Band neutrophils: 8% - elevated, suggests bacterial infection\n   - Neutrophils: 63-80% - elevated\n   - Lymphocytes: 9-19% - lower end, consistent with acute illness\n   \nExamining organ function and coagulation parameters reveals some mild abnormalities. Kidney function shows slight impairment with creatinine and BUN mildly elevated, though urine output remains adequate. Liver enzymes appear normal, and bilirubin levels are within standard range. Coagulation studies indicate a minor disturbance with a slightly elevated INR, suggesting potential mild coagulation challenges.\n\nThe patient presents with inflammatory markers indicating an active infectious process. Despite these signs, the clinical picture suggests a patient who is compromised but not critically decompensated. Moderate physiological stress is evident, with manageable respiratory support and only mild lactate elevation, pointing to a state of controlled systemic response.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "6",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 14, age: 67.0, sex: Male, weight: 90.4, height: 170.2\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=24.000, mean=23.320\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=16.000, max=21.000, mean=19.400\nCalcium (unit: mg/dL): min=7.600, max=8.200, mean=8.008\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=109.000, mean=106.280\nCreatinine (unit: mg/dL): min=1.080, max=1.130, mean=1.096\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=59.000, max=92.000, mean=71.120\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=50.000, mean=49.600\nGlucose (unit: mg/dL): min=116.000, max=159.000, mean=147.920\nHemoglobin (unit: g/dL): min=10.300, max=13.600, mean=12.568\nHeart Rate (unit: bpm): min=52.000, max=99.500, mean=69.080\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.400, max=4.000, mean=3.808\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=73.000, max=110.000, mean=89.280\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.700, mean=30.156\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.800, mean=33.256\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=90.900, mean=90.288\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=139.000, max=141.000, mean=139.640\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=94.000, max=99.500, mean=97.900\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=122.000, max=182.000, mean=162.800\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=14.000, max=21.000, mean=14.560\nSystolic Blood Pressure (unit: mmHg): min=97.000, max=133.000, mean=118.020\nTemperature (unit: °C): min=36.422, max=37.317, mean=36.923\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=10.000, max=250.000, mean=61.160\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=8.900, max=11.000, mean=10.328",
         "0",
         "0.72",
         "mortality",
         "High-risk infection with multi-system involvement: severe inflammation (CRP 76.25 mg/L), bacterial infection markers (neutrophils 80.7%, bands 8%), hypoalbuminemia (2.8 g/dL), mild renal dysfunction (creatinine 1.13 mg/dL), requiring oxygen support (FiO2 50%), and oliguria (minimum 10 mL/h) indicating early organ dysfunction.",
         "0",
         "0",
         "1962",
         "626",
         "0",
         "Let me analyze this patient data systematically to assess mortality risk.\n\nKey concerning findings:\n1. C-Reactive Protein (CRP): 76.25 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n2. Low albumin: 2.8 g/dL (normal 3.5-5.0) - indicates malnutrition or synthetic dysfunction\n3. Elevated band neutrophils: 8% (normal <3%) - suggests bacterial infection\n4. Elevated neutrophils: 80.7% (normal 50-70%) - consistent with bacterial infection\n5. Low lymphocytes: 9% (normal 20-40%) - indicates immune suppression or severe illness\n6. Elevated creatinine: 1.08-1.13 mg/dL - mild kidney dysfunction \n7. Requiring oxygen support: FiO2 40-50% - respiratory compromise\n8. Low urine output range: minimum 10 mL/h - concerning for kidney dysfunction/shock\n9. Slightly elevated troponin: 0.14 ng/mL - suggests some cardiac stress\n10. INR 1.3 - mild coagulopathy\n11. Thrombocytopenia: platelets 122-182 (normal 150-450) - low end concerning\n\nPositive findings:\n- Lactate 1.9 mmol/L is only mildly elevated (normal <2)\n- Blood pressure and MAP are reasonable (MAP 73-110)\n- Heart rate not too high (52-99.5 bpm)\n- pH normal at 7.36\n- Temperature not severely elevated\n- Oxygen saturation decent at 94-99.5%\n\nThis patient shows signs of severe infection/inflammation with some organ dysfunction (kidney, mild cardiac stress, coagulopathy) but vital signs are relatively stable and lactate is not severely elevated. The very high CRP, bandemia, and other inflammatory markers are concerning but not immediately life-threatening.\n \nBased on the comprehensive clinical picture, I assess the patient's prognosis as quite serious. The multisystem inflammatory response and organ dysfunction suggest a substantial mortality risk, likely in the 60-70% range. While not immediately terminal, the patient requires aggressive intervention and close monitoring.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "7",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 15, age: 82.0, sex: Male, weight: 75.3, height: 175.3\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-4.000, max=-1.000, mean=-3.400\nBicarbonate (unit: mmol/L): min=19.000, max=24.000, mean=21.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=44.000, max=51.000, mean=48.200\nCalcium (unit: mg/dL): min=7.900, max=7.900, mean=7.900\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=857.000, mean=751.560\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=89.000, mean=75.752\nChloride (unit: mmol/L): min=107.000, max=110.000, mean=108.800\nCreatinine (unit: mg/dL): min=1.800, max=2.100, mean=1.980\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=40.000, max=60.000, mean=51.020\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=30.000, max=40.000, mean=32.000\nGlucose (unit: mg/dL): min=136.000, max=228.000, mean=177.280\nHemoglobin (unit: g/dL): min=7.800, max=7.800, mean=7.800\nHeart Rate (unit: bpm): min=75.000, max=126.500, mean=85.120\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.600, max=4.700, mean=4.640\nLactate (unit: mmol/L): min=1.200, max=1.200, mean=1.200\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=54.000, max=72.500, mean=65.100\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=33.100, max=33.100, mean=33.100\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.300, max=31.300, mean=31.300\nMean Corpuscular Volume (MCV) (unit: fL): min=105.500, max=105.500, mean=105.500\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=2.200, max=2.200, mean=2.200\nSodium (unit: mmol/L): min=144.000, max=148.000, mean=146.400\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=97.000, max=100.000, mean=99.780\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=31.900, max=40.000, mean=33.520\npH Level (unit: /): min=7.360, max=7.418, mean=7.406\nPhosphate (unit: mg/dL): min=3.900, max=3.900, mean=3.900\nPlatelets (unit: 1000/µL): min=122.000, max=122.000, mean=122.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=87.000, max=101.000, mean=89.800\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=20.000, max=31.000, mean=26.780\nSystolic Blood Pressure (unit: mmHg): min=79.000, max=105.000, mean=94.200\nTemperature (unit: °C): min=36.422, max=36.890, mean=36.804\nTroponin T (unit: ng/mL): min=0.140, max=2.870, mean=2.433\nUrine Output (unit: mL/h): min=0.000, max=100.000, mean=36.640\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=5.000, max=5.000, mean=5.000",
         "0",
         "0.78",
         "mortality",
         "High mortality risk in 82-year-old with acute MI (Troponin T mean 2.433 ng/mL, CK-MB mean 75.8 ng/mL), severe anemia (Hemoglobin 7.8 g/dL), renal failure (Creatinine mean 1.98 mg/dL, BUN mean 48.2 mg/dL), hypotension (MAP mean 65.1 mmHg), and oliguria (minimum urine output 0 mL/h).",
         "0",
         "0",
         "1962",
         "772",
         "0",
         "Let me analyze the patient data to assess mortality risk. This is an 82-year-old male patient in the ICU.\n\nKey concerning findings:\n1. Age 82 - advanced age is a risk factor\n2. Hemoglobin 7.8 g/dL - severe anemia (normal ~14-17 for males)\n3. Creatinine 1.8-2.1 mg/dL (mean 1.98) - significant kidney dysfunction\n4. BUN 44-51 mg/dL (mean 48.2) - elevated, indicating renal impairment\n5. CK-MB 6.2-89.0 ng/mL (mean 75.8) - very high, indicating cardiac muscle damage\n6. CK 198-857 U/L (mean 751.6) - very elevated creatine kinase\n7. Troponin T 0.14-2.87 ng/mL (mean 2.43) - very high, indicating myocardial infarction\n8. CRP 76.25 mg/L - high inflammatory marker\n9. Low calcium 7.9 mg/dL (normal ~8.5-10.5)\n10. Hypotension: systolic BP 79-105 mmHg (mean 94.2), diastolic 40-60 mmHg (mean 51)\n11. Low MAP 54-72.5 mmHg (mean 65.1) - borderline hypotension\n12. Urine output 0-100 mL/h (mean 36.6) - some periods of oliguria (0 mL/h recorded)\n13. Base excess -4 to -1 mmol/L - metabolic acidosis\n14. Low albumin 2.8 g/dL (normal ~3.5-5.0)\n\n\n15. Some positive indicators suggest potential for stabilization, including normal lactate levels, excellent oxygen saturation, and stable temperature.\n\nDespite some promising physiological parameters, the patient's overall clinical picture remains critically complex. Multiple organ systems show significant compromise, with cardiac, renal, and metabolic indicators pointing to severe systemic stress. The interplay of advanced age, profound physiological derangements, and multiple organ dysfunction creates an extremely high-risk scenario requiring aggressive, comprehensive medical intervention.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "8",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 16, age: 87.0, sex: Female, weight: 67.0, height: 160.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=28.000, mean=25.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=43.000, mean=29.800\nCalcium (unit: mg/dL): min=8.200, max=8.700, mean=8.400\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=98.000, max=105.000, mean=102.200\nCreatinine (unit: mg/dL): min=1.080, max=1.510, mean=1.252\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=42.000, max=77.000, mean=57.440\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=149.000, max=260.000, mean=215.680\nHemoglobin (unit: g/dL): min=10.200, max=10.300, mean=10.236\nHeart Rate (unit: bpm): min=63.000, max=97.500, mean=75.780\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.800, max=4.000, mean=3.920\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=63.000, max=99.500, mean=82.420\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=27.800, max=29.900, mean=29.060\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.900, max=33.000, mean=32.960\nMean Corpuscular Volume (MCV) (unit: fL): min=84.400, max=90.000, mean=87.760\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.000, mean=1.940\nSodium (unit: mmol/L): min=136.000, max=139.000, mean=137.800\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=91.000, max=96.000, mean=94.320\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=182.000, max=250.000, mean=209.200\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=18.000, max=25.000, mean=21.320\nSystolic Blood Pressure (unit: mmHg): min=90.000, max=141.000, mean=116.900\nTemperature (unit: °C): min=36.500, max=37.000, mean=36.723\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=80.000, max=280.000, mean=158.400\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=11.300, mean=11.120",
         "0",
         "0.75",
         "mortality",
         "High-risk profile: advanced age (87 years), severe systemic inflammation (CRP 76.25 mg/L), bacterial infection indicators (band neutrophils 8%, neutrophils 80.7%), acute kidney injury (creatinine 1.08-1.51 mg/dL, BUN 21-43 mg/dL), hypoalbuminemia (2.8 g/dL), and hyperglycemia (glucose 149-260 mg/dL) indicating stress response.",
         "0",
         "0",
         "1962",
         "725",
         "0",
         "Let me analyze this patient data carefully for mortality risk factors:\n\nPatient is 87 years old female, which is advanced age and increases mortality risk.\n\nLooking at key abnormal values:\n\n1. CRP = 76.25 mg/L - This is very elevated (normal <3 mg/L), indicating severe inflammation/infection\n2. Band Neutrophils = 8% - This is elevated (normal <3%), indicating left shift and bacterial infection\n3. Neutrophils = 80.7% - This is elevated (normal 50-70%), consistent with bacterial infection\n4. Lymphocytes = 9% - This is low (normal 20-40%), indicating immunosuppression\n5. BUN ranges 21-43 mg/dL with mean 29.8 - elevated (normal 7-20), indicating kidney dysfunction\n6. Creatinine ranges 1.08-1.51 mg/dL with mean 1.252 - elevated (normal 0.6-1.2 for elderly female), indicating acute kidney injury\n7. Glucose ranges 149-260 mg/dL with mean 215.68 - hyperglycemia, stress response\n8. INR = 1.3 - mildly elevated (normal <1.1), indicating coagulopathy\n9. Albumin = 2.8 g/dL - low (normal 3.5-5.0), indicating poor nutritional status/liver synthesis\n10. Hemoglobin = 10.2-10.3 g/dL - mild anemia\n\nSome positive factors:\n- FiO2 only 40%, not requiring high oxygen\n- Oxygen saturation 91-96% (mean 94.3%) - acceptable\n- Lactate = 1.9 mmol/L - only mildly elevated (normal <2.0)\n- MAP 63-99.5 mmHg (mean 82.4) - adequate perfusion\n\n\n- Urine output 80-280 mL/h (mean 158.4) - adequate kidney function\n\nThe patient presents a complex clinical picture with multiple concerning indicators. Multiple physiological systems show significant compromise: inflammatory markers are dramatically elevated, infection markers suggest bacterial involvement, and metabolic parameters indicate substantial stress. Despite some compensatory mechanisms like maintained blood pressure and oxygen saturation, the overall clinical profile suggests a precarious health status with substantial risk of adverse outcomes.\n\nI would estimate moderate to high mortality risk, around 70-75%.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "9",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 17, age: 76.0, sex: Male, weight: 112.8, height: 172.7\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=22.000, max=24.000, mean=22.080\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=29.000, max=49.000, mean=48.200\nCalcium (unit: mg/dL): min=7.800, max=8.100, mean=8.088\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=109.000, max=112.000, mean=109.120\nCreatinine (unit: mg/dL): min=0.770, max=0.870, mean=0.866\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=42.500, max=81.000, mean=58.120\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=84.000, max=255.000, mean=116.360\nHemoglobin (unit: g/dL): min=5.900, max=9.300, mean=7.792\nHeart Rate (unit: bpm): min=80.000, max=101.000, mean=87.860\ninr (unit: ): min=1.100, max=1.100, mean=1.100\nPotassium (unit: mmol/L): min=4.100, max=4.800, mean=4.772\nLactate (unit: mmol/L): min=0.800, max=2.900, mean=1.412\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=58.000, max=86.000, mean=71.420\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=26.400, max=27.400, mean=26.440\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.800, max=32.600, mean=31.832\nMean Corpuscular Volume (MCV) (unit: fL): min=82.900, max=83.900, mean=82.940\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.800, max=1.900, mean=1.804\nSodium (unit: mmol/L): min=139.000, max=140.000, mean=139.040\nNeutrophils (unit: %): min=82.500, max=82.500, mean=82.500\nOxygen Saturation (unit: %): min=85.500, max=100.000, mean=96.240\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.700, max=3.300, mean=3.276\nPlatelets (unit: 1000/µL): min=221.000, max=270.000, mean=268.040\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=22.600, max=22.600, mean=22.600\nRespiratory Rate (unit: breaths/min): min=17.000, max=29.000, mean=21.600\nSystolic Blood Pressure (unit: mmHg): min=96.000, max=133.000, mean=115.000\nTemperature (unit: °C): min=36.500, max=36.890, mean=36.782\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=300.000, mean=93.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=9.900, max=10.600, mean=10.572",
         "0",
         "0.78",
         "mortality",
         "Multiple critical abnormalities: severe anemia (hemoglobin 5.9 g/dL), severe systemic inflammation (CRP 76.25 mg/L), signs of infection (bands 8%, neutrophils 82.5%), kidney dysfunction (BUN 49 mg/dL), hypotension episodes (MAP minimum 58 mmHg), oliguria (urine output minimum 0 mL/h), and hypoxemia (oxygen saturation minimum 85.5%) in elderly patient requiring oxygen support.",
         "0",
         "0",
         "1962",
         "796",
         "0",
         "Let me analyze this patient data systematically looking for concerning signs that might predict mortality.\n\nKey abnormal findings:\n1. Hemoglobin: very low at 5.900-9.300 g/dL, mean 7.792 (normal 12-16 for males) - severe anemia\n2. C-Reactive Protein: very high at 76.250 mg/L (normal <3.0 mg/L) - severe inflammation/infection\n3. Band Neutrophils: elevated at 8% (normal <6%) - left shift suggesting bacterial infection\n4. Neutrophils: elevated at 82.5% (normal 50-70%) - consistent with infection\n5. Lymphocytes: low at 9% (normal 20-40%) - immune suppression\n6. BUN: elevated at 29-49 mg/dL, mean 48.2 (normal 7-20) - kidney dysfunction\n7. Albumin: low at 2.8 g/dL (normal 3.5-5.0) - malnutrition/chronic illness\n8. Calcium: low at 7.8-8.1 mg/dL (normal 8.5-10.5) - hypocalcemia\n9. Diastolic BP: low minimum at 42.5 mmHg - hypotension episodes\n10. MAP: low minimum at 58 mmHg (normal >65) - hypotension\n11. Urine output: minimum 0 mL/h, mean only 93 mL/h - oliguria/anuria episodes\n12. Oxygen saturation: minimum 85.5% - hypoxemia episodes\n13. FiO2: 40% - requiring supplemental oxygen\n14. Age: 76 years old - elderly\n\nPositive findings (less concerning):\n- pH normal at 7.36\n- Lactate reasonable at 0.8-2.9 mmol/L, mean 1.412 (normal <2.0)\n\n\n- Creatinine only mildly elevated at 0.77-0.87 mg/dL\n\nI'm observing a complex clinical picture with multiple critical physiological derangements. The patient presents with a severe multisystem breakdown, characterized by profound inflammatory response, compromised oxygen delivery, and organ dysfunction. The interplay of severe anemia, systemic inflammation, and infection suggests a potentially life-threatening condition requiring immediate, aggressive intervention.\n\nThe metabolic and hemodynamic instability is particularly alarming. Critically low hemoglobin levels combined with elevated inflammatory markers indicate a serious underlying pathology. The patient's compromised immune response, evidenced by low lymphocyte count and elevated neutrophils, further compounds the clinical risk.\n\nOrgan systems are clearly under significant stress. Kidney function is impaired, with elevated BUN and mildly increased creatinine. Hypotensive episodes and reduced urine output point to potential circulatory compromise and early signs of shock. The advanced age of 76 years significantly increases vulnerability to these physiological challenges.\n\nThese cascading clinical findings dramatically elevate mortality risk, suggesting an urgent need for comprehensive medical management and intensive supportive care.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "10",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 18, age: 55.0, sex: Female, weight: 62.3, height: 170.2\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=30.000, max=78.000, mean=39.600\nAlanine Aminotransferase (ALT) (unit: U/L): min=6.000, max=28.000, mean=10.400\nAspartate Aminotransferase (AST) (unit: U/L): min=15.000, max=34.000, mean=18.800\nBase Excess (unit: mmol/L): min=-7.000, max=-1.000, mean=-6.520\nBicarbonate (unit: mmol/L): min=17.000, max=23.000, mean=18.440\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.340\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=10.000, max=21.000, mean=12.640\nCalcium (unit: mg/dL): min=6.700, max=8.200, mean=7.060\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=63.000, max=198.000, mean=73.800\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=109.000, mean=108.040\nCreatinine (unit: mg/dL): min=0.770, max=1.080, mean=0.844\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=44.000, max=69.000, mean=59.280\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=35.000, max=60.000, mean=37.800\nGlucose (unit: mg/dL): min=91.000, max=136.000, mean=106.660\nHemoglobin (unit: g/dL): min=8.600, max=10.300, mean=9.008\nHeart Rate (unit: bpm): min=78.500, max=116.500, mean=95.620\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.200, max=4.000, mean=3.392\nLactate (unit: mmol/L): min=1.700, max=2.500, mean=1.812\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=50.000, max=91.500, mean=74.620\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=34.600, mean=33.472\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=34.400, mean=34.064\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=100.700, mean=98.132\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.500, max=2.000, mean=1.932\nSodium (unit: mmol/L): min=137.000, max=139.000, mean=137.480\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=93.000, max=100.000, mean=98.300\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.300, max=7.360, mean=7.305\nPhosphate (unit: mg/dL): min=2.200, max=3.300, mean=2.360\nPlatelets (unit: 1000/µL): min=160.000, max=182.000, mean=165.280\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=310.000, mean=293.280\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=16.000, max=18.000, mean=16.080\nSystolic Blood Pressure (unit: mmHg): min=76.000, max=128.000, mean=104.340\nTemperature (unit: °C): min=35.894, max=37.789, mean=37.065\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=25.000, max=340.000, mean=143.800\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=9.900, max=11.000, mean=10.164",
         "0",
         "0.85",
         "mortality",
         "Critical multi-organ dysfunction: severe hypotension (MAP min 50 mmHg), metabolic acidosis (Base Excess -7.0 mmol/L, pH 7.30), severe inflammation (CRP 76.25 mg/L), oliguria (min 25 mL/h), hypocalcemia (6.7 mg/dL), anemia (Hgb 8.6 g/dL), and hypothermia (35.9?C) indicating high mortality risk.",
         "0",
         "0",
         "1962",
         "768",
         "0",
         "Let me analyze this patient data systematically to assess mortality risk:\n\nKey abnormal findings that suggest high mortality risk:\n\n1. Metabolic acidosis: \n   - Base Excess: min=-7.000, max=-1.000, mean=-6.520 (significantly negative)\n   - Bicarbonate: min=17.000, max=23.000, mean=18.440 (low normal to low)\n   - pH Level: min=7.300, max=7.360, mean=7.305 (acidemic)\n\n2. Severe inflammation:\n   - C-Reactive Protein (CRP): 76.250 mg/L (very high, normal <3 mg/L)\n\n3. Hypotension and cardiovascular instability:\n   - Mean Arterial Pressure (MAP): min=50.000 mmHg (critically low)\n   - Diastolic Blood Pressure: min=44.000 mmHg (very low)\n   - Systolic Blood Pressure: min=76.000 mmHg (hypotensive)\n\n4. Anemia:\n   - Hemoglobin: min=8.600 g/dL (low, normal ~12-15 for women)\n\n5. Hypocalcemia:\n   - Calcium: min=6.700 mg/dL (very low, normal 8.5-10.5)\n\n6. Coagulopathy:\n   - INR: 1.300 (mildly elevated)\n\n7. Respiratory issues:\n   - FiO2 requirement: min=35%, max=60% (requiring supplemental oxygen)\n   - Oxygen Saturation: min=93% (lower end)\n\n8. Oliguria:\n   - Urine Output: min=25.000 mL/h (very low, suggesting kidney dysfunction)\n\n9. Neutrophilia with lymphopenia:\n   - Neutrophils: 80.7% (high)\n   - Lymphocytes: 9% (low)\n\n10. Hypothermia episodes:\n    - Temperature: min=35.894?C (hypothermic)\n\nThe patient exhibits a critical multi-system breakdown with profound immunological, metabolic, and physiological disruptions. Immune dysregulation is evident through extreme neutrophil elevation and lymphocyte depletion, indicating severe systemic stress. Compounded by profound metabolic derangements, cardiovascular compromise, and organ dysfunction, this clinical picture suggests an extremely high-risk scenario with imminent life-threatening potential.\n\nThe constellation of clinical markers points to an alarmingly elevated mortality probability.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "11",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 19, age: 80.0, sex: Female, weight: 65.6, height: 160.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=52.000, max=78.000, mean=56.160\nAlanine Aminotransferase (ALT) (unit: U/L): min=8.000, max=28.000, mean=11.200\nAspartate Aminotransferase (AST) (unit: U/L): min=28.000, max=34.000, mean=28.960\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=21.000, max=23.000, mean=21.320\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.800, mean=0.668\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=50.000, mean=45.360\nCalcium (unit: mg/dL): min=6.400, max=8.200, mean=6.688\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=106.000, mean=105.840\nCreatinine (unit: mg/dL): min=1.080, max=6.260, mean=5.431\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=34.000, max=70.000, mean=58.240\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=76.000, max=124.000, mean=81.800\nHemoglobin (unit: g/dL): min=10.300, max=10.300, mean=10.300\nHeart Rate (unit: bpm): min=71.000, max=93.500, mean=84.780\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.000, mean=4.000\nLactate (unit: mmol/L): min=0.500, max=1.900, mean=0.668\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=45.000, max=78.500, mean=65.340\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=29.900, mean=29.900\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.000, mean=33.000\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=90.000, mean=90.000\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.500, max=1.900, mean=1.564\nSodium (unit: mmol/L): min=138.000, max=139.000, mean=138.160\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=97.500, max=100.000, mean=97.920\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=5.000, mean=4.728\nPlatelets (unit: 1000/µL): min=182.000, max=182.000, mean=182.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=15.000, max=20.000, mean=17.920\nSystolic Blood Pressure (unit: mmHg): min=71.000, max=106.000, mean=89.740\nTemperature (unit: °C): min=36.890, max=36.890, mean=36.890\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=11.000, mean=11.000",
         "0",
         "0.85",
         "mortality",
         "Critical condition: severe acute kidney injury with creatinine 6.260 mg/dL (normal <1.2), severe systemic inflammation with CRP 76.250 mg/L (normal <3), hypotension with MAP minimum 45.000 mmHg and diastolic BP minimum 34.000 mmHg, signs of infection with band neutrophils 8.000% and neutrophils 80.700%, in an 80-year-old patient.",
         "0",
         "0",
         "1962",
         "615",
         "0",
         "Let me analyze this patient data systematically to assess mortality risk.\n\nKey abnormal findings that concern me:\n\n1. Age: 80.0 - elderly patient, higher mortality risk\n2. Creatinine: min=1.080, max=6.260, mean=5.431 - significantly elevated, indicating severe acute kidney injury or chronic kidney disease\n3. BUN: min=21.000, max=50.000, mean=45.360 - elevated, supporting renal dysfunction  \n4. CRP: 76.250 mg/L - significantly elevated indicating severe inflammation/infection\n5. Calcium: min=6.400, max=8.200, mean=6.688 - low calcium (hypocalcemia)\n6. Diastolic BP: min=34.000 - very low diastolic pressure\n7. MAP: min=45.000 - critically low mean arterial pressure\n8. Band neutrophils: 8.000% - elevated, suggesting bacterial infection\n9. Neutrophils: 80.700% - elevated\n10. WBC: 11.000 - mildly elevated\n\nPositive findings:\n- Lactate: max=1.900, mean=0.668 - not severely elevated\n- Oxygen saturation: 97.5-100%\n- FiO2: only 40% - not requiring high oxygen\n- Urine output: 100 mL/h - adequate\n- pH: 7.360 - normal\n- Heart rate: reasonable range 71-93.5\n\nThe most concerning findings are:\n1. Severe renal dysfunction (creatinine up to 6.26)\n2. Very high CRP indicating severe systemic inflammation\n3. Hypotension (MAP as low as 45, diastolic as low as 34)\n4. Signs of infection (elevated bands, neutrophils, WBC)\n5. Advanced age\n\nThis combination of severe acute kidney injury, systemic inflammation, hypotension, and infection in an 80-year-old patient suggests a high mortality risk.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "12",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 2, age: 65.0, sex: Female, weight: 87.3, height: 168.0\nAlbumin (unit: g/dL): min=2.600, max=2.900, mean=2.700\nAlkaline Phosphatase (unit: U/L): min=31.000, max=34.000, mean=31.920\nAlanine Aminotransferase (ALT) (unit: U/L): min=169.000, max=283.000, mean=241.280\nAspartate Aminotransferase (AST) (unit: U/L): min=246.000, max=309.000, mean=282.720\nBase Excess (unit: mmol/L): min=-1.000, max=1.000, mean=0.600\nBicarbonate (unit: mmol/L): min=26.000, max=28.000, mean=27.320\nTotal Bilirubin (unit: mg/dL): min=2.200, max=7.400, mean=4.912\nBand Neutrophils (unit: %): min=9.000, max=12.000, mean=11.480\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=13.000, max=24.000, mean=18.240\nCalcium (unit: mg/dL): min=8.800, max=10.200, mean=9.240\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=112.000, max=114.000, mean=112.760\nCreatinine (unit: mg/dL): min=0.700, max=0.790, mean=0.730\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=50.000, max=78.000, mean=60.080\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=50.000, max=50.000, mean=50.000\nGlucose (unit: mg/dL): min=112.000, max=183.000, mean=140.660\nHemoglobin (unit: g/dL): min=11.800, max=14.100, mean=12.672\nHeart Rate (unit: bpm): min=62.000, max=81.000, mean=70.940\ninr (unit: ): min=1.300, max=1.400, mean=1.360\nPotassium (unit: mmol/L): min=3.900, max=4.600, mean=4.292\nLactate (unit: mmol/L): min=1.000, max=5.000, mean=2.332\nLymphocytes (unit: %): min=4.400, max=6.400, mean=5.936\nMean Arterial Pressure (MAP) (unit: mmHg): min=68.000, max=100.000, mean=83.920\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=30.200, max=31.000, mean=30.680\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.800, max=35.300, mean=34.624\nMean Corpuscular Volume (MCV) (unit: fL): min=87.900, max=89.800, mean=88.660\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.200, max=1.900, mean=1.816\nSodium (unit: mmol/L): min=142.000, max=147.000, mean=144.280\nNeutrophils (unit: %): min=85.300, max=88.300, mean=86.032\nOxygen Saturation (unit: %): min=93.000, max=96.000, mean=94.300\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=45.000, mean=44.000\npH Level (unit: /): min=7.360, max=7.370, mean=7.368\nPhosphate (unit: mg/dL): min=3.900, max=4.100, mean=3.924\nPlatelets (unit: 1000/µL): min=27.000, max=64.000, mean=38.440\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=73.000, max=101.000, mean=78.600\nPartial Thromboplastin Time (PTT) (unit: sec): min=32.000, max=34.700, mean=33.608\nRespiratory Rate (unit: breaths/min): min=7.000, max=17.000, mean=11.880\nSystolic Blood Pressure (unit: mmHg): min=105.500, max=138.500, mean=124.880\nTemperature (unit: °C): min=36.000, max=37.500, mean=36.696\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=20.000, max=110.000, mean=42.200\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=5.100, max=7.300, mean=6.356",
         "0",
         "0.85",
         "mortality",
         "Multiple organ dysfunction: severe liver failure (ALT max 283 U/L, AST max 309 U/L, bilirubin max 7.4 mg/dL), severe thrombocytopenia (platelets min 27,000/?L), respiratory failure (FiO2 50%), oliguria (min 20 mL/h), elevated lactate (max 5.0 mmol/L), and sepsis indicators (CRP 76.25 mg/L, elevated bands 9-12%).",
         "0",
         "0",
         "1962",
         "707",
         "0",
         "Let me analyze this ICU patient data carefully for signs of mortality risk.\n\nKey concerning findings:\n1. **Liver dysfunction**: Very elevated ALT (169-283 U/L, normal ~10-40) and AST (246-309 U/L, normal ~10-40). These are significantly elevated, suggesting significant liver damage.\n\n2. **Elevated bilirubin**: Total bilirubin 2.2-7.4 mg/dL (normal <1.2), mean 4.912 mg/dL - this indicates severe liver dysfunction or possible cholestasis.\n\n3. **Low albumin**: 2.6-2.9 g/dL (normal 3.5-5.0) - indicates poor synthetic function of liver or malnutrition.\n\n4. **Thrombocytopenia**: Platelets 27-64 thousand/?L (normal 150-450) - this is severe thrombocytopenia, possibly related to liver dysfunction or other serious condition.\n\n5. **Elevated CRP**: 76.25 mg/L (normal <3) - indicates significant inflammation/infection.\n\n6. **Oxygen support**: Patient requires FiO2 50% (normal room air is 21%), indicating respiratory compromise.\n\n7. **Oliguria**: Urine output min 20 mL/h, mean 42.2 mL/h - this is concerning for kidney dysfunction (normal should be >0.5 mL/kg/h, for an 87 kg patient that would be >43 mL/h, so the minimum of 20 mL/h is very low).\n\n8. **Elevated lactate**: Max 5.0 mmol/L (normal <2), mean 2.332 - indicates tissue hypoxia/shock.\n\n9. **Coagulopathy**: INR 1.3-1.4 (normal ~1.0) - mild coagulopathy, likely related to liver dysfunction.\n\n\n10. **High neutrophils with bands**: Neutrophils 85-88% (high), bands 9-12% (elevated) - suggests bacterial infection.\n\nThe inflammatory markers and white blood cell profile point to a severe infectious process. The high neutrophil count with increased band forms strongly indicates an active bacterial infection, further complicating the patient's critical condition. These immunological findings compound the existing multi-organ dysfunction, dramatically increasing the risk of adverse outcomes.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "13",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 20, age: 62.0, sex: Female, weight: 65.7, height: 152.4\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=26.000, mean=25.160\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=7.000, max=21.000, mean=9.720\nCalcium (unit: mg/dL): min=8.200, max=9.600, mean=9.544\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=91.000, max=198.000, mean=95.280\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=83.000, max=105.000, mean=84.960\nCreatinine (unit: mg/dL): min=0.740, max=1.080, mean=0.852\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=48.000, max=69.000, mean=61.960\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=120.500, max=231.000, mean=193.640\nHemoglobin (unit: g/dL): min=10.000, max=10.700, mean=10.544\nHeart Rate (unit: bpm): min=69.500, max=86.500, mean=75.200\ninr (unit: ): min=1.000, max=1.300, mean=1.012\nPotassium (unit: mmol/L): min=3.800, max=4.100, mean=3.988\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=79.000, max=105.000, mean=91.200\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=24.000, max=29.900, mean=24.540\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.600, mean=33.456\nMean Corpuscular Volume (MCV) (unit: fL): min=72.600, max=90.000, mean=73.316\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.200, max=1.900, mean=1.228\nSodium (unit: mmol/L): min=117.000, max=139.000, mean=119.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=98.000, max=100.000, mean=99.500\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=182.000, max=426.000, mean=413.440\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=15.000, max=20.000, mean=18.360\nSystolic Blood Pressure (unit: mmHg): min=110.000, max=152.000, mean=133.600\nTemperature (unit: °C): min=36.890, max=36.890, mean=36.890\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=14.100, mean=12.684",
         "0",
         "0.25",
         "not-mortality",
         "Moderate risk: severe hyponatremia (Na 117 mmol/L), elevated infection markers (CRP 76.25 mg/L, WBC 12.684, bands 8%, neutrophils 80.7%), and hypoalbuminemia (2.8 g/dL). However, patient shows hemodynamic stability (MAP 91.2 mmHg), adequate oxygenation (O2 sat 99.5%), normal pH (7.36), and sufficient urine output (100 mL/h).",
         "0",
         "0",
         "1962",
         "814",
         "0",
         "Let me analyze this patient data for potential mortality risk factors.\n\nKey findings to consider:\n\n1. Age: 62 years old - not extremely high risk age\n2. Weight/Height: 65.7kg/152.4cm - seems reasonable\n\nLooking at specific concerning values:\n\n1. C-Reactive Protein (CRP): 76.250 mg/L - This is quite elevated, indicating significant inflammation/infection\n\n2. Sodium: min=117.000, max=139.000, mean=119.000 - Hyponatremia is present (normal ~135-145), with a minimum of 117 which is quite low\n\n3. Band Neutrophils: 8.000% - slightly elevated (normal <5%), suggesting bacterial infection\n\n4. WBC: 11.000-14.100, mean=12.684 - elevated white cell count, consistent with infection\n\n5. Glucose: max=231.000, mean=193.640 - hyperglycemia, possibly stress response\n\n6. FiO2: 40% - patient requires supplemental oxygen\n\n7. Lactate: 1.900 mmol/L - slightly elevated (normal <2.0), but borderline\n\n8. Neutrophils: 80.700% - elevated (normal ~50-70%), left shift suggesting infection\n\n9. Lymphocytes: 9.000% - low (normal 20-40%), consistent with stress/infection\n\n10. Hemoglobin: 10.000-10.700 g/dL - mild anemia\n\n11. Albumin: 2.800 g/dL - low (normal 3.5-5.0), indicating malnutrition or chronic illness\n\nPositive factors:\n- Oxygen saturation: 98-100% - good\n- pH: 7.360 - normal\n- Blood pressure: reasonably stable\n- Heart rate: 69-86 bpm - not tachycardic\n- Temperature: 36.89?C - not febrile\n\n\n- Urine output: 100 mL/h - adequate (assuming normal weight)\n- Creatinine: 0.74-1.08 mg/dL - normal to mildly elevated\n\nI'm identifying critical risk factors that could impact patient outcomes. The most significant concerns are metabolic and inflammatory markers. Severe hyponatremia and markedly elevated inflammatory indicators suggest a complex clinical picture. Despite these challenges, the patient maintains relatively stable physiological parameters. The infection markers, combined with low albumin and mild electrolyte disturbances, point to a moderate-risk scenario requiring careful monitoring and targeted intervention.\n\nMy clinical assessment suggests a mortality probability around 25-35%, reflecting the patient's mixed clinical presentation - serious enough to warrant close attention, but not immediately life-threatening.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "14",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 21, age: 90.0, sex: Female, weight: 78.0, height: 162.6\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=15.000, max=28.000, mean=20.200\nAspartate Aminotransferase (AST) (unit: U/L): min=22.000, max=34.000, mean=26.800\nBase Excess (unit: mmol/L): min=-1.000, max=3.000, mean=1.560\nBicarbonate (unit: mmol/L): min=23.000, max=28.000, mean=26.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=27.000, mean=24.600\nCalcium (unit: mg/dL): min=8.200, max=10.100, mean=9.340\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=77.000, max=198.000, mean=125.400\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=109.000, mean=107.400\nCreatinine (unit: mg/dL): min=0.810, max=1.080, mean=0.918\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=55.000, max=132.000, mean=78.520\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=30.000, max=40.000, mean=33.600\nGlucose (unit: mg/dL): min=101.000, max=167.000, mean=134.120\nHemoglobin (unit: g/dL): min=10.300, max=11.600, mean=11.080\nHeart Rate (unit: bpm): min=74.500, max=114.500, mean=93.540\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.400, mean=4.240\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=11.400, mean=10.440\nMean Arterial Pressure (MAP) (unit: mmHg): min=78.000, max=143.000, mean=96.420\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.400, mean=30.200\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.200, mean=33.120\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=91.700, mean=91.020\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.100, mean=2.020\nSodium (unit: mmol/L): min=139.000, max=142.000, mean=140.800\nNeutrophils (unit: %): min=79.500, max=80.700, mean=79.980\nOxygen Saturation (unit: %): min=95.000, max=100.000, mean=98.380\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=49.000, mean=45.760\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.600, max=3.300, mean=2.880\nPlatelets (unit: 1000/µL): min=182.000, max=189.000, mean=186.200\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=83.000, max=101.000, mean=89.480\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=19.000, max=25.000, mean=21.340\nSystolic Blood Pressure (unit: mmHg): min=132.000, max=178.000, mean=155.160\nTemperature (unit: °C): min=36.000, max=37.789, mean=37.190\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=30.000, max=350.000, mean=131.600\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=9.500, max=11.000, mean=10.100",
         "1",
         "0.65",
         "mortality",
         "High-risk elderly patient (age 90) with severe inflammation (CRP 76.25 mg/L), requiring oxygen support (FiO2 30-40%), episodes of oliguria (minimum urine output 30 mL/h), hypoalbuminemia (2.8 g/dL), and elevated lactate (1.9 mmol/L). Multiple risk factors indicate significant mortality risk despite relatively stable hemodynamics.",
         "0",
         "0",
         "1962",
         "889",
         "0",
         "Let me analyze this patient data systematically to assess mortality risk:\n\n**Critical Factors to Consider:**\n\n1. **Age**: 90 years old - This is a very elderly patient, which is a significant mortality risk factor\n\n2. **Inflammation markers**: \n   - CRP: 76.25 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n   - Band neutrophils: 8% - Slightly elevated, suggesting bacterial infection\n   - Neutrophils: ~80% - High, consistent with infection/inflammation\n\n3. **Respiratory status**:\n   - FiO2: 30-40% (mean 33.6%) - Patient requires supplemental oxygen\n   - Oxygen saturation: 95-100% (mean 98.38%) - Acceptable but on the lower end\n   - PaO2: 83-101 mmHg (mean 89.48) - Lower normal range\n\n4. **Cardiovascular**: \n   - Heart rate: 74.5-114.5 bpm (mean 93.5) - Mild tachycardia\n   - Blood pressure: Systolic 132-178 (mean 155), Diastolic 55-132 (mean 78.5) - Wide range, some hypertension\n   - MAP: 78-143 (mean 96.4) - Variable but adequate\n\n5. **Renal function**:\n   - Creatinine: 0.81-1.08 mg/dL (mean 0.918) - Normal for age\n   - BUN: 21-27 mg/dL (mean 24.6) - Slightly elevated\n   - Urine output: 30-350 mL/h (mean 131.6) - Wide range, minimum is very low (oliguria)\n\n6. **Metabolic**:\n   - Lactate: 1.9 mmol/L - Slightly elevated (normal <2)\n   - Glucose: 101-167 mg/dL - Mild hyperglycemia\n   - Albumin: 2.8 g/dL - Low (normal 3.4-5.4), indicates poor nutritional status\n\n7. **Hematologic**:\n   - Hemoglobin: 10.3-11.6 g/dL - Mild anemia\n   - WBC: 9.5-11.0 - Normal to slightly elevated\n   - Platelets: 182-189 - Normal\n\n**Risk Assessment:**\nThe patient presents multiple complex health challenges. Metabolic and nutritional markers reveal concerning signs: mild hyperglycemia and low albumin suggest compromised nutritional status. Hematologic parameters show mild anemia but otherwise stable blood counts. These findings compound the inherent risks associated with advanced age, potentially increasing vulnerability to adverse outcomes.\n\nClinical indicators suggest a precarious but not immediately catastrophic condition. Infection markers, oxygen requirements, and intermittent kidney function issues create a nuanced risk profile. While not facing imminent collapse, the patient's prognosis remains guarded.\n\nI estimate mortality risk around 60-70%, reflecting the delicate balance between systemic challenges and remaining physiological resilience.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "15",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 22, age: 84.0, sex: Male, weight: 73.1, height: 180.3\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=7.000, max=8.000, mean=7.480\nBicarbonate (unit: mmol/L): min=23.000, max=32.000, mean=31.280\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=53.000, mean=50.440\nCalcium (unit: mg/dL): min=8.200, max=9.200, mean=9.120\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=101.000, max=105.000, mean=101.320\nCreatinine (unit: mg/dL): min=1.080, max=1.330, mean=1.310\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=34.000, max=62.000, mean=43.980\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=50.000, mean=44.800\nGlucose (unit: mg/dL): min=93.000, max=220.000, mean=138.480\nHemoglobin (unit: g/dL): min=10.300, max=10.300, mean=10.300\nHeart Rate (unit: bpm): min=52.500, max=86.500, mean=63.060\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.600, mean=4.552\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=51.500, max=78.000, mean=59.000\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=29.900, mean=29.900\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.000, mean=33.000\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=90.000, mean=90.000\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.100, mean=2.084\nSodium (unit: mmol/L): min=139.000, max=139.000, mean=139.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=90.000, max=98.000, mean=95.340\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=65.000, max=69.000, mean=67.080\npH Level (unit: /): min=7.290, max=7.320, mean=7.304\nPhosphate (unit: mg/dL): min=3.300, max=4.500, mean=4.404\nPlatelets (unit: 1000/µL): min=182.000, max=182.000, mean=182.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=104.000, max=107.000, mean=105.440\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=19.000, max=27.500, mean=21.680\nSystolic Blood Pressure (unit: mmHg): min=90.000, max=135.000, mean=106.040\nTemperature (unit: °C): min=36.000, max=37.000, mean=36.259\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=5.000, max=100.000, mean=39.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=11.000, mean=11.000",
         "0",
         "0.78",
         "mortality",
         "Multiple critical findings: hypotension with MAP mean=59.0 mmHg (normal >65), acute kidney injury with BUN=50.4 mg/dL and creatinine=1.31 mg/dL, severe systemic inflammation with CRP=76.25 mg/L, respiratory acidosis with pH=7.304 and PaCO2=67.1 mmHg, oliguria episodes (urine output min=5.0 mL/h), and advanced age (84 years) with sepsis indicators.",
         "0",
         "0",
         "1962",
         "975",
         "0",
         "Let me analyze this ICU patient data carefully to determine mortality risk.\n\nKey patient info: 84-year-old male, weight 73.1 kg, height 180.3 cm\n\nLet me look for concerning values:\n\n1. **Cardiovascular/hemodynamic concerns:**\n   - Diastolic BP: min=34.0, mean=44.0 mmHg - very low\n   - MAP: min=51.5, mean=59.0 mmHg - low (normal >65)\n   - Systolic BP: min=90, mean=106 mmHg - hypotensive\n   - Heart rate: 52.5-86.5, mean=63 - relatively normal range\n\n2. **Respiratory:**\n   - FiO2: 40-50%, mean=44.8% - requiring supplemental oxygen\n   - O2 sat: 90-98%, mean=95.3% - acceptable but concerning range\n   - PaCO2: 65-69 mmHg, mean=67.1 - mild hypercapnia (normal 35-45)\n   - pH: 7.29-7.32, mean=7.304 - mild acidosis (normal 7.35-7.45)\n   - Respiratory rate: 19-27.5, mean=21.7 - upper normal/mild tachypnea\n\n3. **Renal function:**\n   - BUN: 21-53, mean=50.4 mg/dL - elevated (normal 7-20)\n   - Creatinine: 1.08-1.33, mean=1.31 mg/dL - elevated for elderly (normal <1.2)\n   - Urine output: 5-100 mL/h, mean=39 mL/h - concerning oliguria episodes\n\n4. **Metabolic/inflammatory:**\n   - CRP: 76.25 mg/L - very elevated (normal <3.0)\n   - Lactate: 1.9 mmol/L - mildly elevated (normal <2.0)\n   - Base excess: +7-8 mmol/L - metabolic alkalosis\n   - Bicarbonate: 23-32, mean=31.3 - elevated\n\n5. **Hematologic findings reveal potential inflammatory response:**\n   - White blood cell count slightly increased at 11.0\n   - Neutrophil percentage significantly high at 80.7%\n   - Lymphocyte count markedly reduced to 9%\n   - Band neutrophils at 8% suggest active infection or inflammatory process\n\nI'm seeing multiple signs of systemic stress and potential critical illness progression.\n\nThe patient's clinical picture indicates severe physiological compromise across multiple organ systems. Advanced age compounds the risk, with inflammatory markers, metabolic derangements, and organ dysfunction pointing to a potentially life-threatening condition requiring immediate, aggressive intervention.\n\nKey concerns include sepsis indicators, respiratory instability, and compromised organ function that collectively suggest a high-risk clinical scenario with significant mortality potential.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "16",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 23, age: 68.0, sex: Male, weight: 84.3, height: 172.7\nAlbumin (unit: g/dL): min=4.000, max=4.000, mean=4.000\nAlkaline Phosphatase (unit: U/L): min=66.000, max=66.000, mean=66.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=17.000, max=17.000, mean=17.000\nAspartate Aminotransferase (AST) (unit: U/L): min=16.000, max=16.000, mean=16.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=25.000, mean=24.680\nTotal Bilirubin (unit: mg/dL): min=0.100, max=0.800, mean=0.450\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=9.000, max=21.000, mean=10.920\nCalcium (unit: mg/dL): min=8.200, max=8.300, mean=8.284\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=109.000, mean=108.360\nCreatinine (unit: mg/dL): min=0.890, max=1.080, mean=0.920\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=53.000, max=77.000, mean=63.960\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=118.000, max=136.000, mean=120.880\nHemoglobin (unit: g/dL): min=10.300, max=13.100, mean=12.652\nHeart Rate (unit: bpm): min=52.000, max=61.000, mean=56.400\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.900, max=4.000, mean=3.916\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=64.000, max=85.000, mean=73.820\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.300, max=29.900, mean=28.556\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.700, mean=33.588\nMean Corpuscular Volume (MCV) (unit: fL): min=84.100, max=90.000, mean=85.044\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.000, mean=1.984\nSodium (unit: mmol/L): min=138.000, max=139.000, mean=138.160\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=96.000, max=100.000, mean=97.780\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.500, mean=3.468\nPlatelets (unit: 1000/µL): min=132.000, max=182.000, mean=140.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=66.000, mean=61.120\nRespiratory Rate (unit: breaths/min): min=14.000, max=18.000, mean=16.120\nSystolic Blood Pressure (unit: mmHg): min=91.000, max=121.500, mean=107.700\nTemperature (unit: °C): min=36.606, max=36.894, mean=36.744\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=700.000, mean=194.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=5.600, max=11.000, mean=6.464",
         "0",
         "0.72",
         "mortality",
         "High-risk septic patient: severely elevated CRP 76.250 mg/L, coagulopathy with INR 1.300 and PTT 66.000 sec, cardiac injury with troponin T 0.140 ng/mL, periods of anuria (urine output min 0.000 mL/h), and infection markers including band neutrophils 8.000% and lymphopenia 9.000%.",
         "0",
         "0",
         "1962",
         "701",
         "0",
         "Let me analyze this ICU patient data for mortality risk. I'll look for critical abnormal values that suggest high mortality risk.\n\nPatient: 68-year-old male, weight 84.3 kg, height 172.7 cm\n\nKey concerning findings:\n1. C-Reactive Protein (CRP): 76.250 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n2. Band Neutrophils: 8.000% - This is elevated (normal <3%), suggesting bacterial infection with left shift\n3. Neutrophils: 80.700% - Elevated, supporting infection\n4. Lymphocytes: 9.000% - Low (normal 20-40%), indicating possible immunosuppression or severe illness\n5. Urine Output: min 0.000 mL/h, mean 194.000 mL/h - The minimum of 0 suggests periods of anuria, which is very concerning for acute kidney injury\n6. FiO2: 40% - Patient requires supplemental oxygen\n7. INR: 1.300 - Slightly elevated, suggesting coagulopathy\n8. PTT: max 66.000 sec (normal 25-35), mean 61.120 - Significantly prolonged, indicating coagulopathy\n9. Troponin T: 0.140 ng/mL - Elevated (normal <0.01), suggesting cardiac injury\n\nPositive findings:\n- Lactate: 1.900 mmol/L - Only mildly elevated (normal <2.0)\n- pH: 7.360 - Normal\n- Blood pressure: MAP 73.820 mmHg - Acceptable\n- Heart rate: 56.400 bpm - Normal/bradycardic but stable\n- Oxygen saturation: 97.780% - Good\n- Creatinine: 0.920 mg/dL - Normal\n \nThe patient presents a complex clinical picture with multiple organ systems compromised. Despite some stabilizing factors, the inflammatory markers and systemic responses indicate a serious medical condition. The interplay of infection, potential organ dysfunction, and coagulation abnormalities suggests a critical but not immediately terminal state. Careful monitoring and aggressive intervention will be crucial for managing this patient's complex clinical trajectory.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "17",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 24, age: 89.0, sex: Female, weight: 37.1, height: 152.4\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=25.000, mean=24.920\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=13.000, max=21.000, mean=13.320\nCalcium (unit: mg/dL): min=8.000, max=8.200, mean=8.008\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=176.000, max=198.000, mean=176.880\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=2.400, max=6.200, mean=2.552\nChloride (unit: mmol/L): min=105.000, max=107.000, mean=106.920\nCreatinine (unit: mg/dL): min=0.520, max=1.080, mean=0.542\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=35.000, max=63.000, mean=53.220\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=84.000, max=136.000, mean=110.720\nHemoglobin (unit: g/dL): min=10.300, max=11.400, mean=11.356\nHeart Rate (unit: bpm): min=64.500, max=92.500, mean=76.320\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.000, mean=4.000\nLactate (unit: mmol/L): min=0.600, max=1.900, mean=0.860\nLymphocytes (unit: %): min=6.700, max=9.000, mean=6.792\nMean Arterial Pressure (MAP) (unit: mmHg): min=43.500, max=81.000, mean=63.760\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.900, max=29.900, mean=28.940\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.600, max=33.000, mean=32.616\nMean Corpuscular Volume (MCV) (unit: fL): min=88.700, max=90.000, mean=88.752\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.300, max=1.900, mean=1.324\nSodium (unit: mmol/L): min=139.000, max=140.000, mean=139.960\nNeutrophils (unit: %): min=80.700, max=84.300, mean=84.156\nOxygen Saturation (unit: %): min=93.000, max=100.000, mean=96.100\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.400, max=3.300, mean=2.436\nPlatelets (unit: 1000/µL): min=182.000, max=196.000, mean=195.440\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=15.000, max=21.000, mean=18.240\nSystolic Blood Pressure (unit: mmHg): min=71.000, max=129.000, mean=98.940\nTemperature (unit: °C): min=36.711, max=36.894, mean=36.811\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=15.200, mean=15.032",
         "0",
         "0.78",
         "mortality",
         "High-risk elderly patient (age 89) with severe frailty (weight 37.1 kg), significant infection (CRP 76.25 mg/L, WBC 15.2, neutrophils 84.3%, bands 8%), episodes of hypotension (MAP min 43.5 mmHg, SBP min 71 mmHg), malnutrition (albumin 2.8 g/dL), and requiring oxygen support (FiO2 40%).",
         "0",
         "0",
         "1962",
         "609",
         "0",
         "Let me analyze this patient's data systematically to assess mortality risk.\n\nKey patient characteristics:\n- Age: 89 years (very elderly)\n- Sex: Female \n- Weight: 37.1 kg (very low weight for height)\n- Height: 152.4 cm\n\nKey concerning findings:\n1. Very advanced age (89 years) - high mortality risk factor\n2. Very low body weight (37.1 kg) - suggests frailty/malnutrition\n3. High CRP (76.25 mg/L) - indicates significant inflammation/infection\n4. Elevated WBC count (max 15.2, mean 15.032) - suggests infection\n5. High neutrophils (80.7-84.3%) and low lymphocytes (6.7-9%) - bacterial infection pattern\n6. Band neutrophils 8% - left shift suggesting acute infection\n7. Low MAP minimum of 43.5 mmHg - concerning hypotension episodes\n8. Low systolic BP minimum of 71 mmHg\n9. Low albumin (2.8 g/dL) - malnutrition/poor prognosis marker\n10. Requiring supplemental oxygen (FiO2 40%)\n\nStable/reassuring findings:\n- Lactate relatively normal (0.6-1.9, mean 0.86)\n- Normal pH (7.36)\n- Normal bicarbonate (23-25)\n- Adequate urine output (100 mL/h)\n- Creatinine reasonable (0.52-1.08)\n- Hemoglobin acceptable (10.3-11.4)\n\nThis is an 89-year-old frail woman with evidence of significant infection (high CRP, elevated WBC with left shift), episodes of hypotension, malnutrition (low albumin, very low weight), and requiring oxygen support. The combination of very advanced age, frailty, infection, and hemodynamic instability suggests high mortality risk.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "18",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 25, age: 65.0, sex: Male, weight: 175.2, height: 180.3\nAlbumin (unit: g/dL): min=2.100, max=2.800, mean=2.492\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=31.000, max=31.000, mean=31.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=8.000, max=8.000, mean=8.000\nCalcium (unit: mg/dL): min=7.400, max=7.500, mean=7.456\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=99.000, max=102.000, mean=100.320\nCreatinine (unit: mg/dL): min=0.660, max=0.740, mean=0.705\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=37.000, max=76.000, mean=52.320\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=75.000, max=126.000, mean=99.880\nHemoglobin (unit: g/dL): min=7.800, max=8.900, mean=8.416\nHeart Rate (unit: bpm): min=69.000, max=94.500, mean=80.980\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.200, max=3.900, mean=3.508\nLactate (unit: mmol/L): min=0.600, max=0.900, mean=0.732\nLymphocytes (unit: %): min=10.000, max=10.000, mean=10.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=47.500, max=86.000, mean=63.300\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.500, max=30.200, mean=29.892\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.200, max=32.900, mean=32.592\nMean Corpuscular Volume (MCV) (unit: fL): min=91.600, max=91.800, mean=91.712\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.400, max=1.800, mean=1.576\nSodium (unit: mmol/L): min=134.000, max=134.000, mean=134.000\nNeutrophils (unit: %): min=79.500, max=79.500, mean=79.500\nOxygen Saturation (unit: %): min=94.500, max=100.000, mean=97.920\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.600, max=2.600, mean=2.600\nPlatelets (unit: 1000/µL): min=168.000, max=202.000, mean=187.040\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=12.000, max=24.000, mean=20.620\nSystolic Blood Pressure (unit: mmHg): min=72.000, max=122.000, mean=103.020\nTemperature (unit: °C): min=36.606, max=39.000, mean=37.409\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=30.000, max=225.000, mean=95.600\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=4.300, max=5.300, mean=4.860",
         "0",
         "0.65",
         "mortality",
         "Concerning systemic illness: severe inflammation with CRP 76.25 mg/L (normal <3), fever up to 39?C, bandemia 8%, severe anemia (hemoglobin 7.8-8.9 g/dL), hypoalbuminemia (2.1-2.8 g/dL), and hemodynamic instability with low diastolic BP (min 37 mmHg) and borderline MAP (mean 63.3 mmHg). However, normal lactate (0.6-0.9 mmol/L), preserved kidney function, and adequate oxygenation provide some reassurance.",
         "0",
         "0",
         "1962",
         "793",
         "0",
         "Let me analyze this ICU patient data systematically to assess mortality risk.\n\nKey concerning findings:\n1. Albumin is low: min=2.100, max=2.800, mean=2.492 g/dL (normal is usually 3.5-5.0)\n2. C-Reactive Protein (CRP) is very high: 76.25 mg/L (normal is <3.0 mg/L)\n3. Hemoglobin is low: min=7.800, max=8.900, mean=8.416 g/dL (normal male 13.5-17.5)\n4. Diastolic BP is concerning: min=37.000, max=76.000, mean=52.320 mmHg (low diastolic)\n5. Mean Arterial Pressure (MAP): min=47.500, max=86.000, mean=63.300 mmHg (borderline low, ideally >65)\n6. Temperature range includes fever: max=39.000?C (102.2?F)\n7. Band neutrophils elevated at 8% (normal <5%)\n8. Calcium is low: min=7.400, max=7.500, mean=7.456 mg/dL (normal 8.5-10.5)\n9. FiO2 at 40% indicates some respiratory support needed\n\nPositive findings:\n1. Lactate is normal/low: min=0.600, max=0.900, mean=0.732 mmol/L (normal <2)\n2. Creatinine is normal: 0.66-0.74 mg/dL\n3. BUN is normal/low: 8.0 mg/dL\n4. Oxygen saturation is good: min=94.5%, max=100%, mean=97.92%\n5. pH is normal: 7.36\n\n\n6. Heart rate is reasonable: mean 80.98 bpm\n7. Urine output is adequate: mean 95.6 mL/h (should be >0.5 mL/kg/h, for 79kg patient that's ~40 mL/h minimum)\n\nThe patient exhibits a complex clinical scenario with multiple inflammatory markers and physiological disruptions. While several critical parameters show concerning trends, the patient maintains some compensatory mechanisms. The combination of elevated inflammatory indicators, low albumin, and hemodynamic variations suggests a serious systemic process requiring aggressive management and close monitoring.\n\nProbability assessment indicates a moderate risk level - significant clinical challenges exist, but not an immediately terminal condition.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "19",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 26, age: 47.0, sex: Female, weight: 67.3, height: 157.4\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-6.000, max=-1.000, mean=-5.000\nBicarbonate (unit: mmol/L): min=20.000, max=23.000, mean=21.040\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=36.000, mean=29.440\nCalcium (unit: mg/dL): min=8.000, max=8.200, mean=8.072\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=125.000, mean=120.040\nCreatinine (unit: mg/dL): min=1.080, max=2.170, mean=1.844\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=55.000, max=62.000, mean=58.420\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=70.000, mean=57.400\nGlucose (unit: mg/dL): min=79.000, max=311.000, mean=154.540\nHemoglobin (unit: g/dL): min=7.800, max=10.300, mean=8.240\nHeart Rate (unit: bpm): min=90.500, max=121.000, mean=104.500\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.600, max=4.700, mean=4.108\nLactate (unit: mmol/L): min=0.800, max=1.900, mean=1.500\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=64.000, max=77.500, mean=71.540\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.500, max=30.300, mean=29.788\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.700, max=33.000, mean=31.996\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=93.700, mean=93.044\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.800, max=2.500, mean=2.180\nSodium (unit: mmol/L): min=139.000, max=155.000, mean=147.480\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=96.500, max=100.000, mean=99.660\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=32.000, max=47.000, mean=39.120\npH Level (unit: /): min=7.280, max=7.400, mean=7.333\nPhosphate (unit: mg/dL): min=2.300, max=3.800, mean=2.952\nPlatelets (unit: 1000/µL): min=63.000, max=182.000, mean=73.720\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=72.000, max=120.000, mean=82.800\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=14.000, max=18.000, mean=16.320\nSystolic Blood Pressure (unit: mmHg): min=89.500, max=109.000, mean=99.640\nTemperature (unit: °C): min=36.394, max=37.894, mean=37.399\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=55.000, max=325.000, mean=172.800\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=2.800, max=11.000, mean=6.276",
         "0",
         "0.3",
         "not-mortality",
         "Moderate risk: acute kidney injury (creatinine 1.844 mg/dL), metabolic acidosis (pH 7.333, base excess -5.0), requiring oxygen support (FiO2 57.4%), thrombocytopenia (platelets 73.7), and high inflammation (CRP 76.25 mg/L). However, lactate only mildly elevated at 1.5 mmol/L, adequate urine output 172.8 mL/h, and stable hemodynamics suggest survivable condition with treatment.",
         "0",
         "0",
         "1962",
         "827",
         "0",
         "Let me analyze this patient data systematically for signs of mortality risk.\n\nKey abnormal findings to examine:\n\n1. Cardiovascular:\n- Mean arterial pressure: 71.5 mmHg (borderline low but not critically low)\n- Heart rate: 104.5 bpm (slightly elevated)\n- Systolic BP: 99.6 mmHg (borderline low)\n\n2. Respiratory:\n- FiO2: 57.4% mean (requiring significant oxygen support)\n- pH: 7.333 mean (slightly acidotic)\n- Base excess: -5.0 mean (metabolic acidosis)\n\n3. Renal:\n- Creatinine: 1.844 mg/dL mean (elevated, suggesting kidney injury)\n- BUN: 29.4 mg/dL (elevated)\n- Urine output: 172.8 mL/h mean (adequate but variable range 55-325)\n\n4. Hematologic:\n- Hemoglobin: 8.24 g/dL (anemia)\n- Platelets: 73.7 thousand/?L mean (thrombocytopenia)\n- WBC: 6.276 (normal range but concerning with other findings)\n\n5. Metabolic:\n- Lactate: 1.5 mmol/L mean (slightly elevated but not critically high)\n- Albumin: 2.8 g/dL (hypoalbuminemia)\n- CRP: 76.25 mg/L (significantly elevated inflammation)\n\n6. Liver function:\n- AST: 34 U/L, ALT: 28 U/L (normal)\n- Bilirubin: 0.5 mg/dL (normal)\n\n7. Coagulation:\n- INR: 1.3 (slightly elevated)\n\nThe concerning findings include:\n- Elevated creatinine suggesting acute kidney injury\n\n\n- Metabolic acidosis indicating potential systemic stress\n- Significant inflammatory response with elevated CRP\n- Compromised hematologic parameters showing anemia and low platelet count\n\nDespite multiple organ system challenges, the patient shows some resilient physiological responses. Mild lactate elevation, consistent urine output, and maintained oxygen saturation suggest the body is attempting to compensate. The cardiovascular and respiratory systems are under strain but not in complete failure, offering a cautiously optimistic clinical picture.\n\nThe overall mortality risk appears moderate, with estimated probability between 25-35%, reflecting the complex but not immediately critical nature of the patient's condition.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "20",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 27, age: 84.0, sex: Female, weight: 60.0, height: 157.5\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=27.000, mean=26.840\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=8.000, max=21.000, mean=8.520\nCalcium (unit: mg/dL): min=8.200, max=10.300, mean=10.216\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=101.000, max=105.000, mean=101.160\nCreatinine (unit: mg/dL): min=0.490, max=1.080, mean=0.514\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=28.000, max=66.500, mean=44.120\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=77.000, max=218.000, mean=150.960\nHemoglobin (unit: g/dL): min=10.300, max=12.300, mean=12.220\nHeart Rate (unit: bpm): min=61.000, max=79.500, mean=68.480\ninr (unit: ): min=1.000, max=1.300, mean=1.012\nPotassium (unit: mmol/L): min=3.500, max=4.000, mean=3.520\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=49.000, max=85.500, mean=67.400\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.300, max=29.900, mean=29.324\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=34.300, mean=34.248\nMean Corpuscular Volume (MCV) (unit: fL): min=85.500, max=90.000, mean=85.680\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.800, max=1.900, mean=1.804\nSodium (unit: mmol/L): min=134.000, max=139.000, mean=134.200\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=98.000, max=100.000, mean=99.800\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.300, max=3.300, mean=2.340\nPlatelets (unit: 1000/µL): min=182.000, max=238.000, mean=235.760\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=28.500, max=35.500, mean=28.780\nRespiratory Rate (unit: breaths/min): min=13.000, max=20.000, mean=15.200\nSystolic Blood Pressure (unit: mmHg): min=111.000, max=176.000, mean=143.140\nTemperature (unit: °C): min=36.211, max=37.289, mean=36.645\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=35.000, max=400.000, mean=112.200\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=8.800, max=11.000, mean=8.888",
         "0",
         "0.72",
         "mortality",
         "Critical hypotension with diastolic BP minimum 28 mmHg and MAP minimum 49 mmHg, severe inflammation with CRP 76.25 mg/L, signs of bacterial infection with neutrophils 80.7% and band neutrophils 8%, plus advanced age 84 years suggesting high mortality risk despite adequate oxygenation and urine output.",
         "0",
         "0",
         "1962",
         "669",
         "0",
         "Let me analyze this patient data systematically to determine mortality risk.\n\nKey findings:\n\n1. Patient demographics: 84-year-old female, which puts her at higher baseline risk\n\n2. Concerning findings:\n- CRP (C-Reactive Protein) = 76.250 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n- Low diastolic BP: min=28.000 mmHg - This is dangerously low (normal 60-80)\n- Low MAP: min=49.000 mmHg - Critically low (normal 70-105), indicating hypotension/shock\n- Neutrophils 80.7% - elevated, suggesting bacterial infection\n- Band neutrophils 8% - elevated, suggesting left shift/acute infection\n- Low lymphocytes 9% - consistent with acute infection\n- Albumin 2.8 g/dL - low (normal 3.4-5.4), suggests poor nutritional status or liver dysfunction\n- FiO2 40% - requiring supplemental oxygen\n\n3. Positive findings:\n- Lactate 1.9 mmol/L - slightly elevated but not critically high (normal <2)\n- pH 7.36 - normal\n- Oxygen saturation 98-100% - good\n- Urine output mean 112.2 mL/h - adequate (should be >0.5 mL/kg/h, so for 60kg patient that's >30 mL/h)\n\n4. Mixed/borderline findings:\n- Creatinine 0.49-1.08 mg/dL - upper end slightly elevated\n- BUN 8-21 mg/dL - some elevation\n\nThe combination of severe inflammation (CRP 76.25), hypotension (diastolic 28, MAP 49), signs of infection (neutrophilia, bandemia, lymphopenia), and advanced age (84) in an ICU setting suggests high mortality risk. The hypotension is particularly concerning as it indicates potential septic shock or cardiovascular compromise.\n\n\nDespite critical indicators, some physiological parameters offer a glimmer of hope. Stable oxygenation and urine output suggest partial organ resilience. While the patient's condition remains grave, the mortality risk isn't absolute. I'm leaning toward a 70-75% probability of fatal outcome, acknowledging the complex interplay of her clinical markers.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "21",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 28, age: 86.0, sex: Female, weight: 58.0, height: 157.5\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=25.000, mean=24.120\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=17.000, max=21.000, mean=18.760\nCalcium (unit: mg/dL): min=8.200, max=8.500, mean=8.368\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=108.000, mean=106.680\nCreatinine (unit: mg/dL): min=0.730, max=1.080, mean=0.884\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=39.500, max=60.000, mean=48.320\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=50.000, mean=47.600\nGlucose (unit: mg/dL): min=97.000, max=183.000, mean=132.280\nHemoglobin (unit: g/dL): min=10.000, max=10.300, mean=10.132\nHeart Rate (unit: bpm): min=59.000, max=91.500, mean=75.260\ninr (unit: ): min=1.200, max=1.300, mean=1.260\nPotassium (unit: mmol/L): min=3.200, max=4.000, mean=3.600\nLactate (unit: mmol/L): min=1.600, max=1.900, mean=1.648\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=60.000, max=78.500, mean=69.180\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.000, max=29.900, mean=28.836\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.400, max=33.000, mean=32.664\nMean Corpuscular Volume (MCV) (unit: fL): min=86.300, max=90.000, mean=87.928\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.200, max=2.500, mean=1.612\nSodium (unit: mmol/L): min=139.000, max=142.000, mean=140.680\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=96.500, max=100.000, mean=99.640\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.500, max=3.300, mean=2.852\nPlatelets (unit: 1000/µL): min=114.000, max=182.000, mean=143.920\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=31.100, max=35.500, mean=31.276\nRespiratory Rate (unit: breaths/min): min=12.000, max=19.000, mean=12.720\nSystolic Blood Pressure (unit: mmHg): min=111.500, max=142.000, mean=129.460\nTemperature (unit: °C): min=34.656, max=37.800, mean=36.712\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=30.000, max=600.000, mean=138.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=13.300, mean=12.288",
         "1",
         "0.85",
         "mortality",
         "High-risk 86-year-old patient with severe sepsis indicators: CRP 76.25 mg/L (severe inflammation), hypothermia 34.656?C, hypotension (diastolic BP 39.5 mmHg), oliguria 30 mL/h, elevated WBC 13.3 with 8% bands indicating bacterial infection, thrombocytopenia 114, and hypoalbuminemia 2.8 g/dL. Multiple organ dysfunction in elderly patient suggests high mortality risk.",
         "0",
         "0",
         "1962",
         "850",
         "0",
         "Let me analyze this patient data carefully:\n\nKey patient info:\n- Age: 86.0 (elderly)\n- Sex: Female\n- Weight: 58.0 kg\n- Height: 157.5 cm\n\nLet me go through the abnormal values:\n\n1. Albumin: 2.8 g/dL - This is low (normal is typically 3.5-5.0 g/dL), indicating possible malnutrition or liver dysfunction.\n\n2. CRP: 76.25 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection.\n\n3. Diastolic BP: min 39.5 mmHg - This is low, indicating possible hypotension.\n\n4. FiO2: 40-50% - Patient requires supplemental oxygen, indicating respiratory compromise.\n\n5. Hemoglobin: 10.0-10.3 g/dL - This is low (normal for women is 12-14 g/dL), indicating anemia.\n\n6. Band Neutrophils: 8% - This is elevated (normal is 0-3%), indicating bacterial infection.\n\n7. Neutrophils: 80.7% - This is elevated (normal is 50-70%), indicating bacterial infection.\n\n8. Lymphocytes: 9% - This is low (normal is 20-40%), indicating immunosuppression or severe infection.\n\n9. WBC: 11.0-13.3 - This is elevated (normal is 4-11), indicating infection.\n\n10. Temperature: min 34.656?C - This is hypothermic, which can be a sign of severe illness.\n\n11. Platelets: min 114 - This is low (normal is 150-450), indicating thrombocytopenia.\n\n12. Urine output: min 30 mL/h - This is very low, indicating oliguria/kidney dysfunction.\n \nSome positive findings provide a nuanced view of the patient's condition. Lactate is only mildly elevated at 1.6-1.9 mmol/L, which isn't critically high. The patient's pH remains within normal range at 7.36, and oxygen parameters look relatively stable with PaO2 at 101 mmHg and oxygen saturation between 96.5-100%. \n\nI'm seeing an elderly patient with complex clinical presentation, characterized by signs of severe systemic infection, compromised physiological reserves, and multiple organ system challenges.\n\nThe patient's critical status is evident through compounding clinical markers: profound infection markers, hypothermic state, low blood pressure, reduced urine output, and hematological abnormalities. These findings collectively indicate a precarious clinical scenario with significant mortality risk for this 86-year-old individual.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "22",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 29, age: 62.0, sex: Male, weight: 76.5, height: 165.0\nAlbumin (unit: g/dL): min=2.800, max=3.300, mean=3.220\nAlkaline Phosphatase (unit: U/L): min=65.000, max=78.000, mean=67.080\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=201.000, mean=173.320\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=296.000, mean=254.080\nBase Excess (unit: mmol/L): min=-11.000, max=-1.000, mean=-7.720\nBicarbonate (unit: mmol/L): min=14.000, max=23.000, mean=16.640\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=1.000, max=8.000, mean=2.120\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=45.000, mean=39.560\nCalcium (unit: mg/dL): min=7.500, max=8.300, mean=7.868\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=110.000, mean=109.000\nCreatinine (unit: mg/dL): min=1.080, max=1.460, mean=1.369\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=51.000, max=73.500, mean=61.900\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=30.000, max=50.000, mean=35.200\nGlucose (unit: mg/dL): min=77.000, max=215.000, mean=157.660\nHemoglobin (unit: g/dL): min=10.300, max=14.400, mean=13.744\nHeart Rate (unit: bpm): min=93.000, max=111.000, mean=101.220\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.500, mean=4.380\nLactate (unit: mmol/L): min=1.200, max=1.900, mean=1.392\nLymphocytes (unit: %): min=9.000, max=9.800, mean=9.672\nMean Arterial Pressure (MAP) (unit: mmHg): min=61.500, max=84.500, mean=73.520\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.800, max=29.900, mean=29.816\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.800, mean=33.672\nMean Corpuscular Volume (MCV) (unit: fL): min=88.200, max=90.000, mean=88.488\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=134.000, max=139.000, mean=136.480\nNeutrophils (unit: %): min=80.700, max=82.100, mean=81.876\nOxygen Saturation (unit: %): min=98.000, max=100.000, mean=99.640\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=28.000, max=40.000, mean=31.600\npH Level (unit: /): min=7.320, max=7.360, mean=7.346\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=127.000, max=182.000, mean=135.800\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=185.000, mean=138.440\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=15.000, max=31.000, mean=22.900\nSystolic Blood Pressure (unit: mmHg): min=84.500, max=115.500, mean=100.060\nTemperature (unit: °C): min=35.606, max=37.394, mean=36.763\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=60.000, mean=34.800\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=20.500, mean=18.980",
         "0",
         "0.78",
         "mortality",
         "Multi-organ dysfunction evident: severe hepatic injury (AST max=296 U/L, ALT max=201 U/L), severe metabolic acidosis (base excess min=-11 mmol/L, bicarbonate min=14 mmol/L), acute kidney injury (creatinine 1.369 mg/dL), critical oliguria (urine output min=0 mL/h), and systemic inflammation (CRP=76.25 mg/L, WBC=18.98k).",
         "0",
         "0",
         "1962",
         "662",
         "0",
         "Let me analyze this patient's data systematically to assess mortality risk:\n\nConcerning findings:\n1. Liver function severely impaired: ALT max=201 U/L (normal ~10-40), AST max=296 U/L (normal ~10-40), indicating significant hepatic injury\n2. Base excess very low: min=-11 mmol/L (normal -2 to +2), indicating severe metabolic acidosis\n3. Bicarbonate low: min=14 mmol/L (normal 22-28), confirming metabolic acidosis\n4. High inflammatory markers: CRP=76.25 mg/L (normal <3), WBC=18.98k (elevated, normal 4-11k)\n5. Renal dysfunction: Creatinine elevated at 1.369 mg/dL (normal 0.7-1.2), BUN elevated at 39.56 mg/dL\n6. Critical urine output: min=0 mL/h, mean=34.8 mL/h (should be >0.5 mL/kg/h = ~38 mL/h for 76.5kg patient)\n7. Low albumin: 2.8-3.3 g/dL (normal 3.5-5.0)\n8. Hypocalcemia: calcium 7.5-8.3 mg/dL (normal 8.5-10.5)\n\nPositive findings:\n1. Lactate relatively normal: 1.2-1.9 mmol/L (normal <2)\n2. Oxygen saturation good: 98-100%\n3. Heart rate elevated but not critically so: 93-111 bpm\n4. Blood pressure low-normal but stable\n5. FiO2 requirement moderate: 30-50%\n\nThe combination of severe hepatic dysfunction, metabolic acidosis, renal impairment, oliguria, and systemic inflammation suggests multi-organ dysfunction. \n\nZero urine output signals critical kidney compromise, dramatically escalating patient risk. This complete urinary shutdown represents a severe warning sign of potential renal failure and systemic collapse. With multiple organ systems showing significant dysfunction, the mortality probability appears extremely high, likely approaching 80-90% without immediate, aggressive intervention.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "23",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 3, age: 44.0, sex: Male, weight: 87.1, height: 178.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=23.000, mean=23.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=21.000, mean=21.000\nCalcium (unit: mg/dL): min=8.200, max=8.200, mean=8.200\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=340.000, mean=328.640\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=105.000, mean=105.000\nCreatinine (unit: mg/dL): min=1.080, max=1.080, mean=1.080\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=60.000, max=84.000, mean=74.760\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=136.000, max=136.000, mean=136.000\nHemoglobin (unit: g/dL): min=10.300, max=10.300, mean=10.300\nHeart Rate (unit: bpm): min=61.000, max=84.500, mean=69.280\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.000, mean=4.000\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=72.000, max=92.000, mean=83.760\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=29.900, mean=29.900\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.000, mean=33.000\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=90.000, mean=90.000\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=139.000, max=139.000, mean=139.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=93.500, max=97.000, mean=94.800\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=182.000, max=182.000, mean=182.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=16.000, max=25.000, mean=19.260\nSystolic Blood Pressure (unit: mmHg): min=98.000, max=125.000, mean=113.120\nTemperature (unit: °C): min=36.317, max=36.890, mean=36.614\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=11.000, mean=11.000",
         "0",
         "0.25",
         "not-mortality",
         "Moderate infection risk: elevated CRP 76.25 mg/L and band neutrophils 8% indicate sepsis, requiring FiO2 40% with oxygen saturation 94.8%. However, stable hemodynamics (MAP 72-92 mmHg), normal lactate 1.9 mmol/L, adequate urine output 100 mL/h, and normal pH 7.36 suggest manageable condition without multi-organ failure.",
         "0",
         "0",
         "1962",
         "756",
         "0",
         "Let me analyze this patient data systematically to assess mortality risk:\n\nPatient: 44-year-old male, weight 87.1 kg, height 178 cm\n\nKey abnormal findings:\n1. CRP: 76.25 mg/L - significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n2. Band neutrophils: 8% - elevated (normal 0-5%), indicating left shift/bacterial infection\n3. Neutrophils: 80.7% - elevated (normal 50-70%), confirming infection\n4. Lymphocytes: 9% - low (normal 20-40%), consistent with sepsis\n5. WBC: 11 thousand/?L - mildly elevated (normal 4-10)\n6. FiO2: 40% - requiring supplemental oxygen\n7. Oxygen saturation: 93.5-97%, mean 94.8% - borderline low\n8. Hemoglobin: 10.3 g/dL - mild anemia (normal 14-17.5 for men)\n9. Albumin: 2.8 g/dL - low (normal 3.5-5.0), indicating poor nutritional status or liver dysfunction\n10. Calcium: 8.2 mg/dL - low (normal 8.5-10.5)\n11. Creatine kinase: 198-340 U/L (mean 328.6) - elevated (normal <200), suggesting muscle damage\n12. INR: 1.3 - mildly elevated (normal <1.1), suggesting coagulopathy\n\nPositive findings:\n- Lactate: 1.9 mmol/L - only mildly elevated (normal <2.0)\n- Blood pressure: stable (SBP 98-125, MAP 72-92)\n- Heart rate: 61-84.5 bpm - normal\n\n\n- Creatinine: 1.08 mg/dL - mild kidney stress\n- Temperature: within normal limits\n- pH: 7.36 - balanced\n- Urine output: 100 mL/h - adequate hydration\n\nI'm seeing a complex clinical picture of moderate-risk sepsis. The patient has significant inflammatory markers and infection indicators, with mild organ dysfunction. While not in critical condition, there are multiple systems showing compromise - respiratory, inflammatory, and metabolic. The stable vital signs and moderate lab abnormalities suggest a guarded but not immediately life-threatening scenario requiring careful monitoring and aggressive infection management.\n\nThe patient's condition indicates a moderate mortality risk, primarily due to preserved hemodynamic stability and organ function maintaining reasonable compensatory mechanisms.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "24",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 30, age: 49.0, sex: Male, weight: 55.5, height: 165.1\nAlbumin (unit: g/dL): min=2.200, max=2.600, mean=2.308\nAlkaline Phosphatase (unit: U/L): min=28.000, max=38.000, mean=33.160\nAlanine Aminotransferase (ALT) (unit: U/L): min=192.000, max=829.000, mean=563.760\nAspartate Aminotransferase (AST) (unit: U/L): min=218.000, max=603.000, mean=412.920\nBase Excess (unit: mmol/L): min=-9.000, max=-6.000, mean=-6.240\nBicarbonate (unit: mmol/L): min=19.000, max=22.000, mean=21.040\nTotal Bilirubin (unit: mg/dL): min=1.600, max=4.500, mean=3.012\nBand Neutrophils (unit: %): min=34.000, max=42.000, mean=41.040\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=12.000, max=26.000, mean=17.960\nCalcium (unit: mg/dL): min=7.200, max=8.500, mean=7.904\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=115.000, max=120.000, mean=117.320\nCreatinine (unit: mg/dL): min=0.680, max=0.760, mean=0.720\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=45.000, max=69.000, mean=53.700\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=60.000, mean=42.400\nGlucose (unit: mg/dL): min=76.000, max=186.000, mean=119.840\nHemoglobin (unit: g/dL): min=8.500, max=10.600, mean=9.164\nHeart Rate (unit: bpm): min=75.000, max=128.000, mean=97.900\ninr (unit: ): min=1.400, max=1.700, mean=1.516\nPotassium (unit: mmol/L): min=4.000, max=4.300, mean=4.120\nLactate (unit: mmol/L): min=1.800, max=4.600, mean=2.448\nLymphocytes (unit: %): min=3.600, max=3.600, mean=3.600\nMean Arterial Pressure (MAP) (unit: mmHg): min=58.500, max=91.500, mean=73.860\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=26.900, max=27.400, mean=27.208\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.900, max=33.000, mean=32.520\nMean Corpuscular Volume (MCV) (unit: fL): min=82.900, max=84.700, mean=83.696\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.400, max=1.900, mean=1.840\nSodium (unit: mmol/L): min=141.000, max=145.000, mean=142.760\nNeutrophils (unit: %): min=87.200, max=87.200, mean=87.200\nOxygen Saturation (unit: %): min=96.000, max=100.000, mean=97.980\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=34.000, max=36.000, mean=35.840\npH Level (unit: /): min=7.310, max=7.350, mean=7.347\nPhosphate (unit: mg/dL): min=3.900, max=4.400, mean=3.960\nPlatelets (unit: 1000/µL): min=28.000, max=58.000, mean=34.800\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=91.000, max=142.000, mean=137.920\nPartial Thromboplastin Time (PTT) (unit: sec): min=33.200, max=33.200, mean=33.200\nRespiratory Rate (unit: breaths/min): min=11.000, max=20.000, mean=14.260\nSystolic Blood Pressure (unit: mmHg): min=85.500, max=142.500, mean=110.580\nTemperature (unit: °C): min=35.894, max=37.106, mean=36.658\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=15.000, max=80.000, mean=30.600\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=4.400, max=7.600, mean=5.812",
         "0",
         "0.85",
         "mortality",
         "Severe multi-organ dysfunction: acute liver failure with ALT 829 U/L and AST 603 U/L, coagulopathy (INR 1.7, platelets 28,000), metabolic acidosis (base excess -9 mmol/L, pH 7.31), sepsis (CRP 76.25 mg/L, bands 42%), oliguria (15 mL/h minimum), and elevated lactate 4.6 mmol/L indicating tissue hypoperfusion.",
         "0",
         "0",
         "1962",
         "875",
         "0",
         "Looking at this patient data, I need to identify key abnormal values that might suggest high mortality risk:\n\nKey concerning findings:\n\n1. Liver function severely impaired:\n   - ALT: min=192, max=829, mean=563.76 (very elevated, normal <40)\n   - AST: min=218, max=603, mean=412.92 (very elevated, normal <40)  \n   - Total Bilirubin: min=1.6, max=4.5, mean=3.012 (elevated, normal <1.2)\n   - Low albumin: min=2.2, max=2.6, mean=2.308 (low, normal 3.5-5.0)\n\n2. Coagulopathy:\n   - INR: min=1.4, max=1.7, mean=1.516 (elevated, normal ~1.0)\n   - Severely low platelets: min=28, max=58, mean=34.8 (critically low, normal 150-450)\n\n3. Metabolic acidosis:\n   - Base excess: min=-9, max=-6, mean=-6.24 (negative base excess indicates acidosis)\n   - pH: min=7.31, max=7.35, mean=7.347 (acidemic, normal 7.35-7.45)\n\n4. Signs of infection/inflammation:\n   - CRP: 76.25 (elevated, normal <3)\n   - Band neutrophils: 34-42% (very high, normal <10%)\n   - High neutrophils: 87.2% (elevated)\n   - Low lymphocytes: 3.6% (lymphopenia)\n\n5. Hemodynamic instability:\n   - Low diastolic BP: min=45 (hypotensive)\n   - MAP: min=58.5 (borderline low)\n   \n6. Respiratory and renal challenges:\n   - Oxygen requirements: 40-60% FiO2 indicating respiratory compromise\n   - Reduced urine output: 15-30.6 mL/h suggests early renal dysfunction\n   - Hemoglobin levels critically low at 8.5-10.6, indicating significant anemia\n\n7. Metabolic and systemic distress:\n   - Lactate elevated at 1.8-4.6, signaling potential tissue hypoperfusion\n   - Markers point to severe systemic inflammatory response\n   - Multi-organ involvement suggests critical clinical condition with high mortality risk\n\nI'm tracking a complex clinical picture of progressive physiological breakdown across multiple organ systems, with metabolic and inflammatory markers indicating profound patient vulnerability.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "25",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 31, age: 88.0, sex: Female, weight: 56.4, height: 155.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=24.000, max=78.000, mean=36.960\nAlanine Aminotransferase (ALT) (unit: U/L): min=17.000, max=28.000, mean=19.640\nAspartate Aminotransferase (AST) (unit: U/L): min=17.000, max=34.000, mean=21.080\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=17.000, max=23.000, mean=18.480\nTotal Bilirubin (unit: mg/dL): min=0.100, max=0.700, mean=0.348\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=10.000, max=21.000, mean=12.560\nCalcium (unit: mg/dL): min=7.100, max=8.200, mean=7.452\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=116.000, mean=113.080\nCreatinine (unit: mg/dL): min=0.610, max=1.080, mean=0.672\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=25.000, max=68.000, mean=45.260\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=73.000, max=136.000, mean=95.840\nHemoglobin (unit: g/dL): min=10.300, max=12.900, mean=12.492\nHeart Rate (unit: bpm): min=77.000, max=97.000, mean=87.100\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.200, max=4.000, mean=3.628\nLactate (unit: mmol/L): min=1.200, max=1.900, mean=1.348\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=45.000, max=77.000, mean=60.920\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.900, mean=30.800\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.700, mean=33.532\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=92.800, mean=91.852\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.200, max=2.200, mean=1.588\nSodium (unit: mmol/L): min=137.000, max=142.000, mean=138.080\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=92.000, max=97.000, mean=94.860\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=1.800, max=3.300, mean=2.156\nPlatelets (unit: 1000/µL): min=182.000, max=219.000, mean=194.720\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=30.300, max=35.500, mean=30.508\nRespiratory Rate (unit: breaths/min): min=18.000, max=25.000, mean=21.680\nSystolic Blood Pressure (unit: mmHg): min=90.000, max=133.000, mean=115.000\nTemperature (unit: °C): min=36.606, max=38.000, mean=37.305\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=20.000, max=400.000, mean=88.400\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=13.000, mean=11.476",
         "0",
         "0.78",
         "mortality",
         "High-risk elderly patient (88 years) with evidence of septic shock: severe hypotension (diastolic BP min 25 mmHg, MAP min 45 mmHg), severe inflammation (CRP 76.25 mg/L), oliguria (urine output min 20 mL/h), and infectious markers (band neutrophils 8%, neutrophils 80.7%). Despite stable lactate and oxygenation, the combination of shock and organ dysfunction indicates high mortality risk.",
         "0",
         "0",
         "1962",
         "621",
         "0",
         "Let me analyze this patient data systematically to determine mortality risk.\n\nPatient info: 88-year-old female, which is a high-risk age group.\n\nKey concerning findings:\n1. CRP = 76.25 mg/L - significantly elevated, indicating severe inflammation/infection\n2. Diastolic BP: min 25 mmHg - very low, concerning for shock\n3. Mean Arterial Pressure: min 45 mmHg - critically low (normal >65 mmHg)\n4. Urine output: min 20 mL/h - oliguria, concerning for kidney dysfunction\n5. Band neutrophils 8% - indicates left shift, bacterial infection\n6. Neutrophils 80.7% with lymphocytes only 9% - suggests severe infection/sepsis\n7. WBC 11-13 - elevated but not extremely high\n8. Calcium low at 7.1-8.2 mg/dL (normal 8.5-10.5)\n9. INR 1.3 - mildly elevated, could indicate liver dysfunction or anticoagulation\n\nPositive findings:\n1. Lactate 1.2-1.9 mmol/L - only mildly elevated (normal <2)\n2. FiO2 40% - not requiring high oxygen\n3. Oxygen saturation 92-97% - acceptable\n4. pH 7.36 - normal\n5. Creatinine 0.61-1.08 - not severely elevated for age\n\nThe most concerning findings are:\n- Very low diastolic BP (25 mmHg) and low MAP (45 mmHg) - indicates shock\n- High CRP (76.25) indicating severe systemic inflammation\n- Oliguria (20 mL/h minimum) - concerning for organ dysfunction\n- Signs of infection (elevated bands, neutrophilia)\n- Advanced age (88 years)\n\nThis combination of hypotension, signs of infection/sepsis, and oliguria in an elderly patient is concerning for high mortality risk.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "26",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 32, age: 43.0, sex: Female, weight: 84.15, height: 165.1\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=23.000, mean=23.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=21.000, mean=21.000\nCalcium (unit: mg/dL): min=8.200, max=8.200, mean=8.200\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=105.000, mean=105.000\nCreatinine (unit: mg/dL): min=1.080, max=1.080, mean=1.080\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=63.000, max=89.000, mean=80.440\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=136.000, max=136.000, mean=136.000\nHemoglobin (unit: g/dL): min=10.300, max=10.300, mean=10.300\nHeart Rate (unit: bpm): min=68.000, max=95.500, mean=79.240\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.000, mean=4.000\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=74.000, max=99.000, mean=92.800\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=29.900, mean=29.900\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.000, mean=33.000\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=90.000, mean=90.000\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=139.000, max=139.000, mean=139.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=90.000, max=97.500, mean=92.900\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=182.000, max=182.000, mean=182.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=19.000, max=21.000, mean=20.120\nSystolic Blood Pressure (unit: mmHg): min=108.000, max=140.000, mean=132.240\nTemperature (unit: °C): min=36.890, max=36.890, mean=36.890\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=11.000, mean=11.000",
         "0",
         "0.25",
         "not-mortality",
         "Moderate infection markers: CRP elevated at 76.25 mg/L, neutrophilia 80.7% with bands 8%, but stable hemodynamics (MAP 92.8 mmHg), normal pH 7.36, lactate only mildly elevated at 1.9 mmol/L, and requiring only moderate oxygen support (FiO2 40%). No severe organ failure present.",
         "0",
         "0",
         "1962",
         "699",
         "0",
         "Let me analyze this patient data systematically:\n\nPatient: 43-year-old female, weight 84.15kg, height 165.1cm\n\nLet me check for concerning values:\n\n1. Albumin: 2.8 g/dL - this is low (normal is 3.4-5.4), indicates protein depletion or liver dysfunction\n2. CRP: 76.25 mg/L - very high (normal <3), indicates significant inflammation/infection\n3. Hemoglobin: 10.3 g/dL - low (normal 12-16), indicates anemia\n4. Lactate: 1.9 mmol/L - mildly elevated (normal <2), suggests possible tissue hypoperfusion\n5. Neutrophils: 80.7% - high (normal 50-70%), suggests bacterial infection\n6. Band neutrophils: 8% - high (normal 0-5%), suggests acute bacterial infection with left shift\n7. Lymphocytes: 9% - low (normal 20-40%), consistent with acute bacterial infection\n8. WBC: 11 1000/?L - mildly elevated (normal 4-11), consistent with infection\n9. FiO2: 40% - indicates patient is on supplemental oxygen\n10. O2 saturation: 90-97.5% (mean 92.9%) - concerning, some readings below normal (>95%)\n11. Urine output: 100 mL/h - this might be low depending on weight, for 84kg patient should be around 84 mL/h minimum\n12. Creatinine: 1.08 mg/dL - mildly elevated for a female (normal 0.6-1.1)\n\nSigns of sepsis/infection:\n- Very high CRP (76.25)\n- Elevated neutrophils with left shift (bands 8%)\n- Low lymphocytes\n- Mildly elevated lactate\n\n\n- Need for supplemental oxygen suggests respiratory compromise\n\nThe patient requires oxygen support, indicating some respiratory distress. However, the oxygen requirements are moderate, with a relatively low FiO2 of 40%. This suggests a mild to moderate respiratory involvement rather than severe respiratory failure. The oxygen saturation fluctuates between 90-97.5%, with an average of 92.9%, which is borderline but not critically low. While the need for supplemental oxygen is concerning, it doesn't appear to represent a life-threatening respiratory emergency at this moment.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "27",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 33, age: 65.0, sex: Male, weight: 54.9, height: 167.6\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=31.000, max=78.000, mean=32.880\nAlanine Aminotransferase (ALT) (unit: U/L): min=8.000, max=28.000, mean=8.800\nAspartate Aminotransferase (AST) (unit: U/L): min=13.000, max=34.000, mean=13.840\nBase Excess (unit: mmol/L): min=-1.000, max=2.000, mean=1.880\nBicarbonate (unit: mmol/L): min=23.000, max=27.000, mean=26.200\nTotal Bilirubin (unit: mg/dL): min=0.300, max=2.200, mean=1.220\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=12.000, max=21.000, mean=13.800\nCalcium (unit: mg/dL): min=8.100, max=8.200, mean=8.120\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=104.000, max=105.000, mean=104.200\nCreatinine (unit: mg/dL): min=0.310, max=1.080, mean=0.464\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=48.000, max=56.500, mean=51.540\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=70.000, mean=42.800\nGlucose (unit: mg/dL): min=106.000, max=163.000, mean=123.160\nHemoglobin (unit: g/dL): min=8.000, max=10.300, mean=8.460\nHeart Rate (unit: bpm): min=57.500, max=70.500, mean=62.760\ninr (unit: ): min=1.100, max=1.300, mean=1.108\nPotassium (unit: mmol/L): min=4.000, max=4.000, mean=4.000\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=68.000, max=80.000, mean=73.800\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.100, mean=30.060\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=34.300, mean=34.040\nMean Corpuscular Volume (MCV) (unit: fL): min=87.900, max=90.000, mean=88.320\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=135.000, max=139.000, mean=135.800\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=98.000, max=100.000, mean=99.880\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=41.000, mean=40.160\npH Level (unit: /): min=7.360, max=7.430, mean=7.426\nPhosphate (unit: mg/dL): min=3.100, max=3.300, mean=3.124\nPlatelets (unit: 1000/µL): min=182.000, max=220.000, mean=212.400\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=263.000, mean=132.520\nPartial Thromboplastin Time (PTT) (unit: sec): min=29.900, max=35.500, mean=30.124\nRespiratory Rate (unit: breaths/min): min=14.000, max=16.000, mean=14.340\nSystolic Blood Pressure (unit: mmHg): min=102.500, max=132.000, mean=114.760\nTemperature (unit: °C): min=36.394, max=37.106, mean=36.844\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=25.000, max=60.000, mean=36.200\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=7.400, max=11.000, mean=8.120",
         "0",
         "0.72",
         "mortality",
         "High-risk profile: severe inflammation with CRP 76.250 mg/L, malnutrition indicated by albumin 2.8 g/dL, anemia with hemoglobin 8.0 g/dL, infection signs with band neutrophils 8% and neutrophils 80.7%, low urine output 25-60 mL/h, requiring oxygen support FiO2 40-70%, and low weight 54.9 kg suggesting wasting. However, normal lactate 1.9 mmol/L and stable pH provide some reassurance.",
         "0",
         "0",
         "1962",
         "652",
         "0",
         "Let me analyze this patient data systematically to assess mortality risk:\n\nPatient is a 65-year-old male, weight 54.9 kg, which appears quite low for his height (167.6 cm), suggesting possible malnutrition or wasting.\n\nKey concerning findings:\n1. Very high CRP at 76.250 mg/L (normal <3 mg/L) - indicates significant inflammation/infection\n2. Low albumin at 2.8 g/dL (normal 3.5-5.0) - suggests malnutrition or liver dysfunction \n3. Low hemoglobin 8.0-10.3 g/dL (normal 13.5-17.5) - anemia\n4. Elevated band neutrophils at 8% (normal <3%) - suggests bacterial infection\n5. High neutrophils at 80.7% (normal 50-70%) - inflammatory response\n6. Low lymphocytes at 9% (normal 20-40%) - immunosuppression\n7. Low urine output 25-60 mL/h (should be >30 mL/h, ideally >0.5 mL/kg/h) - for 54.9 kg patient, should be >27 mL/h minimum, so borderline low\n8. Requiring supplemental oxygen (FiO2 40-70%)\n9. Low diastolic BP 48-56.5 mmHg (normal 60-80)\n\nSome positive findings:\n- Normal lactate at 1.9 mmol/L (normal <2)\n- Adequate oxygen saturation 98-100%\n- Normal pH 7.36-7.43\n- Heart rate not too high (57.5-70.5)\n\nThe combination of severe inflammation (very high CRP), malnutrition (low albumin), anemia, signs of infection (high bands, high neutrophils), and low urine output are concerning. \n\nDespite multiple critical markers, the patient's condition suggests a moderate risk profile. Stabilizing metabolic parameters and addressing underlying inflammatory processes appear crucial, while the normal lactate and relatively stable vital signs provide a cautiously optimistic perspective.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "28",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 34, age: 47.0, sex: Male, weight: 70.9, height: 175.3\nAlbumin (unit: g/dL): min=2.400, max=2.800, mean=2.528\nAlkaline Phosphatase (unit: U/L): min=78.000, max=163.000, mean=146.200\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=48.000, mean=43.520\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=98.000, mean=84.560\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=16.000, max=23.000, mean=17.120\nTotal Bilirubin (unit: mg/dL): min=0.300, max=48.000, mean=20.142\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=121.000, mean=104.200\nCalcium (unit: mg/dL): min=8.200, max=8.700, mean=8.600\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=107.000, mean=106.680\nCreatinine (unit: mg/dL): min=1.080, max=5.910, mean=5.099\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=48.000, max=64.000, mean=54.580\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=74.000, max=136.000, mean=92.880\nHemoglobin (unit: g/dL): min=6.400, max=10.300, mean=7.120\nHeart Rate (unit: bpm): min=72.000, max=92.500, mean=82.020\ninr (unit: ): min=1.300, max=1.800, mean=1.592\nPotassium (unit: mmol/L): min=4.000, max=4.400, mean=4.296\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=63.000, max=78.500, mean=69.420\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=33.500, mean=32.140\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=35.900, mean=34.076\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=95.400, mean=94.136\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.400, mean=2.320\nSodium (unit: mmol/L): min=133.000, max=139.000, mean=134.600\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=92.500, max=99.000, mean=97.000\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=4.800, mean=4.420\nPlatelets (unit: 1000/µL): min=130.000, max=182.000, mean=159.720\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=69.700, mean=57.892\nRespiratory Rate (unit: breaths/min): min=15.000, max=23.000, mean=17.600\nSystolic Blood Pressure (unit: mmHg): min=108.000, max=138.500, mean=118.460\nTemperature (unit: °C): min=36.711, max=37.500, mean=37.106\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=10.000, max=75.000, mean=33.600\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=20.200, mean=17.208",
         "0",
         "0.78",
         "mortality",
         "Multi-organ failure: severe hepatic dysfunction with bilirubin max=48.0 mg/dL (mean=20.142), acute kidney injury with creatinine max=5.91 mg/dL and BUN max=121 mg/dL, severe anemia (hemoglobin min=6.4 g/dL), oliguria (min=10 mL/h), coagulopathy (INR max=1.8), and systemic inflammation (CRP=76.25 mg/L, WBC max=20.2).",
         "0",
         "0",
         "1962",
         "794",
         "0",
         "Looking at this patient data, I need to assess the mortality risk by examining concerning values:\n\nKey concerning findings:\n1. Very high Bilirubin: max=48.0 mg/dL, mean=20.142 mg/dL (normal <1.2) - indicates severe liver dysfunction/failure\n2. High Creatinine: max=5.91 mg/dL, mean=5.099 mg/dL (normal 0.6-1.2) - severe kidney dysfunction\n3. Very high BUN: max=121 mg/dL, mean=104.2 mg/dL (normal 7-20) - renal failure\n4. Low Albumin: min=2.4 g/dL, mean=2.528 g/dL (normal 3.5-5.0) - poor nutritional status/liver dysfunction\n5. Severe anemia: Hemoglobin min=6.4 g/dL, mean=7.12 g/dL (normal 13.5-17.5 for men)\n6. High AST: max=98 U/L, mean=84.56 U/L (normal <40) - liver damage\n7. Elevated INR: max=1.8, mean=1.592 (normal ~1.0) - coagulopathy\n8. Low urine output: min=10 mL/h, mean=33.6 mL/h - oliguria (normal >0.5 mL/kg/h = ~35 mL/h for 70kg patient)\n9. High WBC: max=20.2, mean=17.2 (normal 4.5-11) - infection/inflammation\n10. High CRP: 76.25 mg/L (normal <3.0) - severe inflammation\n\nThis patient shows multi-organ failure:\n- Liver failure (high bilirubin, AST, low albumin, coagulopathy)\n\n\n- Kidney failure (high creatinine, BUN, oliguria)\n- Severe anemia compromising oxygen delivery\n- Significant systemic inflammatory response indicated by elevated WBC and CRP\n\nDespite critical condition, some physiological parameters suggest potential for stabilization. Respiratory and hemodynamic measurements remain relatively moderate, with acceptable oxygen support, lactate levels, and blood pressure. The patient's condition is extremely serious, but not entirely without hope for intervention.\n\nPrognosis appears grim, with approximately three-quarters likelihood of fatal outcome given the extensive multi-organ dysfunction and profound systemic compromise.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "29",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 35, age: 52.0, sex: Male, weight: 150.0, height: 172.7\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=29.000, mean=23.720\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=7.000, max=21.000, mean=19.320\nCalcium (unit: mg/dL): min=8.200, max=9.700, mean=8.380\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=105.000, mean=105.000\nCreatinine (unit: mg/dL): min=0.800, max=1.080, mean=1.046\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=39.000, max=97.000, mean=76.940\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=76.000, max=112.000, mean=92.000\nHemoglobin (unit: g/dL): min=10.300, max=13.400, mean=10.672\nHeart Rate (unit: bpm): min=68.000, max=99.000, mean=83.940\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.700, max=4.000, mean=3.964\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=53.000, max=105.000, mean=86.000\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=32.500, mean=30.212\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=34.900, mean=33.228\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=93.200, mean=90.384\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.800, max=1.900, mean=1.888\nSodium (unit: mmol/L): min=139.000, max=140.000, mean=139.120\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=96.000, max=100.000, mean=99.440\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.600, mean=3.336\nPlatelets (unit: 1000/µL): min=139.000, max=182.000, mean=176.840\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=10.000, max=19.000, mean=13.740\nSystolic Blood Pressure (unit: mmHg): min=85.000, max=151.000, mean=115.340\nTemperature (unit: °C): min=36.394, max=37.000, mean=36.734\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=950.000, mean=230.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=3.200, max=11.000, mean=10.064",
         "0",
         "0.78",
         "mortality",
         "Critical sepsis with multi-organ dysfunction: severe inflammation (CRP 76.25 mg/L), hypotension (MAP min 53 mmHg, diastolic BP min 39 mmHg), oliguria periods (urine output min 0.0 mL/h), sepsis markers (band neutrophils 8%, neutrophils 80.7%, lymphocytes 9%), hypoalbuminemia (2.8 g/dL), and coagulopathy (INR 1.3).",
         "0",
         "0",
         "1962",
         "681",
         "0",
         "Let me analyze this ICU patient data systematically to assess mortality risk:\n\nKey abnormal findings:\n1. C-Reactive Protein (CRP): 76.250 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n2. Albumin: 2.800 g/dL - This is low (normal 3.4-5.4 g/dL), suggesting malnutrition or liver dysfunction\n3. Band Neutrophils: 8.000% - Elevated (normal <3%), indicating acute infection/sepsis\n4. Neutrophils: 80.700% - High (normal 50-70%), consistent with bacterial infection\n5. Lymphocytes: 9.000% - Low (normal 20-40%), typical in sepsis\n6. Urine Output: min=0.000 mL/h, max=950.000 mL/h, mean=230.000 mL/h - The minimum of 0 suggests periods of oliguria/anuria which is concerning\n7. Diastolic BP: min=39.000 mmHg - Very low, indicating hypotension\n8. MAP: min=53.000 mmHg - Critically low (normal >65 mmHg for adequate perfusion)\n9. INR: 1.300 - Slightly elevated, suggesting coagulopathy\n10. Lactate: 1.900 mmol/L - Mildly elevated (normal <2.0), but close to threshold for tissue hypoperfusion\n\nPositive findings:\n- FiO2: 40% - Not critically high oxygen requirement\n- Oxygen saturation: 96-100% - Adequate oxygenation\n- pH: 7.360 - Normal\n- Temperature: Normal range\n- Heart rate: 68-99 bpm - Reasonable range\n\nThe combination of severe inflammation (very high CRP), signs of sepsis (elevated bands, neutrophilia, lymphopenia), hypotension (low MAP, low diastolic BP), periods of oliguria, and mild coagulopathy suggests a critically ill patient with sepsis and potential multi-organ dysfunction.\n \nThe clinical picture strongly indicates an extremely precarious condition with substantial risk of fatal outcome. Multiple physiological systems show signs of severe stress, creating a high-probability scenario for potential mortality without immediate, aggressive intervention.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "30",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 36, age: 81.0, sex: Male, weight: 97.0, height: 162.6\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=25.000, mean=24.440\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=15.000, max=21.000, mean=16.680\nCalcium (unit: mg/dL): min=8.100, max=8.200, mean=8.128\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=107.000, mean=106.440\nCreatinine (unit: mg/dL): min=1.000, max=1.080, mean=1.022\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=42.000, max=61.500, mean=47.800\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=75.000, max=209.000, mean=132.520\nHemoglobin (unit: g/dL): min=8.300, max=10.300, mean=8.860\nHeart Rate (unit: bpm): min=63.000, max=83.000, mean=72.660\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.300, mean=4.216\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=65.500, max=92.500, mean=79.200\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.600, max=29.900, mean=28.964\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.100, max=33.000, mean=32.352\nMean Corpuscular Volume (MCV) (unit: fL): min=89.100, max=90.000, mean=89.352\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=134.000, max=139.000, mean=135.400\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=95.000, max=99.500, mean=97.640\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.600, max=3.300, mean=2.796\nPlatelets (unit: 1000/µL): min=182.000, max=236.000, mean=220.880\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=18.000, max=22.000, mean=19.540\nSystolic Blood Pressure (unit: mmHg): min=126.000, max=160.000, mean=146.420\nTemperature (unit: °C): min=36.500, max=38.211, mean=37.680\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=10.000, max=200.000, mean=97.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=7.300, max=11.000, mean=8.336",
         "0",
         "0.78",
         "mortality",
         "High-risk profile: 81-year-old with severe inflammation (CRP 76.25 mg/L), oliguria (min urine output 10 mL/h indicating kidney dysfunction), anemia (Hgb 8.86 g/dL), hypoalbuminemia (2.8 g/dL), signs of infection (bands 8%, neutrophils 80.7%, fever 38.2?C), hypotension (diastolic BP 42 mmHg), and requiring oxygen support (FiO2 40%).",
         "0",
         "0",
         "1962",
         "811",
         "0",
         "Let me analyze this patient data carefully for mortality risk factors:\n\nPatient: 81-year-old male, weight 97kg, height 162.6cm (overweight/obese for height)\n\nLet me look for concerning values:\n\n1. Age: 81 years old - advanced age is a mortality risk factor\n\n2. C-Reactive Protein (CRP): 76.25 mg/L - This is very elevated (normal <3 mg/L), indicating severe inflammation/infection\n\n3. Hemoglobin: 8.3-10.3 g/dL (mean 8.86) - This is low, indicating anemia (normal male 14-18 g/dL)\n\n4. Albumin: 2.8 g/dL - This is low (normal 3.5-5.0 g/dL), indicating malnutrition or liver dysfunction\n\n5. Band neutrophils: 8% - This is elevated (normal <3%), indicating bacterial infection\n\n6. Neutrophils: 80.7% - This is elevated (normal 50-70%), indicating infection/inflammation\n\n7. Lymphocytes: 9% - This is low (normal 20-40%), indicating immunosuppression\n\n8. Urine output: Min 10 mL/h - This is very concerning as it indicates oliguria/kidney dysfunction (normal >0.5 mL/kg/hr, so for 97kg patient should be >48.5 mL/h)\n\n9. FiO2: 40% - Patient requires supplemental oxygen\n\n10. Diastolic BP: Min 42 mmHg - This is low (normal 60-90), indicating hypotension\n\n11. Temperature: Max 38.211?C - Fever indicating infection\n\n12. Creatinine: 1.0-1.08 mg/dL - Borderline elevated for age\n\nLet me check other values:\n\n\nLactate and metabolic parameters suggest mild systemic stress. The slightly elevated lactate of 1.9 mmol/L and borderline pH of 7.36 indicate early metabolic derangement. Mean arterial pressure hovers at the lower acceptable limit, potentially signaling compromised perfusion.\n\nThe comprehensive clinical picture reveals a critically ill elderly patient with multiple organ system involvement. Inflammatory markers, metabolic parameters, and physiological measurements collectively point to a high-risk scenario requiring immediate, aggressive medical intervention.\n\nOxygen requirements and profound hypotension with a critically low diastolic pressure of 42 mmHg further underscore the severity of the patient's condition. These findings strongly suggest an evolving septic process with significant systemic compromise.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "31",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 37, age: 81.0, sex: Male, weight: 97.0, height: 162.6\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=25.000, mean=24.840\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=26.000, mean=25.280\nCalcium (unit: mg/dL): min=8.200, max=9.100, mean=8.876\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=107.000, mean=106.080\nCreatinine (unit: mg/dL): min=0.990, max=1.080, mean=1.043\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=47.000, max=112.000, mean=59.200\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=113.000, max=227.000, mean=168.320\nHemoglobin (unit: g/dL): min=10.200, max=10.500, mean=10.256\nHeart Rate (unit: bpm): min=73.000, max=105.000, mean=85.960\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=5.000, mean=4.792\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=13.500, mean=13.140\nMean Arterial Pressure (MAP) (unit: mmHg): min=70.000, max=121.000, mean=81.520\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.300, mean=30.220\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.800, mean=33.656\nMean Corpuscular Volume (MCV) (unit: fL): min=89.700, max=90.100, mean=89.788\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.400, max=1.900, mean=1.820\nSodium (unit: mmol/L): min=137.000, max=139.000, mean=137.160\nNeutrophils (unit: %): min=77.800, max=80.700, mean=78.032\nOxygen Saturation (unit: %): min=93.000, max=97.500, mean=95.200\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.900, max=3.300, mean=3.236\nPlatelets (unit: 1000/µL): min=182.000, max=289.000, mean=277.240\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=26.300, max=35.500, mean=34.028\nRespiratory Rate (unit: breaths/min): min=16.000, max=26.000, mean=21.420\nSystolic Blood Pressure (unit: mmHg): min=132.000, max=170.000, mean=151.260\nTemperature (unit: °C): min=36.890, max=37.894, mean=37.638\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=300.000, mean=175.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=8.500, max=11.000, mean=8.796",
         "0",
         "0.35",
         "not-mortality",
         "Moderate risk: Significant infection markers present (CRP 76.25 mg/L, bandemia 8%, neutrophilia 77.8-80.7%) with mild fever (37.89?C) and low albumin (2.8 g/dL), but hemodynamically stable with adequate MAP (mean 81.5 mmHg), normal lactate (1.9 mmol/L), and sufficient urine output (175 mL/h mean).",
         "0",
         "0",
         "1962",
         "780",
         "0",
         "Let me analyze this patient data systematically looking for signs of mortality risk:\n\nPatient: 81-year-old male, weight 97kg, height 162.6cm (overweight/obese BMI around 37)\n\nKey concerning findings:\n1. C-Reactive Protein (CRP): 76.25 mg/L - This is quite elevated (normal <3 mg/L), indicating significant inflammation/infection\n2. Band Neutrophils: 8% - Elevated (normal 0-3%), suggests bacterial infection\n3. Neutrophils: 77.8-80.7% - High neutrophil percentage suggests infection\n4. Lymphocytes: 9-13.5% - Low (normal 20-40%), which with high neutrophils suggests stress response/infection\n5. Albumin: 2.8 g/dL - Low (normal 3.5-5.0), indicating malnutrition or chronic illness\n6. Lactate: 1.9 mmol/L - Slightly elevated (normal <2.0), borderline but not critically high\n7. Creatinine: 0.99-1.08 mg/dL - Borderline elevated for age\n8. INR: 1.3 - Slightly elevated coagulation time\n9. Temperature: up to 37.894?C - Mild fever\n10. FiO2: 40% - Requiring supplemental oxygen\n11. Diastolic BP range: 47-112 mmHg with mean 59.2 - The low end is concerning (hypotension)\n12. Urine output: 100-300 mL/h, mean 175 mL/h - This seems adequate\n\nPositive signs:\n- Heart rate 73-105 bpm - not severely tachycardic\n- MAP 70-121 mmHg, mean 81.5 - adequate perfusion pressure\n\n\n- Oxygen saturation 93-97.5% - acceptable respiratory function\n- Acid-base balance remains stable\n- Glucose levels show mild elevation\n- Platelet count within acceptable range\n\nCritically, the patient exhibits complex clinical markers suggesting an infectious process with potential systemic implications. Advanced age compounds the risk, with multiple physiological systems showing subtle signs of compromise. While not in immediate critical condition, the patient requires close monitoring and aggressive intervention to prevent potential deterioration.\n\nI assess the clinical trajectory as moderately precarious, with approximately 40% probability of clinical progression requiring escalated medical management.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "32",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 38, age: 50.0, sex: Male, weight: 85.7, height: 185.4\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=3.000, max=3.000, mean=3.000\nBicarbonate (unit: mmol/L): min=28.000, max=33.000, mean=31.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=6.000, max=6.000, mean=6.000\nCalcium (unit: mg/dL): min=7.900, max=8.300, mean=8.140\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=100.000, max=102.000, mean=100.800\nCreatinine (unit: mg/dL): min=0.510, max=0.590, mean=0.542\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=48.000, max=82.000, mean=61.900\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=50.000, max=50.000, mean=50.000\nGlucose (unit: mg/dL): min=105.000, max=181.000, mean=130.360\nHemoglobin (unit: g/dL): min=9.600, max=9.700, mean=9.660\nHeart Rate (unit: bpm): min=61.500, max=99.000, mean=69.260\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.400, max=3.800, mean=3.560\nLactate (unit: mmol/L): min=0.700, max=0.700, mean=0.700\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=65.000, max=112.500, mean=83.480\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=25.100, max=25.700, mean=25.460\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.900, max=33.000, mean=32.560\nMean Corpuscular Volume (MCV) (unit: fL): min=77.800, max=78.500, mean=78.080\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.300, max=2.500, mean=2.020\nSodium (unit: mmol/L): min=139.000, max=139.000, mean=139.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=99.000, max=100.000, mean=99.960\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=46.000, max=46.000, mean=46.000\npH Level (unit: /): min=7.390, max=7.390, mean=7.390\nPhosphate (unit: mg/dL): min=2.700, max=3.400, mean=2.980\nPlatelets (unit: 1000/µL): min=111.000, max=112.000, mean=111.600\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=182.000, max=182.000, mean=182.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=10.000, max=15.000, mean=12.140\nSystolic Blood Pressure (unit: mmHg): min=93.500, max=168.000, mean=122.180\nTemperature (unit: °C): min=36.000, max=37.894, mean=36.734\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=40.000, max=465.000, mean=167.200\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=4.000, max=4.400, mean=4.240",
         "0",
         "0.35",
         "not-mortality",
         "Mixed clinical picture: concerning inflammation with CRP 76.25 mg/L, band neutrophils 8%, requiring oxygen support (FiO2 50%), and mild organ dysfunction (albumin 2.8 g/dL, INR 1.3, hemoglobin 9.6 g/dL). However, reassuring signs include normal lactate 0.7 mmol/L, adequate MAP 83.5 mmHg, good urine output 167 mL/h, and normal pH 7.39, suggesting preserved organ perfusion despite systemic inflammation.",
         "0",
         "0",
         "1962",
         "608",
         "0",
         "Let me analyze this patient data carefully to determine the probability of mortality:\n\nKey concerning findings:\n1. CRP is very high at 76.25 mg/L - this indicates significant inflammation/infection\n2. Band neutrophils at 8% with neutrophils at 80.7% suggests infection/inflammation\n3. Albumin is low at 2.8 g/dL (normal is 3.5-5.0) indicating malnutrition or acute illness\n4. Patient is on supplemental oxygen (FiO2 50%) indicating respiratory compromise\n5. INR is elevated at 1.3 suggesting coagulopathy\n6. Hemoglobin is low at 9.6-9.7 g/dL indicating anemia\n7. Platelets are low at 111-112K (borderline low, normal >150K)\n\nReassuring findings:\n1. Lactate is normal at 0.7 mmol/L (good organ perfusion)\n2. MAP is adequate at 83.5 mmHg on average\n3. Urine output is good at 167 mL/h on average\n4. pH is normal at 7.39\n5. Creatinine is actually low at 0.54 mg/dL suggesting good kidney function\n6. Heart rate is controlled at 69 bpm average\n\nThe patient appears to have significant systemic inflammation (high CRP, left shift in WBC differential) with some organ dysfunction (requiring oxygen support, low albumin, mild coagulopathy) but maintains adequate perfusion (normal lactate, good MAP, good urine output). This suggests serious illness but not immediately life-threatening.\n\nThe combination of high inflammation markers, respiratory support needs, and mild multi-organ dysfunction suggests moderate-high risk but the normal lactate and adequate perfusion are reassuring.\n\nI would estimate this as moderate risk - around 30-40% probability of mortality.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "33",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 39, age: 62.0, sex: Female, weight: 105.0, height: 155.0\nAlbumin (unit: g/dL): min=2.800, max=3.600, mean=3.536\nAlkaline Phosphatase (unit: U/L): min=60.000, max=78.000, mean=61.440\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=181.000, mean=168.760\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=503.000, mean=465.480\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=27.000, mean=25.880\nTotal Bilirubin (unit: mg/dL): min=0.100, max=0.700, mean=0.316\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=18.000, max=21.000, mean=19.680\nCalcium (unit: mg/dL): min=8.200, max=8.900, mean=8.796\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=104.000, max=107.000, mean=105.160\nCreatinine (unit: mg/dL): min=0.880, max=1.080, mean=0.913\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=58.000, max=81.000, mean=65.140\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=104.000, max=182.000, mean=134.960\nHemoglobin (unit: g/dL): min=10.300, max=13.400, mean=12.540\nHeart Rate (unit: bpm): min=62.000, max=96.000, mean=78.600\ninr (unit: ): min=1.000, max=1.300, mean=1.024\nPotassium (unit: mmol/L): min=3.100, max=4.100, mean=3.888\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=66.000, max=92.000, mean=73.940\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.900, mean=30.772\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.200, mean=33.136\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=93.200, mean=92.896\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.800, max=1.900, mean=1.808\nSodium (unit: mmol/L): min=136.000, max=139.000, mean=136.920\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=93.500, max=99.500, mean=96.480\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.600, mean=3.552\nPlatelets (unit: 1000/µL): min=182.000, max=206.000, mean=200.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=47.100, mean=46.172\nRespiratory Rate (unit: breaths/min): min=17.000, max=26.000, mean=21.200\nSystolic Blood Pressure (unit: mmHg): min=91.000, max=134.000, mean=106.220\nTemperature (unit: °C): min=35.789, max=37.894, mean=36.596\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=600.000, mean=292.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=14.300, mean=11.860",
         "0",
         "0.78",
         "mortality",
         "Critical multi-organ dysfunction: severe hepatic injury with AST max 503 U/L and ALT max 181 U/L (>10x normal), severe systemic inflammation with CRP 76.25 mg/L, periods of complete anuria (urine output min 0.0 mL/h), and signs of sepsis with elevated bands 8% and neutrophils 80.7% with lymphopenia 9%.",
         "0",
         "0",
         "1962",
         "709",
         "0",
         "I need to analyze this patient data for indicators of mortality during ICU stay. Let me look at the key indicators:\n\nKey concerning findings:\n1. AST (Aspartate Aminotransferase): min=34.000, max=503.000, mean=465.480 - This is extremely elevated (normal <40 U/L), suggesting severe hepatic injury\n2. ALT (Alanine Aminotransferase): min=28.000, max=181.000, mean=168.760 - Also very elevated (normal <40 U/L), liver injury\n3. CRP (C-Reactive Protein): min=76.250, max=76.250, mean=76.250 - Severely elevated (normal <3 mg/L), indicating significant inflammation/infection\n4. Urine Output: min=0.000, max=600.000, mean=292.000 - The minimum of 0.000 suggests periods of complete anuria, which is very concerning for acute kidney injury\n5. Band Neutrophils: 8% - elevated, suggesting bacterial infection\n6. Neutrophils: 80.7% - elevated\n7. Lymphocytes: 9% - low, suggesting immune suppression\n8. WBC: elevated at 11-14.3 (normal 4-11)\n\nModerately concerning:\n- Creatinine: 0.88-1.08 mg/dL - slightly elevated for a female\n- Lactate: 1.9 mmol/L - mildly elevated (normal <2), but not critically high\n- Temperature range: 35.789-37.894?C - includes hypothermia which can be concerning\n- Blood pressure: systolic 91-134, diastolic 58-81, MAP 66-92 - some hypotension noted\n\nLess concerning findings:\n- FiO2: 40% - not critically high oxygen requirement\n\n\n- pH: 7.36 - normal\n- Oxygen saturation: 93.5-99.5% - reasonable range\n- Heart rate: 62-96 bpm - normal range\n\nThe patient's vital signs appear relatively stable, with normal pH, oxygen saturation, and heart rate. However, these seemingly stable parameters mask the underlying critical condition. The metabolic and inflammatory markers paint a dire picture of multi-organ compromise. Severe hepatic dysfunction, marked by astronomical AST and ALT levels, combined with profound inflammatory response and potential kidney injury, indicates an extremely high-risk clinical scenario. The immune system's compromised state, evidenced by lymphopenia and elevated neutrophil counts, further underscores the patient's precarious condition.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "34",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 4, age: 55.0, sex: Male, weight: 156.5, height: 177.8\nAlbumin (unit: g/dL): min=2.800, max=3.900, mean=3.812\nAlkaline Phosphatase (unit: U/L): min=78.000, max=81.000, mean=80.760\nAlanine Aminotransferase (ALT) (unit: U/L): min=21.000, max=28.000, mean=21.560\nAspartate Aminotransferase (AST) (unit: U/L): min=14.000, max=34.000, mean=15.600\nBase Excess (unit: mmol/L): min=-1.000, max=5.000, mean=3.560\nBicarbonate (unit: mmol/L): min=23.000, max=34.000, mean=29.920\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.316\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=14.000, max=21.000, mean=15.360\nCalcium (unit: mg/dL): min=8.200, max=8.900, mean=8.808\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=99.000, max=105.000, mean=99.720\nCreatinine (unit: mg/dL): min=0.840, max=1.080, mean=0.947\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=59.500, max=98.000, mean=70.540\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=136.000, max=287.000, mean=267.480\nHemoglobin (unit: g/dL): min=10.300, max=15.200, mean=14.676\nHeart Rate (unit: bpm): min=82.000, max=103.000, mean=92.820\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=5.100, mean=4.904\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=72.500, max=109.000, mean=83.080\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.000, max=29.900, mean=28.632\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.800, max=33.700, mean=33.416\nMean Corpuscular Volume (MCV) (unit: fL): min=84.900, max=90.000, mean=85.692\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=135.000, max=139.000, mean=135.560\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=90.500, max=98.500, mean=93.160\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=69.000, mean=62.040\npH Level (unit: /): min=7.280, max=7.360, mean=7.299\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=164.000, max=182.000, mean=174.240\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=70.000, max=101.000, mean=77.440\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=15.000, max=20.000, mean=17.420\nSystolic Blood Pressure (unit: mmHg): min=112.000, max=158.000, mean=128.880\nTemperature (unit: °C): min=36.317, max=38.106, mean=37.364\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=40.000, max=1100.000, mean=143.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=8.900, max=18.800, mean=16.988",
         "0",
         "0.65",
         "mortality",
         "Concerning sepsis indicators: severe inflammation with CRP 76.25 mg/L, WBC 16.99 (1000/?L), neutrophils 80.7% with 8% bands, severe hyperglycemia (glucose mean 267.48 mg/dL), hypoxemia requiring FiO2 40% with O2 saturation min 90.5%, mild acidosis (pH min 7.28), and fever (temp max 38.106?C). However, lactate only mildly elevated at 1.9 mmol/L and hemodynamics relatively stable.",
         "0",
         "0",
         "1963",
         "730",
         "0",
         "Let me analyze this patient data systematically to determine mortality risk.\n\nKey concerning findings:\n1. Elevated CRP: 76.25 mg/L - this is significantly elevated indicating severe inflammation/infection\n2. Elevated glucose: max 287 mg/dL, mean 267.48 mg/dL - severe hyperglycemia\n3. Elevated WBC: max 18.8, mean 16.99 (1000/?L) - indicates infection/inflammation\n4. Elevated neutrophils: 80.7% - left shift suggesting infection\n5. Band neutrophils: 8% - indicates immature neutrophils, sign of severe infection\n6. Low lymphocytes: 9% - lymphopenia can indicate severe infection\n7. Lactate: 1.9 mmol/L - slightly elevated but not critically high\n8. FiO2: 40% - patient requires supplemental oxygen\n9. Oxygen saturation: min 90.5%, mean 93.16% - hypoxemia\n10. PaO2: min 70 mmHg, mean 77.44 mmHg - hypoxemia\n11. pH: min 7.28, mean 7.299 - mild acidosis\n12. PaCO2: max 69 mmHg, mean 62.04 mmHg - elevated CO2, respiratory acidosis\n13. Temperature: max 38.106?C - fever\n14. Urine output: variable with min 40 mL/h which could indicate kidney stress\n\nPositive findings (less concerning):\n- Albumin relatively normal (2.8-3.9 g/dL)\n- Liver enzymes relatively normal\n- Creatinine slightly elevated but not severely (0.84-1.08 mg/dL)\n- Blood pressure stable\n- Heart rate stable\n\nThe combination of severe infection markers (high CRP, WBC, neutrophils, bands), severe hyperglycemia, hypoxemia requiring oxygen support, mild acidosis, and fever suggests this patient has a serious condition that could progress to sepsis or multi-organ dysfunction.\n \nWhile the clinical picture is serious, some stabilizing factors suggest the patient isn't in immediate critical decline. The mildly elevated lactate, maintained blood pressure, and relatively preserved organ function indicate a guarded but not immediately terminal prognosis. I'd assess the mortality risk around 60-70%, reflecting the significant but not yet catastrophic clinical presentation.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "35",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 40, age: 65.0, sex: Male, weight: 100.0, height: 175.3\nAlbumin (unit: g/dL): min=2.800, max=3.550, mean=3.520\nAlkaline Phosphatase (unit: U/L): min=40.000, max=78.000, mean=41.520\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=32.000, mean=31.840\nAspartate Aminotransferase (AST) (unit: U/L): min=27.500, max=34.000, mean=27.760\nBase Excess (unit: mmol/L): min=-1.000, max=0.200, mean=0.104\nBicarbonate (unit: mmol/L): min=23.000, max=26.000, mean=25.080\nTotal Bilirubin (unit: mg/dL): min=0.200, max=0.700, mean=0.452\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=18.000, max=21.000, mean=19.800\nCalcium (unit: mg/dL): min=7.700, max=8.700, mean=8.280\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=701.000, mean=591.480\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=2.900, max=6.200, mean=3.192\nChloride (unit: mmol/L): min=94.000, max=105.000, mean=97.640\nCreatinine (unit: mg/dL): min=1.080, max=1.280, mean=1.260\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=41.500, max=83.000, mean=57.640\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=100.000, mean=46.400\nGlucose (unit: mg/dL): min=101.000, max=205.000, mean=153.720\nHemoglobin (unit: g/dL): min=10.300, max=12.400, mean=12.036\nHeart Rate (unit: bpm): min=53.500, max=82.000, mean=61.840\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.100, max=4.000, mean=3.192\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=8.500, max=9.000, mean=8.520\nMean Arterial Pressure (MAP) (unit: mmHg): min=51.000, max=99.000, mean=70.940\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.700, mean=30.500\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.600, mean=33.408\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=91.500, mean=91.328\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=0.900, max=2.100, mean=1.420\nSodium (unit: mmol/L): min=131.000, max=139.000, mean=133.320\nNeutrophils (unit: %): min=80.700, max=83.400, mean=83.292\nOxygen Saturation (unit: %): min=94.500, max=99.000, mean=97.460\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=44.500, mean=44.140\npH Level (unit: /): min=7.360, max=7.378, mean=7.377\nPhosphate (unit: mg/dL): min=2.700, max=3.300, mean=2.780\nPlatelets (unit: 1000/µL): min=182.000, max=203.000, mean=194.880\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=111.600, mean=110.752\nPartial Thromboplastin Time (PTT) (unit: sec): min=24.300, max=35.500, mean=26.164\nRespiratory Rate (unit: breaths/min): min=2.000, max=30.500, mean=21.200\nSystolic Blood Pressure (unit: mmHg): min=80.000, max=159.000, mean=111.660\nTemperature (unit: °C): min=37.106, max=38.500, mean=37.621\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=7.500, max=11.200, mean=9.712",
         "0",
         "0.72",
         "mortality",
         "Severe septic shock with critical hypotension (MAP min 51 mmHg, DBP min 41.5 mmHg), requiring maximum oxygen support (FiO2 100%), severe inflammation (CRP 76.25 mg/L), muscle damage (CK max 701 U/L), and signs of bacterial infection (band neutrophils 8%, neutrophils 83.3%, fever 38.5?C). Despite adequate urine output, the combination of shock and multi-organ involvement indicates high mortality risk.",
         "0",
         "0",
         "1962",
         "776",
         "0",
         "Let me analyze this patient's data systematically:\n\n**Critical abnormal values:**\n1. CRP = 76.250 mg/L - This is very elevated (normal <3-10 mg/L), indicating significant inflammation/infection\n2. FiO2 max = 100.000% - This indicates the patient required maximum oxygen support at some point\n3. Diastolic BP min = 41.5 mmHg - Very low, indicating hypotension (normal >60 mmHg)\n4. MAP min = 51.0 mmHg - Very low (normal >65 mmHg), indicating severe hypotension\n5. Respiratory rate max = 30.5 breaths/min - Tachypnea (normal 12-20)\n6. Temperature max = 38.5?C - Fever, consistent with infection\n7. Creatine Kinase max = 701 U/L - Very elevated (normal <200 U/L), indicating muscle damage\n8. Band neutrophils = 8% - Left shift indicating bacterial infection\n9. Neutrophils = 83.3% - Elevated, consistent with infection\n10. Lymphocytes = 8.5% - Low (normal 20-40%), indicating immunosuppression or severe infection\n\n**Concerning patterns:**\n- Systolic BP min = 80 mmHg - Hypotension\n- Heart rate range 53.5-82 - Relatively normal but concerning given hypotension\n- Creatinine elevated at 1.26 mg/dL (mild kidney dysfunction)\n- Sodium low at 131 mmol/L (hyponatremia)\n\n**Positive indicators:**\n- pH normal at 7.36-7.378\n- Lactate only 1.9 mmol/L (not severely elevated)\n- Urine output 100 mL/h (adequate)\n- Oxygen saturation 94.5-99%\n \nThe clinical picture reveals a critical sepsis scenario with multiple systemic inflammatory markers. Despite alarming signs of infection and organ stress, there are subtle hints of potential recovery. The patient's physiological responses suggest a complex clinical trajectory - severe enough to warrant intensive intervention, yet with some promising compensatory mechanisms still functioning.\n\nThe combination of inflammatory markers, organ dysfunction, and hemodynamic instability points to a life-threatening condition requiring immediate and aggressive medical management. While the prognosis appears guarded, the maintained urine output and relatively stable oxygenation offer a glimmer of hope for potential recovery with prompt, targeted treatment.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "36",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 41, age: 76.0, sex: Female, weight: 54.0, height: 167.6\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=54.000, max=78.000, mean=55.920\nAlanine Aminotransferase (ALT) (unit: U/L): min=11.000, max=28.000, mean=12.360\nAspartate Aminotransferase (AST) (unit: U/L): min=13.000, max=34.000, mean=14.680\nBase Excess (unit: mmol/L): min=-3.000, max=-1.000, mean=-2.760\nBicarbonate (unit: mmol/L): min=23.000, max=24.000, mean=23.720\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.408\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=37.000, mean=34.280\nCalcium (unit: mg/dL): min=7.900, max=8.300, mean=8.212\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=122.000, mean=119.920\nCreatinine (unit: mg/dL): min=0.540, max=1.080, mean=0.585\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=51.000, max=94.000, mean=65.260\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=50.000, max=60.000, mean=52.000\nGlucose (unit: mg/dL): min=95.000, max=151.000, mean=119.040\nHemoglobin (unit: g/dL): min=10.300, max=10.600, mean=10.516\nHeart Rate (unit: bpm): min=48.000, max=57.500, mean=51.600\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.500, max=4.700, mean=4.404\nLactate (unit: mmol/L): min=1.500, max=1.900, mean=1.532\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=61.000, max=104.000, mean=78.120\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.700, mean=30.476\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=32.100, max=33.000, mean=32.352\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=95.600, mean=94.032\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.000, mean=1.920\nSodium (unit: mmol/L): min=139.000, max=152.000, mean=147.360\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=95.000, max=100.000, mean=98.500\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=43.000, mean=42.640\npH Level (unit: /): min=7.340, max=7.360, mean=7.342\nPhosphate (unit: mg/dL): min=1.800, max=3.300, mean=2.220\nPlatelets (unit: 1000/µL): min=131.000, max=182.000, mean=145.280\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=102.000, mean=101.880\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=15.000, max=23.000, mean=15.880\nSystolic Blood Pressure (unit: mmHg): min=93.500, max=153.000, mean=122.300\nTemperature (unit: °C): min=35.894, max=37.606, mean=36.767\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=25.000, max=150.000, mean=78.400\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=4.400, max=11.000, mean=6.248",
         "0",
         "0.78",
         "mortality",
         "High mortality risk: Severe systemic inflammation with CRP 76.25 mg/L (normal <3), bacterial infection indicated by elevated band neutrophils 8% and neutrophils 80.7%, requiring supplemental oxygen FiO2 50-60%, bradycardia 48-57.5 bpm, hypothermia minimum 35.894?C, oliguria minimum 25 mL/h, and hypoalbuminemia 2.8 g/dL in elderly patient age 76.",
         "0",
         "0",
         "1962",
         "683",
         "0",
         "Let me analyze this patient data carefully for signs that might indicate mortality risk:\n\nAge: 76 years old - advanced age is a risk factor\n\nCritical abnormal values I need to identify:\n\n1. CRP: 76.25 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n\n2. Band neutrophils: 8% - This is elevated (normal <3%), indicating bacterial infection or severe inflammation\n\n3. Neutrophils: 80.7% - This is elevated (normal 50-70%), indicating infection\n\n4. Lymphocytes: 9% - This is low (normal 20-40%), indicating possible immunosuppression or severe illness\n\n5. FiO2: 50-60% - Patient requires supplemental oxygen, indicating respiratory compromise\n\n6. BUN: 21-37 mg/dL with mean 34.28 - Upper end is elevated (normal 6-20), suggesting possible kidney dysfunction\n\n7. Creatinine: 0.54-1.08 mg/dL - The max of 1.08 is slightly elevated for an elderly female\n\n8. Heart rate: 48-57.5 bpm - This is bradycardia (normal 60-100 bpm)\n\n9. Low urine output: minimum 25 mL/h - This could indicate oliguria (normal >30 mL/h)\n\n10. Temperature: minimum 35.894?C - This is hypothermic (normal 36.1-37.2?C)\n\n11. Albumin: 2.8 g/dL - This is low (normal 3.5-5.0 g/dL), indicating malnutrition or illness\n\nHowever, some positive signs:\n- Lactate is normal (1.5-1.9 mmol/L, normal <2)\n- pH is normal (7.34-7.36)\n- Blood pressure seems stable\n\n\n- Oxygen saturation is good (95-100%)\n\nThe patient's clinical picture reveals an extremely precarious condition. Multiple physiological systems show significant compromise, with inflammatory markers, infection indicators, and systemic stress signals pointing to a critical health state. The combination of advanced age, severe inflammatory response, and multiple organ system dysfunctions creates a profoundly concerning scenario with substantial mortality risk.\n\nI assess the patient's probability of mortality as extremely high, likely between 75-85%, given the complex and multifaceted clinical presentation.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "37",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 42, age: 48.0, sex: Male, weight: 138.8, height: 185.4\nAlbumin (unit: g/dL): min=2.800, max=3.800, mean=3.440\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=23.000, mean=23.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=61.000, mean=46.600\nCalcium (unit: mg/dL): min=8.200, max=8.500, mean=8.392\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=98.000, max=105.000, mean=100.520\nCreatinine (unit: mg/dL): min=1.080, max=7.200, mean=4.997\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=57.000, max=99.000, mean=70.000\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=82.000, max=117.000, mean=99.840\nHemoglobin (unit: g/dL): min=10.300, max=11.700, mean=11.196\nHeart Rate (unit: bpm): min=71.000, max=86.000, mean=77.480\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.600, mean=4.384\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=75.000, max=103.000, mean=85.760\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.600, mean=30.348\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.500, mean=33.320\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=91.500, mean=90.960\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=134.000, max=139.000, mean=135.800\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=91.000, max=99.500, mean=95.780\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=8.200, mean=6.436\nPlatelets (unit: 1000/µL): min=153.000, max=182.000, mean=163.440\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=13.000, max=20.000, mean=17.040\nSystolic Blood Pressure (unit: mmHg): min=95.000, max=160.000, mean=122.800\nTemperature (unit: °C): min=36.394, max=37.000, mean=36.599\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=50.000, mean=9.400\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=10.800, max=11.000, mean=10.872",
         "0",
         "0.85",
         "mortality",
         "Critical renal failure with creatinine max 7.200 mg/dL (normal 0.6-1.3), severe oliguria with urine output min 0.000 mL/h (normal >30), extreme inflammation with CRP 76.250 mg/L (normal <3.0), and multi-organ dysfunction requiring oxygen support (FiO2 40%). BUN elevated to 61.000 mg/dL confirms acute kidney injury.",
         "0",
         "0",
         "1962",
         "559",
         "0",
         "Let me analyze this patient data systematically for mortality risk factors:\n\nConcerning findings:\n1. Creatinine: min=1.080, max=7.200, mean=4.997 mg/dL - This is extremely elevated, indicating severe renal failure (normal is 0.6-1.3 mg/dL)\n2. BUN: min=21.000, max=61.000, mean=46.600 mg/dL - Elevated, consistent with renal failure (normal 7-20 mg/dL)\n3. CRP: 76.250 mg/L - Very high indicating severe inflammation/infection (normal <3.0 mg/L)\n4. Urine Output: min=0.000, max=50.000, mean=9.400 mL/h - This is oliguria/anuria (normal >30 mL/h), very concerning\n5. Phosphate: min=3.300, max=8.200, mean=6.436 mg/dL - Elevated (normal 2.5-4.5), consistent with renal failure\n\nLess concerning but noteworthy:\n- Lactate: 1.900 mmol/L - slightly elevated (normal <2.0)\n- FiO2: 40% - patient requires supplemental oxygen\n- Temperature range suggests possible infection\n- Band neutrophils 8% - indicates left shift, possible infection\n- Neutrophils 80.7%, lymphocytes 9% - consistent with bacterial infection\n\nThe combination of severe renal failure (creatinine up to 7.2), oliguria/anuria (urine output as low as 0), severe inflammation (CRP 76.2), and need for oxygen support indicates a critically ill patient with multi-organ dysfunction. This pattern suggests high mortality risk.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "38",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 43, age: 29.0, sex: Male, weight: 104.3, height: 190.5\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=30.000, mean=23.840\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=15.000, max=21.000, mean=20.280\nCalcium (unit: mg/dL): min=8.000, max=8.200, mean=8.176\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=106.000, mean=105.120\nCreatinine (unit: mg/dL): min=0.940, max=1.080, mean=1.063\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=45.000, max=71.000, mean=59.080\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=106.000, max=160.000, mean=141.160\nHemoglobin (unit: g/dL): min=10.300, max=13.600, mean=10.696\nHeart Rate (unit: bpm): min=82.000, max=108.500, mean=95.240\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.000, mean=4.000\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=54.500, max=82.500, mean=70.720\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=30.600, mean=29.984\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=34.200, mean=33.144\nMean Corpuscular Volume (MCV) (unit: fL): min=89.400, max=90.000, mean=89.928\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.500, max=1.900, mean=1.852\nSodium (unit: mmol/L): min=137.000, max=139.000, mean=138.760\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=91.000, max=100.000, mean=96.280\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.200, max=3.300, mean=3.168\nPlatelets (unit: 1000/µL): min=107.000, max=182.000, mean=173.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=16.000, max=31.000, mean=23.040\nSystolic Blood Pressure (unit: mmHg): min=81.500, max=131.000, mean=111.100\nTemperature (unit: °C): min=36.500, max=37.894, mean=37.320\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=675.000, mean=271.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=10.200, max=11.000, mean=10.904",
         "0",
         "0.3",
         "not-mortality",
         "Sepsis with concerning features but stabilizing factors: severe inflammation (CRP 76.25 mg/L), neutrophilia 80.7% with left shift (bands 8%), hypotension episodes (MAP min 54.5 mmHg), hypoxemia (O2 sat min 91%), and oliguria periods (urine output min 0.000 mL/h). However, lactate relatively controlled at 1.9 mmol/L, normal pH 7.36, and young age 29 years suggest potential for recovery.",
         "0",
         "0",
         "1962",
         "772",
         "0",
         "Let me analyze this patient data for mortality risk factors systematically.\n\nKey abnormal values I'm noticing:\n\n1. **CRP is very high**: 76.25 mg/L - this is significantly elevated (normal <3.0 mg/L), indicating severe inflammation/infection\n\n2. **Low albumin**: 2.8 g/dL (normal 3.5-5.0 g/dL) - indicates poor nutrition/liver function/protein loss\n\n3. **Elevated neutrophils**: 80.7% (normal 50-70%) with low lymphocytes 9% (normal 20-40%) - suggests bacterial infection/sepsis\n\n4. **Band neutrophils elevated**: 8% (normal 0-3%) - indicates left shift, bacterial infection\n\n5. **Low hemoglobin**: 10.3-13.6 g/dL, mean 10.696 - mild anemia\n\n6. **Urine output concerning**: min 0.000 mL/h, max 675 mL/h, mean 271 mL/h - the minimum of 0 suggests periods of oliguria/anuria which is concerning for kidney function\n\n7. **Oxygen saturation**: min 91% - below normal (>95%), indicating hypoxemia\n\n8. **Respiratory rate elevated**: max 31 breaths/min, mean 23 - tachypnea\n\n9. **Blood pressure**: Systolic min 81.5 mmHg, Diastolic min 45 mmHg, MAP min 54.5 mmHg - hypotension episodes\n\n10. **Heart rate**: max 108.5 bpm, mean 95.2 - tachycardia\n\n11. **Temperature**: max 37.894?C - fever\n\n12. **Lactate**: 1.9 mmol/L - borderline elevated (normal <2.0)\n\n13. **INR**: 1.3 - mildly elevated coagulation\n \nThe clinical picture reveals a complex infectious process with multiple systemic complications. Multiple inflammatory and physiological markers point to a serious infection, likely sepsis, with significant organ involvement. Despite some mitigating factors like normal pH and intermittent stable vital signs, the patient demonstrates substantial physiological stress. The young age provides some resilience, but the multi-system dysfunction suggests a considerable mortality risk around 25-35%.\n\nKey concerns include potential progression of inflammatory cascade, risk of organ dysfunction, and need for aggressive supportive management and targeted antimicrobial intervention.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "39",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 44, age: 59.0, sex: Male, weight: 100.0, height: 185.4\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=0.000, mean=-0.840\nBicarbonate (unit: mmol/L): min=23.000, max=26.000, mean=23.720\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=9.000, mean=8.240\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=20.000, max=21.000, mean=20.760\nCalcium (unit: mg/dL): min=8.200, max=9.000, mean=8.392\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=103.000, max=105.000, mean=104.520\nCreatinine (unit: mg/dL): min=0.980, max=1.080, mean=1.056\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=54.000, max=83.000, mean=69.260\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=100.000, mean=51.800\nGlucose (unit: mg/dL): min=103.000, max=316.000, mean=195.800\nHemoglobin (unit: g/dL): min=10.300, max=11.900, mean=10.684\nHeart Rate (unit: bpm): min=67.500, max=92.000, mean=81.040\ninr (unit: ): min=1.100, max=1.300, mean=1.252\nPotassium (unit: mmol/L): min=3.600, max=4.000, mean=3.904\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=2.800, max=9.000, mean=7.512\nMean Arterial Pressure (MAP) (unit: mmHg): min=62.000, max=95.000, mean=80.180\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=32.400, mean=30.500\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=34.700, mean=33.408\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=93.400, mean=90.816\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.600, max=1.900, mean=1.828\nSodium (unit: mmol/L): min=139.000, max=139.000, mean=139.000\nNeutrophils (unit: %): min=80.700, max=90.500, mean=83.052\nOxygen Saturation (unit: %): min=93.000, max=99.000, mean=95.940\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=52.000, mean=41.920\npH Level (unit: /): min=7.320, max=7.360, mean=7.354\nPhosphate (unit: mg/dL): min=2.800, max=3.300, mean=3.180\nPlatelets (unit: 1000/µL): min=182.000, max=245.000, mean=197.120\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=27.300, max=35.500, mean=33.532\nRespiratory Rate (unit: breaths/min): min=12.000, max=19.000, mean=17.080\nSystolic Blood Pressure (unit: mmHg): min=87.000, max=140.500, mean=117.840\nTemperature (unit: °C): min=36.890, max=37.211, mean=37.071\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=50.000, max=550.000, mean=413.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=26.200, mean=14.648",
         "0",
         "0.3",
         "not-mortality",
         "Mixed clinical picture: significant infection markers (CRP 76.25 mg/L, WBC max 26.2, band neutrophils 8-9%) and oxygen requirement (FiO2 40-100%), but stable organ function with good urine output (mean 413 mL/h), normal creatinine (0.98-1.08 mg/dL), adequate MAP (mean 80.18 mmHg), and normal pH (7.32-7.36). Lactate borderline at 1.9 mmol/L.",
         "0",
         "0",
         "1962",
         "807",
         "0",
         "Let me analyze this patient data systematically for mortality risk factors:\n\n**Concerning findings:**\n1. CRP = 76.25 mg/L - This is quite elevated, indicating significant inflammation/infection\n2. WBC count: max 26.2, mean 14.648 - This is elevated, suggesting infection/inflammatory response\n3. Band neutrophils: 8-9% - This is elevated (normally <5%), indicating left shift/bacterial infection\n4. Neutrophils: 80.7-90.5% - High neutrophil percentage\n5. Lymphocytes: 2.8-9% - Low lymphocytes, consistent with acute infection\n6. FiO2: 40-100%, mean 51.8% - Patient requiring supplemental oxygen, indicating respiratory compromise\n7. Glucose: max 316 mg/dL, mean 195.8 - Hyperglycemia, possibly stress response or diabetes\n8. Hemoglobin: 10.3-11.9 g/dL - Mild anemia\n9. Albumin: 2.8 g/dL - Low albumin (normal 3.5-5.0), indicating poor nutritional status or acute illness\n\n**Moderately concerning:**\n1. Lactate: 1.9 mmol/L - Slightly elevated (normal <2.0), but borderline\n2. Diastolic BP: min 54 mmHg - Low diastolic pressure at times\n3. MAP: min 62 mmHg - Borderline low mean arterial pressure\n4. Oxygen saturation: min 93% - Lower end of acceptable range\n\n**Stable/normal findings:**\n1. pH: 7.32-7.36 - Normal range\n2. Base excess: -1 to 0 - Normal\n3. Bicarbonate: 23-26 - Normal\n4. Heart rate: 67.5-92 bpm - Normal range\n\n\n5. Temperature: 36.89-37.21?C - Normal to low-grade fever\n6. Urine output: 50-550 mL/h, mean 413 - Good urine output\n7. Creatinine: 0.98-1.08 - Normal kidney function\n8. Liver enzymes (ALT, AST): Normal\n9. Coagulation (INR, PTT): Normal ranges\n\nI observe multiple infection markers suggesting a significant inflammatory process. Despite concerning respiratory and metabolic indicators, the patient maintains relatively stable physiological parameters. The combination of elevated inflammatory markers with preserved organ function requires careful monitoring and targeted intervention.\n\nMortality risk seems intermediate, likely between 25-35%, reflecting the complex clinical picture of ongoing infection balanced against preserved systemic resilience.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "40",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 45, age: 49.0, sex: Male, weight: 81.7, height: 172.7\nAlbumin (unit: g/dL): min=2.800, max=4.300, mean=3.340\nAlkaline Phosphatase (unit: U/L): min=59.000, max=78.000, mean=71.160\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=50.000, mean=35.920\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=144.000, mean=73.600\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=27.000, mean=26.680\nTotal Bilirubin (unit: mg/dL): min=0.200, max=1.100, mean=0.554\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=14.000, max=21.000, mean=14.560\nCalcium (unit: mg/dL): min=8.200, max=9.100, mean=9.028\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=101.000, max=105.000, mean=101.320\nCreatinine (unit: mg/dL): min=1.060, max=1.080, mean=1.062\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=51.000, max=79.500, mean=69.020\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=116.000, max=136.000, mean=123.960\nHemoglobin (unit: g/dL): min=10.300, max=14.500, mean=14.164\nHeart Rate (unit: bpm): min=71.500, max=102.000, mean=85.240\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.000, mean=4.000\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=55.000, max=90.500, mean=79.240\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=32.200, mean=32.016\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=35.200, mean=35.024\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=91.300, mean=91.196\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=137.000, max=139.000, mean=137.160\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=95.000, max=97.500, mean=96.340\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.600, mean=3.576\nPlatelets (unit: 1000/µL): min=182.000, max=182.000, mean=182.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=13.000, max=20.000, mean=16.760\nSystolic Blood Pressure (unit: mmHg): min=93.000, max=136.000, mean=115.140\nTemperature (unit: °C): min=36.789, max=37.394, mean=37.110\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=700.000, mean=312.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=14.400, mean=14.128",
         "0",
         "0.75",
         "mortality",
         "High mortality risk due to sepsis with multi-organ dysfunction: CRP 76.25 mg/L (severe inflammation), AST max 144 U/L (liver injury), Troponin T 0.14 ng/mL (cardiac injury), urine output min 0 mL/h (acute kidney injury), MAP min 55 mmHg (hypotension), WBC 14.128 with 8% bands and 9% lymphocytes (severe infection with immunosuppression), and lactate 1.9 mmol/L (tissue hypoperfusion).",
         "0",
         "0",
         "1962",
         "695",
         "0",
         "Let me analyze this patient data for mortality risk by looking at key indicators:\n\nAge: 49 years old - not particularly high risk from age alone\nSex: Male\n\nKey concerning findings:\n1. C-Reactive Protein (CRP): 76.25 mg/L - this is quite high, indicating significant inflammation/infection (normal is typically <3 mg/L)\n2. White Blood Cell Count: 11.0-14.4, mean 14.128 - elevated, suggesting infection/inflammation\n3. Band Neutrophils: 8% - this is elevated (normal <3%), indicating bacterial infection\n4. Neutrophils: 80.7% - high normal to elevated\n5. Lymphocytes: 9% - low (normal 20-40%), suggests immunosuppression or severe infection\n6. AST: max 144 U/L - elevated (normal <40), suggesting liver injury\n7. Troponin T: 0.14 ng/mL - elevated (normal <0.04), indicating cardiac injury\n8. Creatinine: 1.06-1.08 mg/dL - slightly elevated for this age/sex\n9. Urine Output: min 0 mL/h, max 700 mL/h, mean 312 mL/h - the minimum of 0 is concerning for acute kidney injury\n10. Blood pressure: Systolic 93-136, Diastolic 51-79.5, MAP 55-90.5 - the minimums show hypotension episodes\n11. Lactate: 1.9 mmol/L - mildly elevated (normal <2), suggests tissue hypoperfusion\n12. FiO2: 40% - requires supplemental oxygen\n\nHowever, some stabilizing factors:\n- Hemoglobin: 14.164 g/dL - good\n- Oxygen saturation: 95-97.5% - acceptable\n- pH: 7.36 - normal\n\n\n- Heart rate: 71.5-102 bpm - reasonable range\n- Temperature: normal range\n\nThe clinical picture reveals a critical patient with systemic inflammatory response. Vital signs show moderate stability, but underlying markers point to severe septic condition with potential multi-organ dysfunction. The patient's physiological parameters indicate a precarious state requiring immediate intensive medical intervention.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "41",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 46, age: 57.0, sex: Female, weight: 116.0, height: 160.0\nAlbumin (unit: g/dL): min=2.500, max=2.800, mean=2.680\nAlkaline Phosphatase (unit: U/L): min=78.000, max=111.000, mean=91.200\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=29.000, mean=28.400\nAspartate Aminotransferase (AST) (unit: U/L): min=20.000, max=34.000, mean=28.400\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=29.000, mean=25.400\nTotal Bilirubin (unit: mg/dL): min=0.100, max=0.700, mean=0.400\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=30.000, mean=24.600\nCalcium (unit: mg/dL): min=8.200, max=8.600, mean=8.360\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=105.000, mean=105.000\nCreatinine (unit: mg/dL): min=1.080, max=1.650, mean=1.308\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=24.000, max=70.000, mean=40.760\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=50.000, mean=48.000\nGlucose (unit: mg/dL): min=95.000, max=192.000, mean=144.120\nHemoglobin (unit: g/dL): min=7.100, max=10.300, mean=7.724\nHeart Rate (unit: bpm): min=78.000, max=97.000, mean=87.100\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.600, mean=4.240\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=38.000, max=83.000, mean=59.560\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=28.000, max=29.900, mean=29.140\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.100, max=33.000, mean=32.240\nMean Corpuscular Volume (MCV) (unit: fL): min=89.900, max=90.000, mean=89.960\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.800, max=1.900, mean=1.860\nSodium (unit: mmol/L): min=138.000, max=139.000, mean=138.600\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=96.000, max=100.000, mean=98.840\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.100, max=3.300, mean=2.820\nPlatelets (unit: 1000/µL): min=119.000, max=182.000, mean=156.800\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=60.300, mean=45.420\nRespiratory Rate (unit: breaths/min): min=18.000, max=30.000, mean=25.040\nSystolic Blood Pressure (unit: mmHg): min=90.000, max=159.000, mean=125.140\nTemperature (unit: °C): min=36.890, max=37.789, mean=37.432\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=12.400, mean=11.560",
         "0",
         "0.85",
         "mortality",
         "Critical septic condition: CRP extremely elevated at 76.25 mg/L indicating severe inflammation, severe anemia (hemoglobin 7.1 g/dL), hypotension with MAP min 38 mmHg and diastolic BP min 24 mmHg, requiring oxygen support (FiO2 48%), elevated infection markers (WBC 12.4, neutrophils 80.7%, bands 8%), and multi-organ dysfunction with creatinine 1.65 mg/dL and low albumin 2.5 g/dL.",
         "0",
         "0",
         "1962",
         "637",
         "0",
         "Let me analyze this patient data systematically to determine mortality risk:\n\nKey concerning findings:\n1. CRP (C-Reactive Protein): 76.25 mg/L - this is very high and indicates significant inflammation/sepsis (normal <3 mg/L)\n2. Hemoglobin: min 7.1 g/dL, mean 7.724 g/dL - severe anemia (normal ~12-15 g/dL for women)\n3. Diastolic BP: min 24 mmHg, mean 40.76 mmHg - dangerously low diastolic pressure \n4. Mean Arterial Pressure: min 38 mmHg, mean 59.56 mmHg - hypotension (normal >65 mmHg)\n5. FiO2: 40-50%, mean 48% - requiring supplemental oxygen\n6. Band neutrophils: 8% - elevated, indicating bacterial infection\n7. Neutrophils: 80.7% - elevated\n8. WBC: 11-12.4 - elevated indicating infection\n9. Creatinine: max 1.65 mg/dL, mean 1.308 mg/dL - kidney dysfunction\n10. INR: 1.3 - slightly elevated coagulation time\n11. Lactate: 1.9 mmol/L - slightly elevated (normal <2 mmol/L)\n12. Low albumin: 2.5-2.8 g/dL (normal 3.5-5 g/dL) - malnutrition/liver dysfunction\n\nThe patient appears to have severe sepsis with:\n- High inflammatory markers (CRP 76.25)\n- Hemodynamic instability (hypotension, low MAP)\n- Severe anemia\n- Signs of infection (elevated WBC, bands, neutrophils)\n- Multi-organ dysfunction (kidney, coagulation)\n\n\n- Respiratory compromise necessitating oxygen intervention\n\nI'm seeing critical respiratory distress that compounds the patient's already grave clinical condition. The need for supplemental oxygen underscores the severity of the underlying pathological processes, further elevating the risk of adverse outcomes.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "42",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 47, age: 57.0, sex: Female, weight: 116.0, height: 160.0\nAlbumin (unit: g/dL): min=3.200, max=3.200, mean=3.200\nAlkaline Phosphatase (unit: U/L): min=134.000, max=134.000, mean=134.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=16.000, max=16.000, mean=16.000\nAspartate Aminotransferase (AST) (unit: U/L): min=43.000, max=43.000, mean=43.000\nBase Excess (unit: mmol/L): min=-15.000, max=-1.000, mean=-7.840\nBicarbonate (unit: mmol/L): min=16.000, max=20.000, mean=18.080\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.300, mean=0.300\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=29.000, max=37.000, mean=32.840\nCalcium (unit: mg/dL): min=8.400, max=8.500, mean=8.448\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=106.000, mean=105.520\nCreatinine (unit: mg/dL): min=4.170, max=4.980, mean=4.559\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=35.000, max=49.000, mean=41.640\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=100.000, mean=63.200\nGlucose (unit: mg/dL): min=69.000, max=221.000, mean=159.680\nHemoglobin (unit: g/dL): min=7.700, max=8.000, mean=7.844\nHeart Rate (unit: bpm): min=91.000, max=141.000, mean=100.600\ninr (unit: ): min=1.000, max=1.300, mean=1.156\nPotassium (unit: mmol/L): min=4.800, max=4.800, mean=4.800\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=51.500, max=63.000, mean=57.240\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=26.700, max=26.900, mean=26.796\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=30.400, max=30.800, mean=30.608\nMean Corpuscular Volume (MCV) (unit: fL): min=86.700, max=88.300, mean=87.468\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=2.100, max=2.600, mean=2.340\nSodium (unit: mmol/L): min=134.000, max=138.000, mean=136.080\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=90.000, max=98.000, mean=94.780\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=55.000, mean=45.040\npH Level (unit: /): min=7.130, max=7.360, mean=7.240\nPhosphate (unit: mg/dL): min=5.500, max=7.000, mean=6.220\nPlatelets (unit: 1000/µL): min=350.000, max=466.000, mean=405.680\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=72.000, max=217.000, mean=122.840\nPartial Thromboplastin Time (PTT) (unit: sec): min=41.400, max=141.500, mean=95.456\nRespiratory Rate (unit: breaths/min): min=14.000, max=24.000, mean=19.560\nSystolic Blood Pressure (unit: mmHg): min=94.500, max=123.000, mean=109.540\nTemperature (unit: °C): min=36.890, max=37.894, mean=37.321\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=100.000, mean=4.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=13.500, max=15.600, mean=14.592",
         "0",
         "0.85",
         "mortality",
         "Multi-organ failure: severe acute kidney injury (creatinine 4.17-4.98 mg/dL, urine output mean 4.0 mL/h), hypotension (MAP 51.5-63.0 mmHg), severe metabolic acidosis (base excess -15.0 to -1.0 mmol/L, pH 7.13-7.36), respiratory failure (FiO2 40-100%), severe anemia (Hgb 7.7-8.0 g/dL), and systemic inflammation (CRP 76.25 mg/L).",
         "0",
         "0",
         "1962",
         "693",
         "0",
         "Let me analyze this patient data systematically to assess mortality risk:\n\nCritical abnormalities:\n1. **Kidney function**: Creatinine is extremely high (4.17-4.98 mg/dL, normal ~0.6-1.2), indicating severe kidney failure\n2. **Urine output**: Very concerning with min=0.000, max=100.000, mean=4.000 mL/h - this is oliguria/anuria (normal ~30-50 mL/h minimum)\n3. **Acid-base status**: Base excess very negative (-15.000 to -1.000 mmol/L), pH low (7.130-7.360), indicating metabolic acidosis\n4. **Hemoglobin**: Very low (7.7-8.0 g/dL, normal ~12-15 for women) - severe anemia\n5. **Blood pressure**: Hypotensive with MAP 51.5-63.0 mmHg (normal >65), diastolic BP very low (35-49 mmHg)\n6. **Respiratory support**: High FiO2 requirement (40-100%, mean 63.2%) suggesting respiratory failure\n7. **Inflammation**: Very high CRP (76.25 mg/L, normal <3), elevated WBC (13.5-15.6), high neutrophils (80.7%)\n8. **Coagulation**: Prolonged PTT (41.4-141.5 sec, mean 95.5, normal ~25-35)\n9. **Electrolytes**: High phosphate (5.5-7.0 mg/dL, normal 2.5-4.5), suggesting kidney failure\n10. **BUN**: Elevated (29-37 mg/dL, normal 7-20), confirming kidney dysfunction\n\nThis patient shows multi-organ failure:\n- Severe acute kidney injury with oliguria/anuria\n\n\n- Profound physiological derangements suggest an extremely critical condition with imminent life-threatening risks\n\nI observe cascading systemic breakdowns across multiple organ systems. The patient's clinical picture reveals a perfect storm of critical pathophysiological disruptions - cardiovascular compromise, respiratory distress, metabolic derangement, and inflammatory response. Each individual abnormality would be concerning, but their combined presentation indicates an overwhelmingly grave prognosis with potential rapid deterioration.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "43",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 48, age: 57.0, sex: Female, weight: 116.0, height: 160.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=21.000, max=23.000, mean=22.360\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=21.000, max=30.000, mean=25.480\nCalcium (unit: mg/dL): min=8.200, max=8.500, mean=8.316\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=104.000, max=107.000, mean=105.080\nCreatinine (unit: mg/dL): min=1.080, max=2.180, mean=1.591\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=48.500, max=83.500, mean=59.240\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=100.000, mean=59.200\nGlucose (unit: mg/dL): min=102.000, max=238.000, mean=159.280\nHemoglobin (unit: g/dL): min=7.900, max=10.300, mean=9.148\nHeart Rate (unit: bpm): min=88.000, max=120.000, mean=104.400\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.900, max=4.500, mean=4.140\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=66.500, max=96.000, mean=82.560\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=25.900, max=29.900, mean=28.080\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=30.300, max=33.000, mean=32.016\nMean Corpuscular Volume (MCV) (unit: fL): min=84.000, max=90.000, mean=87.296\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.700, max=1.900, mean=1.796\nSodium (unit: mmol/L): min=134.000, max=139.000, mean=137.200\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=90.000, max=99.500, mean=94.220\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.600, mean=3.360\nPlatelets (unit: 1000/µL): min=182.000, max=295.000, mean=240.440\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=16.500, max=36.000, mean=28.760\nSystolic Blood Pressure (unit: mmHg): min=119.000, max=193.000, mean=154.800\nTemperature (unit: °C): min=37.000, max=38.711, mean=38.008\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=30.000, max=285.000, mean=73.800\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=8.600, max=11.000, mean=10.488",
         "0",
         "0.78",
         "mortality",
         "Severe sepsis with multi-organ dysfunction: CRP extremely elevated at 76.25 mg/L, acute kidney injury (creatinine max 2.18 mg/dL), respiratory failure requiring high FiO2 (max 100%, mean 59.2%), fever up to 38.7?C, severe anemia (hemoglobin min 7.9 g/dL), hypoalbuminemia (2.8 g/dL), and oliguria (minimum urine output 30 mL/h).",
         "0",
         "0",
         "1962",
         "694",
         "0",
         "Let me analyze this patient's data carefully to determine mortality risk. I need to look for concerning abnormal values:\n\nKey concerning findings:\n1. CRP is very high at 76.25 mg/L (normal <3 mg/L) - indicating severe inflammation/infection\n2. Creatinine is elevated: min=1.08, max=2.18, mean=1.59 mg/dL - indicates acute kidney injury (normal ~0.6-1.2)\n3. FiO2 requirements are high: min=40%, max=100%, mean=59.2% - indicating respiratory failure requiring high oxygen\n4. Hemoglobin is low: min=7.9, max=10.3, mean=9.1 g/dL - anemia (normal 12-16 for women)\n5. Temperature elevated: max=38.7?C (101.7?F) - fever indicating infection\n6. Band neutrophils at 8% with neutrophils at 80.7% suggests left shift/infection\n7. Low lymphocytes at 9% (normal 20-40%) - immunosuppression\n8. Low albumin at 2.8 g/dL (normal 3.5-5.0) - malnutrition or liver dysfunction\n9. INR slightly elevated at 1.3 - coagulopathy\n10. Urine output variable: min=30 mL/h, max=285 mL/h, mean=73.8 mL/h - the minimum of 30 mL/h is concerning for oliguria\n\nHowever, some stabilizing factors:\n- Lactate is only 1.9 mmol/L (not severely elevated, normal <2)\n- pH is normal at 7.36\n- MAP has reasonable range 66.5-96 mmHg\n- Oxygen saturation 90-99.5% despite high FiO2 needs\n\n\nThe patient presents a critical clinical picture with systemic inflammatory response and widespread organ compromise. Multiple physiological systems are failing simultaneously, creating an extremely grave prognosis. The extensive clinical markers point to a life-threatening condition with substantial risk of mortality, likely exceeding 75%. Immediate, aggressive intervention is crucial to prevent potential fatal outcomes.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "44",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 49, age: 49.0, sex: Male, weight: 119.0, height: 193.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=11.000, max=19.200, mean=14.032\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=9.600, max=19.200, mean=15.200\nCalcium (unit: mg/dL): min=7.100, max=7.900, mean=7.588\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=84.000, max=93.000, mean=89.800\nCreatinine (unit: mg/dL): min=0.850, max=1.000, mean=0.967\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=38.000, max=92.000, mean=76.800\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=204.000, max=395.000, mean=263.140\nHemoglobin (unit: g/dL): min=10.300, max=10.300, mean=10.300\nHeart Rate (unit: bpm): min=74.000, max=93.000, mean=84.960\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.400, max=4.300, mean=4.000\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=54.000, max=103.500, mean=88.920\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=29.900, mean=29.900\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.000, mean=33.000\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=91.200, mean=90.576\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.600, max=2.000, mean=1.780\nSodium (unit: mmol/L): min=117.000, max=123.000, mean=120.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=92.000, max=99.000, mean=95.380\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.400, max=3.200, mean=2.744\nPlatelets (unit: 1000/µL): min=159.000, max=182.000, mean=170.960\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=16.500, max=22.000, mean=19.500\nSystolic Blood Pressure (unit: mmHg): min=97.000, max=154.000, mean=128.000\nTemperature (unit: °C): min=36.606, max=37.000, mean=36.844\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=3.100, max=11.000, mean=7.208",
         "0",
         "0.78",
         "mortality",
         "Multiple critical abnormalities: severe hyponatremia (sodium min=117 mmol/L), metabolic acidosis (bicarbonate min=11.0 mmol/L), severe hyperglycemia (glucose max=395 mg/dL), systemic inflammation (CRP=76.25 mg/L), hypocalcemia (calcium min=7.1 mg/dL), and hypoalbuminemia (2.8 g/dL) indicating multi-organ dysfunction.",
         "0",
         "0",
         "1962",
         "636",
         "0",
         "I need to analyze this patient data carefully to determine if this patient is at risk for mortality. Let me look for abnormal values and concerning patterns:\n\nKey concerning findings:\n1. Severe hyponatremia: Sodium min=117.000, max=123.000, mean=120.000 - this is significantly below normal (135-145 mmol/L)\n2. Metabolic acidosis: Bicarbonate min=11.000, max=19.200, mean=14.032 - the minimum is severely low (normal ~22-26 mmol/L)\n3. Hyperglycemia: Glucose min=204.000, max=395.000, mean=263.140 - significantly elevated (normal <140 mg/dL fasting)\n4. Elevated CRP: 76.250 mg/L - indicates significant inflammation (normal <3 mg/L)\n5. Hypocalcemia: Calcium min=7.100, max=7.900, mean=7.588 - below normal (8.5-10.5 mg/dL)\n6. Anemia: Hemoglobin 10.300 g/dL - below normal for males (13.5-17.5 g/dL)\n7. Low albumin: 2.800 g/dL - below normal (3.5-5.0 g/dL)\n\nSome positive signs:\n- Lactate 1.900 mmol/L is only mildly elevated (normal <2.0)\n- FiO2 is only 40%, suggesting not severe respiratory compromise\n- Urine output 100 mL/h is adequate\n- Blood pressure seems stable (though MAP minimum of 54 is concerning)\n\nHowever, the combination of severe hyponatremia, metabolic acidosis, severe hyperglycemia, and systemic inflammation (high CRP) suggests this patient is critically ill. \n\nThe electrolyte and acid-base disturbances signal profound physiological stress. These critical imbalances point to a dire clinical scenario with substantial risk of adverse outcomes. The patient's multiple metabolic derangements create a complex and potentially life-threatening condition that demands immediate, aggressive intervention.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "45",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 5, age: 30.0, sex: Male, weight: 90.1, height: 157.5\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=23.000, max=23.000, mean=23.000\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=44.000, max=44.000, mean=44.000\nCalcium (unit: mg/dL): min=8.800, max=8.800, mean=8.800\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=107.000, max=107.000, mean=107.000\nCreatinine (unit: mg/dL): min=4.230, max=4.230, mean=4.230\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=63.000, max=100.000, mean=79.860\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=82.000, max=114.000, mean=94.560\nHemoglobin (unit: g/dL): min=12.200, max=12.200, mean=12.200\nHeart Rate (unit: bpm): min=79.000, max=106.000, mean=91.240\ninr (unit: ): min=1.000, max=1.000, mean=1.000\nPotassium (unit: mmol/L): min=3.300, max=3.300, mean=3.300\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=76.500, max=108.000, mean=92.300\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=21.400, max=21.400, mean=21.400\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=31.700, max=31.700, mean=31.700\nMean Corpuscular Volume (MCV) (unit: fL): min=67.400, max=67.400, mean=67.400\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=2.100, max=2.100, mean=2.100\nSodium (unit: mmol/L): min=137.000, max=137.000, mean=137.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=95.000, max=99.000, mean=96.620\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.300, max=2.300, mean=2.300\nPlatelets (unit: 1000/µL): min=229.000, max=229.000, mean=229.000\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=37.600, max=37.600, mean=37.600\nRespiratory Rate (unit: breaths/min): min=17.000, max=22.000, mean=19.760\nSystolic Blood Pressure (unit: mmHg): min=120.500, max=157.500, mean=136.500\nTemperature (unit: °C): min=36.394, max=37.000, mean=36.761\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=550.000, mean=348.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=5.400, max=5.400, mean=5.400",
         "0",
         "0.72",
         "mortality",
         "High mortality risk due to severe acute kidney injury (creatinine 4.230 mg/dL, normal 0.6-1.3) with elevated BUN 44.000 mg/dL, combined with severe systemic inflammation (CRP 76.250 mg/L, normal <3) and bacterial infection indicators (band neutrophils 8%, neutrophils 80.7%, lymphocytes 9%). Despite stable hemodynamics and adequate urine output 348 mL/h, the combination of severe AKI and sepsis carries significant mortality risk.",
         "0",
         "0",
         "1962",
         "644",
         "0",
         "Let me analyze the patient data systematically for mortality risk:\n\nKey concerning findings:\n1. Creatinine: 4.230 mg/dL - This is severely elevated (normal is 0.6-1.3 mg/dL). This indicates severe acute kidney injury.\n2. BUN: 44.000 mg/dL - This is elevated (normal 7-20 mg/dL), supporting kidney dysfunction\n3. CRP: 76.250 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n4. Band neutrophils: 8% - This is elevated (normal 0-3%), indicating bacterial infection with left shift\n5. Neutrophils: 80.7% - This is elevated (normal 50-70%), supporting infection\n6. Lymphocytes: 9% - This is low (normal 20-40%), which can indicate severe infection/sepsis\n\nModerately concerning:\n- FiO2: 40% - Patient is on supplemental oxygen\n- Lactate: 1.9 mmol/L - This is slightly elevated (normal <2), borderline concerning\n\nPositive findings:\n- Hemodynamics appear stable (MAP 92.3 mmHg, SBP 136.5 mmHg)\n- Urine output is adequate (348 mL/h is good)\n- pH is normal (7.36)\n- Temperature is not severely elevated\n- Heart rate is not severely elevated\n\nThe most concerning finding is the severe acute kidney injury (creatinine 4.23) combined with signs of severe infection (very high CRP, left shift with bands). This combination in a 30-year-old suggests severe sepsis with acute kidney injury, which has significant mortality risk.\n\nHowever, the patient's hemodynamics are stable, urine output is maintained, and they're not on high oxygen support or vasopressors. This suggests they may be responding to treatment.\n\nGiven the severe kidney injury and signs of severe infection, but stable hemodynamics, I'd estimate moderate-high mortality risk around 65-75%.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "46",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 50, age: 63.0, sex: Male, weight: 105.7, height: 178.0\nAlbumin (unit: g/dL): min=2.800, max=3.100, mean=3.028\nAlkaline Phosphatase (unit: U/L): min=78.000, max=94.000, mean=90.160\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=29.000, mean=28.760\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=43.000, mean=40.840\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=21.000, max=25.000, mean=22.440\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=9.000, max=21.000, mean=13.960\nCalcium (unit: mg/dL): min=7.300, max=8.200, mean=7.636\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=105.000, max=112.000, mean=109.600\nCreatinine (unit: mg/dL): min=1.080, max=1.260, mean=1.181\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=52.000, max=111.000, mean=81.780\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=86.000, max=136.000, mean=104.320\nHemoglobin (unit: g/dL): min=10.300, max=11.900, mean=11.516\nHeart Rate (unit: bpm): min=79.000, max=97.000, mean=89.320\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.900, max=4.000, mean=3.948\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=67.000, max=115.000, mean=93.820\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=31.300, mean=30.964\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.400, mean=33.304\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=93.700, mean=92.812\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=2.700, mean=2.508\nSodium (unit: mmol/L): min=139.000, max=142.000, mean=141.280\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=94.500, max=99.000, mean=97.340\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=3.300, max=3.300, mean=3.300\nPlatelets (unit: 1000/µL): min=182.000, max=231.000, mean=219.240\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=18.000, max=26.000, mean=20.560\nSystolic Blood Pressure (unit: mmHg): min=113.000, max=149.000, mean=126.580\nTemperature (unit: °C): min=36.606, max=37.789, mean=36.803\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=12.100, mean=11.836",
         "0",
         "0.3",
         "not-mortality",
         "Moderate risk patient: severe inflammation with CRP 76.250 mg/L, hypocalcemia 7.636 mg/dL, and infection markers (neutrophils 80.7%, bands 8%). However, stable hemodynamics (MAP 93.8 mmHg), adequate urine output 100 mL/h, normal pH 7.36, and only mild lactate elevation 1.9 mmol/L suggest manageable condition.",
         "0",
         "0",
         "1962",
         "775",
         "0",
         "Let me analyze this patient's data systematically:\n\nKey concerning findings:\n1. C-Reactive Protein (CRP): 76.250 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n2. Calcium: min=7.300, max=8.200, mean=7.636 mg/dL - This is hypocalcemia (normal 8.5-10.5 mg/dL)\n3. Ionized Calcium: 1.140 mmol/L - This is also low (normal 1.15-1.35 mmol/L)\n4. Band Neutrophils: 8% - This is elevated (normal 0-5%), suggesting bacterial infection\n5. Neutrophils: 80.7% - This is elevated (normal 50-70%), also suggesting infection\n6. Lymphocytes: 9% - This is low (normal 20-40%), consistent with acute infection\n7. WBC: 11.0-12.1 (mean 11.836) - Mild leukocytosis\n8. Lactate: 1.9 mmol/L - Mildly elevated (normal <2.0 mmol/L)\n9. Creatinine: 1.08-1.26 mg/dL (mean 1.181) - Mild kidney impairment (normal 0.7-1.3 for males)\n10. FiO2: 40% - Requiring supplemental oxygen\n11. INR: 1.3 - Mild coagulopathy (normal 0.8-1.1)\n\nPositive findings:\n1. Heart rate: 79-97 bpm (mean 89.3) - Normal range\n2. Blood pressure: Systolic 113-149, MAP 67-115 - Reasonable range\n3. Temperature: 36.6-37.8?C - Mild fever but not severe\n\n\n4. Urine output: 100 mL/h - Adequate\n5. pH: 7.36 - Normal\n6. Oxygen saturation: 94.5-99% - Acceptable\n7. Hemoglobin: 10.3-11.9 g/dL - Mild anemia but not severe\n\nI'm seeing a complex clinical picture with significant inflammatory markers and potential infection. The patient shows mild systemic compromise with moderate organ stress. While supplemental oxygen is required and there are signs of infection, the patient's overall physiological parameters remain relatively stable. The combination of elevated inflammatory markers, mild organ dysfunction, and moderate respiratory support suggests a serious but potentially manageable condition.\n\nThe probability of mortality seems moderate - there are concerning signs but also stabilizing factors. I'd estimate around 25-35% mortality risk, indicating a guarded but not critically dire prognosis.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "47",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 51, age: 47.0, sex: Female, weight: 71.8, height: 165.1\nAlbumin (unit: g/dL): min=3.600, max=3.900, mean=3.864\nAlkaline Phosphatase (unit: U/L): min=60.000, max=77.000, mean=62.040\nAlanine Aminotransferase (ALT) (unit: U/L): min=10.000, max=18.000, mean=10.960\nAspartate Aminotransferase (AST) (unit: U/L): min=11.000, max=44.000, mean=14.960\nBase Excess (unit: mmol/L): min=-1.000, max=-1.000, mean=-1.000\nBicarbonate (unit: mmol/L): min=15.000, max=20.000, mean=16.720\nTotal Bilirubin (unit: mg/dL): min=0.100, max=1.800, mean=0.590\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=10.000, max=17.000, mean=14.200\nCalcium (unit: mg/dL): min=8.600, max=9.200, mean=8.804\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=33.000, max=33.000, mean=33.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=108.000, max=111.000, mean=109.800\nCreatinine (unit: mg/dL): min=1.240, max=1.510, mean=1.398\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=64.000, max=117.000, mean=83.900\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=79.000, max=209.000, mean=127.600\nHemoglobin (unit: g/dL): min=10.000, max=10.600, mean=10.528\nHeart Rate (unit: bpm): min=108.000, max=126.000, mean=116.760\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=3.700, max=4.300, mean=4.012\nLactate (unit: mmol/L): min=2.400, max=2.400, mean=2.400\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=74.000, max=121.000, mean=94.340\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=23.300, max=24.200, mean=24.092\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=30.800, max=32.100, mean=31.944\nMean Corpuscular Volume (MCV) (unit: fL): min=75.400, max=75.700, mean=75.436\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.000, max=2.200, mean=1.444\nSodium (unit: mmol/L): min=135.000, max=137.000, mean=136.320\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=91.000, max=100.000, mean=97.460\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=40.000, max=40.000, mean=40.000\npH Level (unit: /): min=7.360, max=7.360, mean=7.360\nPhosphate (unit: mg/dL): min=2.100, max=4.600, mean=2.520\nPlatelets (unit: 1000/µL): min=222.000, max=242.000, mean=239.600\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=101.000, max=101.000, mean=101.000\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=14.000, max=24.000, mean=18.020\nSystolic Blood Pressure (unit: mmHg): min=104.000, max=150.000, mean=131.720\nTemperature (unit: °C): min=37.711, max=38.606, mean=38.110\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=0.000, max=400.000, mean=158.120\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=10.900, max=11.100, mean=10.924",
         "0",
         "0.65",
         "mortality",
         "Septic patient with organ dysfunction: CRP 76.25 mg/L (severe inflammation), fever up to 38.606?C, tachycardia 108-126 bpm, lactate 2.4 mmol/L, AKI with creatinine 1.24-1.51 mg/dL, periods of oliguria (0 mL/h minimum), requiring FiO2 40%, and neutrophilia 80.7% with bandemia 8%. However, relatively stable hemodynamics (MAP 74-121 mmHg) and adequate oxygenation (SpO2 mean 97.4%) provide some reassurance.",
         "0",
         "0",
         "1962",
         "661",
         "0",
         "Let me analyze this patient data systematically to determine mortality risk:\n\nKey concerning findings:\n1. CRP 76.25 mg/L - this is significantly elevated, indicating severe inflammation/infection (normal <3 mg/L)\n2. Elevated temperature 37.711-38.606?C (fever)\n3. Elevated heart rate 108-126 bpm (tachycardia)\n4. Neutrophils 80.7% (elevated, normal ~50-70%), with bands 8% - suggests bacterial infection\n5. Low lymphocytes 9% (lymphopenia)\n6. Lactate 2.4 mmol/L - mildly elevated (normal <2), suggests some tissue hypoperfusion\n7. Creatinine 1.24-1.51 mg/dL - elevated, suggesting acute kidney injury\n8. Urine output ranges 0-400 mL/h with mean 158 - some periods of oliguria (0 mL/h is concerning)\n9. FiO2 40% - requiring supplemental oxygen\n10. pH 7.36 - on lower end of normal\n11. Bicarbonate 15-20 mmol/L (low normal to low) - mild metabolic acidosis\n\nHowever, some stabilizing factors:\n- Blood pressure reasonably stable (systolic 104-150, MAP 74-121)\n- Oxygen saturation 91-100% with mean 97.4%\n- Albumin normal (3.6-3.9)\n- Liver enzymes relatively normal\n- Platelets normal\n- No severe electrolyte abnormalities\n\nThis appears to be a septic patient with signs of organ dysfunction but not in extremis. The combination of high CRP, fever, tachycardia, elevated lactate, AKI, and periods of oliguria are concerning, but the patient seems to have some physiologic reserve.\n\nGiven the mixed picture - significant inflammation/sepsis markers but relatively stable hemodynamics and oxygenation - I'd estimate moderate mortality risk.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "48",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 52, age: 63.0, sex: Female, weight: 103.0, height: 162.6\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=98.000, mean=92.720\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=202.000, mean=170.080\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=273.000, mean=232.520\nBase Excess (unit: mmol/L): min=-4.000, max=-2.000, mean=-2.640\nBicarbonate (unit: mmol/L): min=20.000, max=22.000, mean=21.360\nTotal Bilirubin (unit: mg/dL): min=0.300, max=2.300, mean=1.068\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=10.000, max=11.000, mean=10.320\nCalcium (unit: mg/dL): min=7.600, max=8.000, mean=7.872\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=198.000, max=198.000, mean=198.000\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=6.200, max=6.200, mean=6.200\nChloride (unit: mmol/L): min=108.000, max=108.000, mean=108.000\nCreatinine (unit: mg/dL): min=0.620, max=0.640, mean=0.634\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=62.000, max=93.500, mean=72.820\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=50.000, max=50.000, mean=50.000\nGlucose (unit: mg/dL): min=113.000, max=183.000, mean=157.040\nHemoglobin (unit: g/dL): min=11.800, max=12.200, mean=12.072\nHeart Rate (unit: bpm): min=101.000, max=121.500, mean=114.080\ninr (unit: ): min=1.000, max=1.100, mean=1.068\nPotassium (unit: mmol/L): min=4.100, max=4.200, mean=4.168\nLactate (unit: mmol/L): min=1.100, max=3.000, mean=2.016\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=83.000, max=106.500, mean=96.160\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.700, max=30.000, mean=29.796\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.100, max=33.500, mean=33.228\nMean Corpuscular Volume (MCV) (unit: fL): min=89.500, max=89.700, mean=89.636\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.100, max=2.300, mean=1.916\nSodium (unit: mmol/L): min=138.000, max=138.000, mean=138.000\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=99.000, max=100.000, mean=99.920\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=42.000, max=47.000, mean=45.400\npH Level (unit: /): min=7.320, max=7.320, mean=7.320\nPhosphate (unit: mg/dL): min=2.000, max=3.200, mean=2.816\nPlatelets (unit: 1000/µL): min=313.000, max=321.000, mean=315.560\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=149.000, max=165.000, mean=159.880\nPartial Thromboplastin Time (PTT) (unit: sec): min=24.200, max=25.600, mean=25.152\nRespiratory Rate (unit: breaths/min): min=13.000, max=19.000, mean=14.800\nSystolic Blood Pressure (unit: mmHg): min=103.000, max=175.500, mean=145.620\nTemperature (unit: °C): min=36.394, max=37.894, mean=37.125\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=20.000, max=200.000, mean=70.200\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.800, max=12.400, mean=12.208",
         "0",
         "0.75",
         "mortality",
         "Critical hepatic dysfunction with AST 273 U/L and ALT 202 U/L, severe sepsis with CRP 76.25 mg/L and neutrophilia 80.7%, metabolic acidosis with pH 7.32 and lactate 3.0 mmol/L, requiring 50% FiO2 support, and oliguria minimum 20 mL/h indicating multi-organ involvement.",
         "0",
         "0",
         "1962",
         "669",
         "0",
         "Let me carefully analyze the patient data to assess mortality risk:\n\nKey concerning findings:\n\n1. Liver function severely compromised:\n   - AST very high: max 273 U/L, mean 232.52 U/L (normal <40)\n   - ALT very high: max 202 U/L, mean 170.08 U/L (normal <40)  \n   - Total bilirubin elevated: max 2.3 mg/dL, mean 1.068 mg/dL (normal <1.2)\n\n2. Severe infection/inflammation:\n   - CRP very elevated: 76.25 mg/L (normal <3)\n   - High neutrophils: 80.7%\n   - Band neutrophils present: 8%\n   - WBC elevated: 12.208 (normal 4-11)\n\n3. Respiratory compromise:\n   - FiO2 requirement of 50% (significant oxygen support needed)\n\n4. Metabolic concerns:\n   - Lactate elevated: max 3.0 mmol/L, mean 2.016 (normal <2)\n   - Base excess negative: -4 to -2 mmol/L\n   - pH low: 7.32 (acidemic, normal 7.35-7.45)\n\n5. Other concerning findings:\n   - Low albumin: 2.8 g/dL (normal 3.5-5.0)\n   - Low calcium: min 7.6 mg/dL (normal 8.5-10.5)\n   - Variable urine output: min 20 mL/h (very low)\n\nHowever, some stabilizing factors:\n   - Hemodynamics relatively stable (MAP mean 96.16)\n   - Adequate oxygenation (O2 sat 99-100%, PaO2 149-165)\n   - Kidney function preserved (creatinine 0.62-0.64, BUN 10-11)\n   - No severe coagulopathy (INR 1.0-1.1, PTT normal)\n\nI'm deeply concerned about the patient's critical condition. The multisystem involvement suggests an extremely high-risk scenario. Liver dysfunction, inflammatory markers, and metabolic derangements paint a grim picture of potential multi-organ failure. While some parameters show relative stability, the overall clinical picture remains extremely precarious.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ],
        [
         "49",
         "Suggest a diagnosis of mortality for the following patient data. Reply with mortality or not-mortality.\nGive exact numbers and/or text quotes from the data that made you think of each of the diagnoses.\nBefore finalizing your answer check if you haven't missed any abnormal data points. \n\n\nPatient data:\n\nPatient Info — index: 53, age: 56.0, sex: Male, weight: 97.1, height: 188.0\nAlbumin (unit: g/dL): min=2.800, max=2.800, mean=2.800\nAlkaline Phosphatase (unit: U/L): min=78.000, max=78.000, mean=78.000\nAlanine Aminotransferase (ALT) (unit: U/L): min=28.000, max=28.000, mean=28.000\nAspartate Aminotransferase (AST) (unit: U/L): min=34.000, max=34.000, mean=34.000\nBase Excess (unit: mmol/L): min=3.700, max=3.700, mean=3.700\nBicarbonate (unit: mmol/L): min=23.000, max=27.000, mean=25.720\nTotal Bilirubin (unit: mg/dL): min=0.300, max=0.700, mean=0.500\nBand Neutrophils (unit: %): min=8.000, max=8.000, mean=8.000\nBlood Urea Nitrogen (BUN) (unit: mg/dL): min=20.000, max=21.000, mean=20.320\nCalcium (unit: mg/dL): min=8.200, max=9.000, mean=8.744\nIonized Calcium (unit: mmol/L): min=1.140, max=1.140, mean=1.140\nCreatine Kinase (CK) (unit: U/L): min=118.000, max=135.000, mean=124.240\nCreatine Kinase-MB (CK-MB) (unit: ng/mL): min=4.700, max=5.500, mean=5.060\nChloride (unit: mmol/L): min=100.000, max=105.000, mean=101.600\nCreatinine (unit: mg/dL): min=0.830, max=1.080, mean=0.910\nC-Reactive Protein (CRP) (unit: mg/L): min=76.250, max=76.250, mean=76.250\nDiastolic Blood Pressure (unit: mmHg): min=69.000, max=88.000, mean=77.220\nFibrinogen (unit: mg/dL): min=288.000, max=288.000, mean=288.000\nFraction of Inspired Oxygen (FiO2) (unit: %): min=40.000, max=40.000, mean=40.000\nGlucose (unit: mg/dL): min=136.000, max=201.000, mean=161.120\nHemoglobin (unit: g/dL): min=10.300, max=13.100, mean=12.204\nHeart Rate (unit: bpm): min=72.000, max=92.000, mean=83.580\ninr (unit: ): min=1.300, max=1.300, mean=1.300\nPotassium (unit: mmol/L): min=4.000, max=4.300, mean=4.204\nLactate (unit: mmol/L): min=1.900, max=1.900, mean=1.900\nLymphocytes (unit: %): min=9.000, max=9.000, mean=9.000\nMean Arterial Pressure (MAP) (unit: mmHg): min=84.000, max=110.000, mean=93.280\nMean Corpuscular Hemoglobin (MCH) (unit: pg): min=29.900, max=33.000, mean=32.008\nMean Corpuscular Hemoglobin Concentration (MCHC) (unit: g/dL): min=33.000, max=33.800, mean=33.544\nMean Corpuscular Volume (MCV) (unit: fL): min=90.000, max=97.500, mean=95.100\nMethemoglobin (unit: %): min=0.400, max=0.400, mean=0.400\nMagnesium (unit: mg/dL): min=1.900, max=1.900, mean=1.900\nSodium (unit: mmol/L): min=135.000, max=139.000, mean=136.280\nNeutrophils (unit: %): min=80.700, max=80.700, mean=80.700\nOxygen Saturation (unit: %): min=92.000, max=97.000, mean=94.160\nPartial Pressure of Carbon Dioxide (PaCO2) (unit: mmHg): min=38.800, max=38.800, mean=38.800\npH Level (unit: /): min=7.462, max=7.462, mean=7.462\nPhosphate (unit: mg/dL): min=2.900, max=3.300, mean=3.028\nPlatelets (unit: 1000/µL): min=182.000, max=186.000, mean=184.720\nPartial Pressure of Oxygen (PaO2) (unit: mmHg): min=84.200, max=84.200, mean=84.200\nPartial Thromboplastin Time (PTT) (unit: sec): min=35.500, max=35.500, mean=35.500\nRespiratory Rate (unit: breaths/min): min=17.000, max=25.000, mean=20.920\nSystolic Blood Pressure (unit: mmHg): min=121.000, max=164.000, mean=140.320\nTemperature (unit: °C): min=36.211, max=37.000, mean=36.549\nTroponin T (unit: ng/mL): min=0.140, max=0.140, mean=0.140\nUrine Output (unit: mL/h): min=100.000, max=100.000, mean=100.000\nWhite Blood Cell Count (WBC) (unit: 1000/µL): min=11.000, max=24.700, mean=20.316",
         "0",
         "0.25",
         "not-mortality",
         "Moderate sepsis risk: severely elevated CRP 76.25 mg/L and WBC 20.316 with neutrophilia 80.7% and bandemia 8%, requiring FiO2 40% with O2 sat 94.16%. However, stable hemodynamics (MAP 93.28 mmHg), preserved renal function (creatinine 0.91 mg/dL), adequate urine output 100 mL/h, and normal coagulation suggest controlled infection without organ failure.",
         "0",
         "0",
         "1962",
         "768",
         "0",
         "Let me analyze this patient data for signs of mortality risk:\n\nAge: 56 years old male - not extremely elderly, but age is a risk factor\n\nKey concerning findings:\n1. CRP: 76.25 mg/L - This is significantly elevated (normal <3 mg/L), indicating severe inflammation/infection\n2. WBC: 11.0-24.7, mean 20.316 - Elevated white cell count, suggesting infection/sepsis\n3. Neutrophils: 80.7% - High neutrophil percentage, consistent with bacterial infection\n4. Band neutrophils: 8% - Elevated bands (left shift), indicating severe infection\n5. Lymphocytes: 9% - Low lymphocyte percentage (normal 20-40%), suggesting immunosuppression or severe infection\n6. FiO2: 40% - Patient requires supplemental oxygen\n7. Oxygen saturation: 92-97%, mean 94.16% - Lower end of normal, suggesting respiratory compromise\n8. Lactate: 1.9 mmol/L - Mildly elevated (normal <2), suggesting possible tissue hypoperfusion but not critically high\n9. Albumin: 2.8 g/dL - Low (normal 3.5-5.0), indicating malnutrition or severe illness\n10. Hemoglobin: 10.3-13.1, mean 12.2 - Lower end of normal for males\n11. Glucose: 136-201, mean 161 - Elevated, possibly stress-related hyperglycemia\n12. Troponin T: 0.14 ng/mL - Mildly elevated, suggesting cardiac involvement\n\nPositive findings:\n- Stable vital signs (HR 72-92, BP 121-164/69-88, MAP 84-110)\n- Normal pH 7.462 (alkalemic but compensated)\n- Normal bicarbonate 23-27\n\n\n- Kidney function appears intact with normal creatinine and good urine output\n- Coagulation parameters and platelet count within normal ranges\n\nThe patient presents with a complex clinical picture of severe infection with inflammatory markers, yet demonstrates remarkable physiological resilience. Despite significant inflammatory response, organ systems seem to be maintaining functional integrity. The interplay between inflammatory markers and relatively stable physiological parameters suggests a guarded but not immediately critical condition.\n\nI would characterize this as a moderate-risk scenario requiring close monitoring and aggressive infectious disease management.\n\nTreatment appears effective, with patient showing positive response and hemodynamic stability emerging as a promising clinical indicator.",
         "ClaudeSonnet4",
         "mortality",
         "eicu",
         "20250722_130446"
        ]
       ],
       "shape": {
        "columns": 15,
        "rows": 300
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Input Prompt</th>\n",
       "      <th>Target Label</th>\n",
       "      <th>Predicted Probability</th>\n",
       "      <th>Predicted Diagnosis</th>\n",
       "      <th>Predicted Explanation</th>\n",
       "      <th>Tokenization Time</th>\n",
       "      <th>Inference Time</th>\n",
       "      <th>Input Tokens</th>\n",
       "      <th>Output Tokens</th>\n",
       "      <th>Thinking Tokens</th>\n",
       "      <th>Thinking Output</th>\n",
       "      <th>model_name</th>\n",
       "      <th>task</th>\n",
       "      <th>dataset</th>\n",
       "      <th>timestamp</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.72</td>\n",
       "      <td>mortality</td>\n",
       "      <td>Septic shock presentation: severe inflammation...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>844</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient's data systematica...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>eicu</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.25</td>\n",
       "      <td>not-mortality</td>\n",
       "      <td>Mixed clinical picture: severe inflammation (C...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1963</td>\n",
       "      <td>1088</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient data systematicall...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>eicu</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.78</td>\n",
       "      <td>mortality</td>\n",
       "      <td>Sepsis with multi-organ dysfunction: CRP 76.25...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>678</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient data systematicall...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>eicu</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.85</td>\n",
       "      <td>mortality</td>\n",
       "      <td>Critical sepsis with multi-organ dysfunction: ...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>841</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient data systematicall...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>eicu</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.30</td>\n",
       "      <td>not-mortality</td>\n",
       "      <td>Moderate risk profile: elevated inflammatory m...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>696</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient data carefully to ...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>eicu</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.78</td>\n",
       "      <td>mortality</td>\n",
       "      <td>High-risk 91-year-old with severe immunosuppre...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>707</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze the patient data systematically...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>miiv</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.25</td>\n",
       "      <td>not-mortality</td>\n",
       "      <td>Young patient (27 years) with signs of infecti...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>788</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient data for signs of ...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>miiv</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.75</td>\n",
       "      <td>mortality</td>\n",
       "      <td>Severe acute kidney injury with creatinine up ...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>601</td>\n",
       "      <td>0</td>\n",
       "      <td>Looking at this patient data, I need to assess...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>miiv</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.35</td>\n",
       "      <td>not-mortality</td>\n",
       "      <td>Moderate risk patient with severe inflammation...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>823</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient data to look for s...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>miiv</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>Suggest a diagnosis of mortality for the follo...</td>\n",
       "      <td>0</td>\n",
       "      <td>0.87</td>\n",
       "      <td>mortality</td>\n",
       "      <td>Critical multi-organ dysfunction: severe malnu...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1962</td>\n",
       "      <td>666</td>\n",
       "      <td>0</td>\n",
       "      <td>Let me analyze this patient's data for mortali...</td>\n",
       "      <td>ClaudeSonnet4</td>\n",
       "      <td>mortality</td>\n",
       "      <td>miiv</td>\n",
       "      <td>20250722_130446</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>300 rows × 15 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          Input Prompt  Target Label  \\\n",
       "0    Suggest a diagnosis of mortality for the follo...             0   \n",
       "1    Suggest a diagnosis of mortality for the follo...             0   \n",
       "2    Suggest a diagnosis of mortality for the follo...             0   \n",
       "3    Suggest a diagnosis of mortality for the follo...             0   \n",
       "4    Suggest a diagnosis of mortality for the follo...             0   \n",
       "..                                                 ...           ...   \n",
       "295  Suggest a diagnosis of mortality for the follo...             0   \n",
       "296  Suggest a diagnosis of mortality for the follo...             0   \n",
       "297  Suggest a diagnosis of mortality for the follo...             0   \n",
       "298  Suggest a diagnosis of mortality for the follo...             0   \n",
       "299  Suggest a diagnosis of mortality for the follo...             0   \n",
       "\n",
       "     Predicted Probability Predicted Diagnosis  \\\n",
       "0                     0.72           mortality   \n",
       "1                     0.25       not-mortality   \n",
       "2                     0.78           mortality   \n",
       "3                     0.85           mortality   \n",
       "4                     0.30       not-mortality   \n",
       "..                     ...                 ...   \n",
       "295                   0.78           mortality   \n",
       "296                   0.25       not-mortality   \n",
       "297                   0.75           mortality   \n",
       "298                   0.35       not-mortality   \n",
       "299                   0.87           mortality   \n",
       "\n",
       "                                 Predicted Explanation  Tokenization Time  \\\n",
       "0    Septic shock presentation: severe inflammation...                  0   \n",
       "1    Mixed clinical picture: severe inflammation (C...                  0   \n",
       "2    Sepsis with multi-organ dysfunction: CRP 76.25...                  0   \n",
       "3    Critical sepsis with multi-organ dysfunction: ...                  0   \n",
       "4    Moderate risk profile: elevated inflammatory m...                  0   \n",
       "..                                                 ...                ...   \n",
       "295  High-risk 91-year-old with severe immunosuppre...                  0   \n",
       "296  Young patient (27 years) with signs of infecti...                  0   \n",
       "297  Severe acute kidney injury with creatinine up ...                  0   \n",
       "298  Moderate risk patient with severe inflammation...                  0   \n",
       "299  Critical multi-organ dysfunction: severe malnu...                  0   \n",
       "\n",
       "     Inference Time  Input Tokens  Output Tokens  Thinking Tokens  \\\n",
       "0                 0          1962            844                0   \n",
       "1                 0          1963           1088                0   \n",
       "2                 0          1962            678                0   \n",
       "3                 0          1962            841                0   \n",
       "4                 0          1962            696                0   \n",
       "..              ...           ...            ...              ...   \n",
       "295               0          1962            707                0   \n",
       "296               0          1962            788                0   \n",
       "297               0          1962            601                0   \n",
       "298               0          1962            823                0   \n",
       "299               0          1962            666                0   \n",
       "\n",
       "                                       Thinking Output     model_name  \\\n",
       "0    Let me analyze this patient's data systematica...  ClaudeSonnet4   \n",
       "1    Let me analyze this patient data systematicall...  ClaudeSonnet4   \n",
       "2    Let me analyze this patient data systematicall...  ClaudeSonnet4   \n",
       "3    Let me analyze this patient data systematicall...  ClaudeSonnet4   \n",
       "4    Let me analyze this patient data carefully to ...  ClaudeSonnet4   \n",
       "..                                                 ...            ...   \n",
       "295  Let me analyze the patient data systematically...  ClaudeSonnet4   \n",
       "296  Let me analyze this patient data for signs of ...  ClaudeSonnet4   \n",
       "297  Looking at this patient data, I need to assess...  ClaudeSonnet4   \n",
       "298  Let me analyze this patient data to look for s...  ClaudeSonnet4   \n",
       "299  Let me analyze this patient's data for mortali...  ClaudeSonnet4   \n",
       "\n",
       "          task dataset        timestamp  \n",
       "0    mortality    eicu  20250722_130446  \n",
       "1    mortality    eicu  20250722_130446  \n",
       "2    mortality    eicu  20250722_130446  \n",
       "3    mortality    eicu  20250722_130446  \n",
       "4    mortality    eicu  20250722_130446  \n",
       "..         ...     ...              ...  \n",
       "295  mortality    miiv  20250722_130446  \n",
       "296  mortality    miiv  20250722_130446  \n",
       "297  mortality    miiv  20250722_130446  \n",
       "298  mortality    miiv  20250722_130446  \n",
       "299  mortality    miiv  20250722_130446  \n",
       "\n",
       "[300 rows x 15 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mdata_dict[\"sarvari_2024_aggregation_preprocessor\"]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cacb43bf",
   "metadata": {},
   "source": [
    "Summary Metrics of all Prompting Appraches"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "7b61d036",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\janbe\\Documents\\GitHub Repos\\pulse\\src\\eval\\llm_analyzer.py:865: FutureWarning: The default of observed=False is deprecated and will be changed to True in a future version of pandas. Pass observed=False to retain current behavior or observed=True to adopt the future default and silence this warning.\n",
      "  agg_df = plot_df.groupby([\"Group\", \"Metric\"], as_index=False).agg(\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_results = LLMAnalyzer.load_metrics_from_prompt_approaches(\n",
    "    base_output_dir, prompt_approaches\n",
    ")\n",
    "\n",
    "\n",
    "\n",
    "LLMAnalyzer.plot_metrics(\n",
    "    df_results, group=[\"prompting_id\"], title_prefix=\"Gemini 2.5 Flash - \"\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4030629e",
   "metadata": {},
   "source": [
    "Metrics per Prompt and Task"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "ad81ecff",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\janbe\\Documents\\GitHub Repos\\pulse\\src\\eval\\llm_analyzer.py:865: FutureWarning: The default of observed=False is deprecated and will be changed to True in a future version of pandas. Pass observed=False to retain current behavior or observed=True to adopt the future default and silence this warning.\n",
      "  agg_df = plot_df.groupby([\"Group\", \"Metric\"], as_index=False).agg(\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "LLMAnalyzer.plot_metrics(\n",
    "    df_results,\n",
    "    group=[\"task_id\", \"prompting_id\"],\n",
    "    title_prefix=\"Gemini 2.5 Flash - \",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9e6f1d27",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "1adbc074",
   "metadata": {},
   "source": [
    "Analysis of best prompting approach"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "e1f0ee32",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ea41c4c15a9e4cb0bfc63315f1e73df7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Dropdown(description='Prompt Approach:', index=1, options=('collaborative_reasoning_agent_preprocessor', 'liu_…"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "prompt_dropdown = widgets.Dropdown(\n",
    "    options=prompt_approaches,\n",
    "    value=best_prompt_approach[0],\n",
    "    description='Prompt Approach:',\n",
    "    style={'description_width': 'initial'}\n",
    ")\n",
    "display(prompt_dropdown)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "38715134",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading metadata from: C:\\Users\\janbe\\Documents\\GitHub Repos\\pulse\\output_to_keep\\results_benchmark\\llms\\gemini2p5flash\\liu_2023_few_shot_preprocessor\n",
      "======================================================\n",
      "Model Name: Gemini2p5flash, Task: aki, Dataset: eicu, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: aki, Dataset: hirid, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: aki, Dataset: miiv, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: mortality, Dataset: eicu, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: mortality, Dataset: hirid, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: mortality, Dataset: miiv, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: sepsis, Dataset: eicu, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: sepsis, Dataset: hirid, Timestamp: 20250623_140022\n",
      "Model Name: Gemini2p5flash, Task: sepsis, Dataset: miiv, Timestamp: 20250623_140022\n"
     ]
    }
   ],
   "source": [
    "best_approach_path = os.path.join(\n",
    "    base_output_dir, prompt_dropdown.value\n",
    ")\n",
    "print(f\"Loading metadata from: {best_approach_path}\")\n",
    "print(\"======================================================\")\n",
    "cat_files = LLMAnalyzer.categorize_files([best_approach_path], verbose=False)\n",
    "df_mdata = LLMAnalyzer.load_metadata(cat_files[\"metadata_files\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "be40792e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "        <h3>Summary of Approach</h3>\n",
       "        <ul>\n",
       "            <li><b>Number of samples:</b> 6,189</li>\n",
       "            <li><b>Tasks:</b> aki, mortality, sepsis</li>\n",
       "            <li><b>Datasets:</b> eicu, hirid, miiv</li>\n",
       "            <li><b>Predicted diagnoses:</b> aki, not-aki, mortality, not-mortality, sepsis, not-sepsis, error, diagnosis</li>\n",
       "            <li><b>Total inference time:</b> 4.19 h</li>\n",
       "            <li><b>Total input tokens:</b> 64,886,076</li>\n",
       "            <li><b>Total output tokens:</b> 823,214</li>\n",
       "        </ul>\n",
       "        "
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<style type=\"text/css\">\n",
       "#T_802f4_row0_col2, #T_802f4_row0_col6 {\n",
       "  background-color: #8fc2de;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row0_col4, #T_802f4_row1_col2, #T_802f4_row1_col6, #T_802f4_row2_col4, #T_802f4_row8_col4, #T_802f4_row8_col11 {\n",
       "  background-color: #f7fbff;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row0_col11, #T_802f4_row4_col4, #T_802f4_row5_col2, #T_802f4_row6_col6, #T_802f4_row7_col6 {\n",
       "  background-color: #08306b;\n",
       "  color: #f1f1f1;\n",
       "}\n",
       "#T_802f4_row1_col4 {\n",
       "  background-color: #f0f6fd;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row1_col11 {\n",
       "  background-color: #95c5df;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row2_col2 {\n",
       "  background-color: #f5fafe;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row2_col6 {\n",
       "  background-color: #d0e2f2;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row2_col11, #T_802f4_row8_col6 {\n",
       "  background-color: #3a8ac2;\n",
       "  color: #f1f1f1;\n",
       "}\n",
       "#T_802f4_row3_col2 {\n",
       "  background-color: #d4e4f4;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row3_col4, #T_802f4_row5_col4 {\n",
       "  background-color: #105ba4;\n",
       "  color: #f1f1f1;\n",
       "}\n",
       "#T_802f4_row3_col6 {\n",
       "  background-color: #aacfe5;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row3_col11 {\n",
       "  background-color: #e0ecf8;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row4_col2 {\n",
       "  background-color: #91c3de;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row4_col6 {\n",
       "  background-color: #0e59a2;\n",
       "  color: #f1f1f1;\n",
       "}\n",
       "#T_802f4_row4_col11 {\n",
       "  background-color: #caddf0;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row5_col6 {\n",
       "  background-color: #edf4fc;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row5_col11 {\n",
       "  background-color: #c3daee;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row6_col2 {\n",
       "  background-color: #1c6ab0;\n",
       "  color: #f1f1f1;\n",
       "}\n",
       "#T_802f4_row6_col4 {\n",
       "  background-color: #f6faff;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row6_col11 {\n",
       "  background-color: #ecf4fb;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row7_col2 {\n",
       "  background-color: #a8cee4;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row7_col4 {\n",
       "  background-color: #eff6fc;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row7_col11 {\n",
       "  background-color: #ddeaf7;\n",
       "  color: #000000;\n",
       "}\n",
       "#T_802f4_row8_col2 {\n",
       "  background-color: #f3f8fe;\n",
       "  color: #000000;\n",
       "}\n",
       "</style>\n",
       "<table id=\"T_802f4\">\n",
       "  <thead>\n",
       "    <tr>\n",
       "      <th class=\"blank level0\" >&nbsp;</th>\n",
       "      <th id=\"T_802f4_level0_col0\" class=\"col_heading level0 col0\" >task</th>\n",
       "      <th id=\"T_802f4_level0_col1\" class=\"col_heading level0 col1\" >dataset</th>\n",
       "      <th id=\"T_802f4_level0_col2\" class=\"col_heading level0 col2\" >mean_inference_time</th>\n",
       "      <th id=\"T_802f4_level0_col3\" class=\"col_heading level0 col3\" >total_inference_time</th>\n",
       "      <th id=\"T_802f4_level0_col4\" class=\"col_heading level0 col4\" >mean_input_tokens</th>\n",
       "      <th id=\"T_802f4_level0_col5\" class=\"col_heading level0 col5\" >total_input_tokens</th>\n",
       "      <th id=\"T_802f4_level0_col6\" class=\"col_heading level0 col6\" >mean_output_tokens</th>\n",
       "      <th id=\"T_802f4_level0_col7\" class=\"col_heading level0 col7\" >total_output_tokens</th>\n",
       "      <th id=\"T_802f4_level0_col8\" class=\"col_heading level0 col8\" >positive_samples</th>\n",
       "      <th id=\"T_802f4_level0_col9\" class=\"col_heading level0 col9\" >negative_samples</th>\n",
       "      <th id=\"T_802f4_level0_col10\" class=\"col_heading level0 col10\" >total_samples</th>\n",
       "      <th id=\"T_802f4_level0_col11\" class=\"col_heading level0 col11\" >pos_neg_ratio</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row0\" class=\"row_heading level0 row0\" >0</th>\n",
       "      <td id=\"T_802f4_row0_col0\" class=\"data row0 col0\" >aki</td>\n",
       "      <td id=\"T_802f4_row0_col1\" class=\"data row0 col1\" >eicu</td>\n",
       "      <td id=\"T_802f4_row0_col2\" class=\"data row0 col2\" >2.75s</td>\n",
       "      <td id=\"T_802f4_row0_col3\" class=\"data row0 col3\" >2703.15s</td>\n",
       "      <td id=\"T_802f4_row0_col4\" class=\"data row0 col4\" >9010</td>\n",
       "      <td id=\"T_802f4_row0_col5\" class=\"data row0 col5\" >8866155</td>\n",
       "      <td id=\"T_802f4_row0_col6\" class=\"data row0 col6\" >128</td>\n",
       "      <td id=\"T_802f4_row0_col7\" class=\"data row0 col7\" >126038</td>\n",
       "      <td id=\"T_802f4_row0_col8\" class=\"data row0 col8\" >305</td>\n",
       "      <td id=\"T_802f4_row0_col9\" class=\"data row0 col9\" >679</td>\n",
       "      <td id=\"T_802f4_row0_col10\" class=\"data row0 col10\" >984</td>\n",
       "      <td id=\"T_802f4_row0_col11\" class=\"data row0 col11\" >0.45</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row1\" class=\"row_heading level0 row1\" >1</th>\n",
       "      <td id=\"T_802f4_row1_col0\" class=\"data row1 col0\" >aki</td>\n",
       "      <td id=\"T_802f4_row1_col1\" class=\"data row1 col1\" >hirid</td>\n",
       "      <td id=\"T_802f4_row1_col2\" class=\"data row1 col2\" >1.84s</td>\n",
       "      <td id=\"T_802f4_row1_col3\" class=\"data row1 col3\" >1806.64s</td>\n",
       "      <td id=\"T_802f4_row1_col4\" class=\"data row1 col4\" >9964</td>\n",
       "      <td id=\"T_802f4_row1_col5\" class=\"data row1 col5\" >9784235</td>\n",
       "      <td id=\"T_802f4_row1_col6\" class=\"data row1 col6\" >112</td>\n",
       "      <td id=\"T_802f4_row1_col7\" class=\"data row1 col7\" >109797</td>\n",
       "      <td id=\"T_802f4_row1_col8\" class=\"data row1 col8\" >159</td>\n",
       "      <td id=\"T_802f4_row1_col9\" class=\"data row1 col9\" >823</td>\n",
       "      <td id=\"T_802f4_row1_col10\" class=\"data row1 col10\" >982</td>\n",
       "      <td id=\"T_802f4_row1_col11\" class=\"data row1 col11\" >0.19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row2\" class=\"row_heading level0 row2\" >2</th>\n",
       "      <td id=\"T_802f4_row2_col0\" class=\"data row2 col0\" >aki</td>\n",
       "      <td id=\"T_802f4_row2_col1\" class=\"data row2 col1\" >miiv</td>\n",
       "      <td id=\"T_802f4_row2_col2\" class=\"data row2 col2\" >1.86s</td>\n",
       "      <td id=\"T_802f4_row2_col3\" class=\"data row2 col3\" >1833.72s</td>\n",
       "      <td id=\"T_802f4_row2_col4\" class=\"data row2 col4\" >9100</td>\n",
       "      <td id=\"T_802f4_row2_col5\" class=\"data row2 col5\" >8954791</td>\n",
       "      <td id=\"T_802f4_row2_col6\" class=\"data row2 col6\" >120</td>\n",
       "      <td id=\"T_802f4_row2_col7\" class=\"data row2 col7\" >117705</td>\n",
       "      <td id=\"T_802f4_row2_col8\" class=\"data row2 col8\" >229</td>\n",
       "      <td id=\"T_802f4_row2_col9\" class=\"data row2 col9\" >755</td>\n",
       "      <td id=\"T_802f4_row2_col10\" class=\"data row2 col10\" >984</td>\n",
       "      <td id=\"T_802f4_row2_col11\" class=\"data row2 col11\" >0.30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row3\" class=\"row_heading level0 row3\" >3</th>\n",
       "      <td id=\"T_802f4_row3_col0\" class=\"data row3 col0\" >mortality</td>\n",
       "      <td id=\"T_802f4_row3_col1\" class=\"data row3 col1\" >eicu</td>\n",
       "      <td id=\"T_802f4_row3_col2\" class=\"data row3 col2\" >2.23s</td>\n",
       "      <td id=\"T_802f4_row3_col3\" class=\"data row3 col3\" >222.84s</td>\n",
       "      <td id=\"T_802f4_row3_col4\" class=\"data row3 col4\" >30493</td>\n",
       "      <td id=\"T_802f4_row3_col5\" class=\"data row3 col5\" >3049349</td>\n",
       "      <td id=\"T_802f4_row3_col6\" class=\"data row3 col6\" >125</td>\n",
       "      <td id=\"T_802f4_row3_col7\" class=\"data row3 col7\" >12511</td>\n",
       "      <td id=\"T_802f4_row3_col8\" class=\"data row3 col8\" >7</td>\n",
       "      <td id=\"T_802f4_row3_col9\" class=\"data row3 col9\" >93</td>\n",
       "      <td id=\"T_802f4_row3_col10\" class=\"data row3 col10\" >100</td>\n",
       "      <td id=\"T_802f4_row3_col11\" class=\"data row3 col11\" >0.08</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row4\" class=\"row_heading level0 row4\" >4</th>\n",
       "      <td id=\"T_802f4_row4_col0\" class=\"data row4 col0\" >mortality</td>\n",
       "      <td id=\"T_802f4_row4_col1\" class=\"data row4 col1\" >hirid</td>\n",
       "      <td id=\"T_802f4_row4_col2\" class=\"data row4 col2\" >2.74s</td>\n",
       "      <td id=\"T_802f4_row4_col3\" class=\"data row4 col3\" >273.80s</td>\n",
       "      <td id=\"T_802f4_row4_col4\" class=\"data row4 col4\" >34755</td>\n",
       "      <td id=\"T_802f4_row4_col5\" class=\"data row4 col5\" >3475511</td>\n",
       "      <td id=\"T_802f4_row4_col6\" class=\"data row4 col6\" >145</td>\n",
       "      <td id=\"T_802f4_row4_col7\" class=\"data row4 col7\" >14503</td>\n",
       "      <td id=\"T_802f4_row4_col8\" class=\"data row4 col8\" >11</td>\n",
       "      <td id=\"T_802f4_row4_col9\" class=\"data row4 col9\" >89</td>\n",
       "      <td id=\"T_802f4_row4_col10\" class=\"data row4 col10\" >100</td>\n",
       "      <td id=\"T_802f4_row4_col11\" class=\"data row4 col11\" >0.12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row5\" class=\"row_heading level0 row5\" >5</th>\n",
       "      <td id=\"T_802f4_row5_col0\" class=\"data row5 col0\" >mortality</td>\n",
       "      <td id=\"T_802f4_row5_col1\" class=\"data row5 col1\" >miiv</td>\n",
       "      <td id=\"T_802f4_row5_col2\" class=\"data row5 col2\" >4.03s</td>\n",
       "      <td id=\"T_802f4_row5_col3\" class=\"data row5 col3\" >403.40s</td>\n",
       "      <td id=\"T_802f4_row5_col4\" class=\"data row5 col4\" >30507</td>\n",
       "      <td id=\"T_802f4_row5_col5\" class=\"data row5 col5\" >3050680</td>\n",
       "      <td id=\"T_802f4_row5_col6\" class=\"data row5 col6\" >114</td>\n",
       "      <td id=\"T_802f4_row5_col7\" class=\"data row5 col7\" >11390</td>\n",
       "      <td id=\"T_802f4_row5_col8\" class=\"data row5 col8\" >12</td>\n",
       "      <td id=\"T_802f4_row5_col9\" class=\"data row5 col9\" >88</td>\n",
       "      <td id=\"T_802f4_row5_col10\" class=\"data row5 col10\" >100</td>\n",
       "      <td id=\"T_802f4_row5_col11\" class=\"data row5 col11\" >0.14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row6\" class=\"row_heading level0 row6\" >6</th>\n",
       "      <td id=\"T_802f4_row6_col0\" class=\"data row6 col0\" >sepsis</td>\n",
       "      <td id=\"T_802f4_row6_col1\" class=\"data row6 col1\" >eicu</td>\n",
       "      <td id=\"T_802f4_row6_col2\" class=\"data row6 col2\" >3.54s</td>\n",
       "      <td id=\"T_802f4_row6_col3\" class=\"data row6 col3\" >3466.62s</td>\n",
       "      <td id=\"T_802f4_row6_col4\" class=\"data row6 col4\" >9121</td>\n",
       "      <td id=\"T_802f4_row6_col5\" class=\"data row6 col5\" >8938234</td>\n",
       "      <td id=\"T_802f4_row6_col6\" class=\"data row6 col6\" >151</td>\n",
       "      <td id=\"T_802f4_row6_col7\" class=\"data row6 col7\" >148284</td>\n",
       "      <td id=\"T_802f4_row6_col8\" class=\"data row6 col8\" >47</td>\n",
       "      <td id=\"T_802f4_row6_col9\" class=\"data row6 col9\" >933</td>\n",
       "      <td id=\"T_802f4_row6_col10\" class=\"data row6 col10\" >980</td>\n",
       "      <td id=\"T_802f4_row6_col11\" class=\"data row6 col11\" >0.05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row7\" class=\"row_heading level0 row7\" >7</th>\n",
       "      <td id=\"T_802f4_row7_col0\" class=\"data row7 col0\" >sepsis</td>\n",
       "      <td id=\"T_802f4_row7_col1\" class=\"data row7 col1\" >hirid</td>\n",
       "      <td id=\"T_802f4_row7_col2\" class=\"data row7 col2\" >2.60s</td>\n",
       "      <td id=\"T_802f4_row7_col3\" class=\"data row7 col3\" >2516.43s</td>\n",
       "      <td id=\"T_802f4_row7_col4\" class=\"data row7 col4\" >10108</td>\n",
       "      <td id=\"T_802f4_row7_col5\" class=\"data row7 col5\" >9794475</td>\n",
       "      <td id=\"T_802f4_row7_col6\" class=\"data row7 col6\" >151</td>\n",
       "      <td id=\"T_802f4_row7_col7\" class=\"data row7 col7\" >146664</td>\n",
       "      <td id=\"T_802f4_row7_col8\" class=\"data row7 col8\" >73</td>\n",
       "      <td id=\"T_802f4_row7_col9\" class=\"data row7 col9\" >896</td>\n",
       "      <td id=\"T_802f4_row7_col10\" class=\"data row7 col10\" >969</td>\n",
       "      <td id=\"T_802f4_row7_col11\" class=\"data row7 col11\" >0.08</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th id=\"T_802f4_level0_row8\" class=\"row_heading level0 row8\" >8</th>\n",
       "      <td id=\"T_802f4_row8_col0\" class=\"data row8 col0\" >sepsis</td>\n",
       "      <td id=\"T_802f4_row8_col1\" class=\"data row8 col1\" >miiv</td>\n",
       "      <td id=\"T_802f4_row8_col2\" class=\"data row8 col2\" >1.89s</td>\n",
       "      <td id=\"T_802f4_row8_col3\" class=\"data row8 col3\" >1867.99s</td>\n",
       "      <td id=\"T_802f4_row8_col4\" class=\"data row8 col4\" >9063</td>\n",
       "      <td id=\"T_802f4_row8_col5\" class=\"data row8 col5\" >8972646</td>\n",
       "      <td id=\"T_802f4_row8_col6\" class=\"data row8 col6\" >138</td>\n",
       "      <td id=\"T_802f4_row8_col7\" class=\"data row8 col7\" >136322</td>\n",
       "      <td id=\"T_802f4_row8_col8\" class=\"data row8 col8\" >25</td>\n",
       "      <td id=\"T_802f4_row8_col9\" class=\"data row8 col9\" >965</td>\n",
       "      <td id=\"T_802f4_row8_col10\" class=\"data row8 col10\" >990</td>\n",
       "      <td id=\"T_802f4_row8_col11\" class=\"data row8 col11\" >0.03</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n"
      ],
      "text/plain": [
       "<pandas.io.formats.style.Styler at 0x1888272b6b0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "LLMAnalyzer.print_approach_summary(df_mdata)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "461699f1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Prediction Distribution Statistics ---\n",
      "Total Records: 300\n",
      "Ground Truth Positive Samples: 30\n",
      "Ground Truth Negative Samples: 270\n",
      "Mean Predicted Probability (Average of All Predictions): 0.456\n",
      "Std Predicted Probability: 0.330\n",
      "Calibration Error (|Mean Pred. Prob. - Ground Truth Pos. Rate|): 0.356\n",
      "True Positives: 23\n",
      "True Negatives: 143\n",
      "False Positives: 127\n",
      "False Negatives: 7\n",
      "Accuracy (at 0.5 threshold): 0.553\n",
      "AUPRC: 0.482\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Prediction Distribution Statistics ---\n",
      "Total Records: 2939\n",
      "Ground Truth Positive Samples: 145\n",
      "Ground Truth Negative Samples: 2794\n",
      "Mean Predicted Probability (Average of All Predictions): 0.415\n",
      "Std Predicted Probability: 0.338\n",
      "Calibration Error (|Mean Pred. Prob. - Ground Truth Pos. Rate|): 0.366\n",
      "True Positives: 103\n",
      "True Negatives: 1761\n",
      "False Positives: 1032\n",
      "False Negatives: 42\n",
      "Accuracy (at 0.5 threshold): 0.635\n",
      "Could not calculate AUPRC: Input contains NaN.. Make sure sklearn.metrics.average_precision_score is available.\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAk4AAAGGCAYAAACNCg6xAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjEsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvc2/+5QAAAAlwSFlzAAAPYQAAD2EBqD+naQAAkpBJREFUeJztnQd4FPXzxieVEhISAgQIEHrvXaWIIF0pggqo2BuK5WfDhmDFLooVOwqKSJMuIE0B6S2h1wCBQCAhJJBy/+cd/nteTS7hLrlL3s/Dcne7e7uze5vb92bmO+NnMplMQgghhBBCcsU/91UIIYQQQgigcCKEEEIIcREKJ0IIIYQQF6FwIoQQQghxEQonQgghhBAXoXAihBBCCHERCidCCCGEEBehcCKEEEIIcREKJ0II8WKKco1ibzg2b7CB+BYUTsQn2bdvn7z66qvSs2dPad68ubRu3VpuvfVW+fnnnyUzM7PA7Lj99tt1cvd7Dh06JI899ph07NhRj23o0KHyzz//5Lrtp556SurXr283LViwwOl7Pv74Y4fvMaavv/4638eaG8a+PcXvv/9udzwNGzaUtm3byt133y0bNmwQT4L94RjB0aNH9TVscpVPP/3UfP4L4nzldl00a9ZM/+bGjx8vZ8+etVr/ueeek+uuu87l7e/Zs0eva1c/Q5y//OzHW88v8V0CC9sAQvLKvHnzZPTo0VK7dm256667pGbNmpKeni7Lly+XN954Q1auXKlfiH5+fh63ZcyYMW5/T1JSktx2220SHh4uzz//vJQpU0amTZumN/rvv/9e2rVr5/S9cXFx0q9fPzuBU6NGjVzt+uWXXxzOr1Klivg6n3zyiVSoUEGfZ2dnS2JiokycOFFGjBghv/32mzRo0MDjNlSsWFHPcfXq1V1+z0cffSSPPPKI+fWQIUOkU6dOUpAY1wU8MxcuXJBt27bJV199JUuXLpUpU6ZIuXLldPnDDz8sd9xxh8vbhZjftGlTrutde+21agPOn7vxhvNLfA8KJ+JzniaIJny5ffjhhxIY+N8l3KVLF2nfvr2MGjVK5s+fL3369PG4PXXq1HH7e2bOnKniCTf0qKgonXfNNddI//799dexM+F08eJFOXDggIqBFi1a5Nmu/LzHV4CXqWrVqlbzGjVqJNdff716KceNG+dxG4KDg6/4HFeqVEmngsTWZlyLV199tQwbNkzef/99ee2113R+XgRhXoAwM8SZpymM80t8D4bqiE8xadIk8ff3l7Fjx1qJJgOEEQYMGGA1Dx6GL7/8Um+STZo00XV+/PFHq3XgoXn55ZfVUwVRhvDffffdp56J6dOn63tbtmwpd955pzlkYLzP0rsDN/9PP/0kL7zwggocvAchN2zH2XtsgVjCfgzRBAICAiQmJkYOHz7s9H27d+/WMCVEQkFw5swZ/Ry6du2q5xXHO3LkSKvzA3sffPBBFbQ4p7fccot6Bm3566+/5MYbb5SmTZvq5wPx6GkgpCIiIuTYsWPmkBDEFLx7EAc4nr179+qyP//8UwYNGqT2YRnEArwvlqxbt06PD8eJY/j777+tljsK1e3fv189HtgXwocPPPCA/jgARsgI3jLjuaNQEjywsA3XGmzDdXzu3DnzcrwH1y/O8Q033GD+G7iSc4yQXY8ePXQbaWlpDkNo27dvVxGPULPxt7N582azTTgu23AmnmM+jgf7wHPbUJ0BvFDwRmE97Gfnzp25htxs9+Wt55d4NxROxKdYsmSJdOjQQSIjI52ug/wLS2/TK6+8IhMmTNAb8+effy69evXSkB5CNZb88ccfmkf0+uuvq/DBc4TMfvjhB3n22WfVK7Fly5ZcvRMffPCBijX8Gn/mmWdk2bJluj9Xge3IVbIEX9T//vuv1K1bN8cwHcCNH7lR+AKHVwA2uwJEl+2E43AEwja4ya9evVpthScMAgDnzAhF4r1YBzfWt99+W0Upwo8PPfSQ5nBZgpsRbqyfffaZ/uLHTdg4Hk8Brx4mS09JVlaWfPPNN3oNGOHgOXPmqCCsVauWXjM4ztmzZ2toykgs3rFjh4ZSQ0ND9VpDyOrJJ5/Mcf8JCQkqtA4ePKjX6DvvvKMCGyIA+UNGiGzw4MFOw6g4p9gPvELYL+xcuHChCnOErw1OnTql1y3swo8IiEZc04ZIyw8QERkZGRq6s+X8+fNy7733qjCFsMDfBK6De+65R1JSUjQkhuMCODa8NsDfKAQIjgcCxBEnTpxQwfP444/r3xn+PnDMhgh2BW8/v8R7YaiO+Az4csTkKF/HNiEc+U3w0iB09euvv+qX3/3336/LICqw/IsvvlBhgS93Yxv4Mi5btqy+XrRokeZLwdtQrVo1nYdfzLNmzcrRznr16smbb75pfr1169Yck7NzAwLkpZdeMt+MnBEbG6uPuEG99957evPFlzi+zHFjyC2Pp3HjxnbzcGN3JBRPnjwppUqV0ptDmzZtdB68SvAwGTeh06dPq0cFAgNhVGB4ES5dumS1PXhwOnfurM8hZPALHh4cd+Ue4Rwa1whCmhAr7777rnovcYyWwEMGTwaAMMJ68ELi0QDXIIQevGdYF9cSxDyEX1BQkK6D6+qJJ55watN3332n5+Hbb78151/heJEwDbFrnDMISUchPvwtYH8333yzCk/L62/48OHqKcWjcU1ADF511VVm++EphP0Qh/mhfPny+mjpTTWApw6iFNdeq1atdB6EJ66N1NRUq5CY7bHhekLuooEjYQaBCxGL6wnAy9e9e3f1JOOadAVjv956fon3QuFEfAZn3g94LxA2sCQ6OlqTV9esWaM3P4QQLMUVXuNLEaOq8IUL8AVniCbjxoCbnyGaADwm+MWcE7ZfwvhiNsIZeQW/6OF9wa9cfHkbNwpHwDuGL2vL5FZ8kePc4Fc8csJyAjlVtjjz7CGMCE8czi1CKPgMIJI2btxoFkU4f8jnguhbtWqVClaII3hybDHEFzBykZKTkx3uG/vEjdMSiOScBgNAiNmCawReHtvQjGWoE8cE7wY8Z5bXD8JqSNqHxw3CCdcRzr0hmgDOO+xyBt6Da8UQTca1Ag+lK0DE41xjMIDtucSxQXgaN3bb69IQLbbhRncBzyjykiBC4eHFNQkP1dNPP53re10JNeNv0vJvAecQxwevrLvw5vNLChcKJ+IzQMSULl1a4uPjreZXrlzZ6qaPX6LI9wHGkOm+ffs6DZcY4EZoC/aXV+CJsQRejfzUioFwQFgINwOID8svaUfgFz0mS8LCwvQXvythL+Tv5AWEqxAmOX78uApK3PBKlixpXg4hg7AXBOrixYs15wPCAkIVuVGWItXyPON8AWfnDDcs29FbEHHweDkDNhgCBTbgWrLMIbPE0hbj+oG9mBx53gzvhOG5NEAOnu08S7Bt24T1vGDk2RieH0swz1bgW16XuZ1jV4CgBI6SqUNCQjTXD+cdAzXgacK1gQEOL774oibKO8OVvzlHxwyRj2vRXRT2+SXeC4UT8SngKcIvcoStDKGDL2HLmz5u4pbCAWAYP77MfWWoPW5KCFfAmwNx0rt371zfgyRWHC88O5YgNOXuUUnr16/XkAhyPZC3YogQ5DJZ1kbCfOTvIO8J4g0hSwxlh6DITykHI6Ro6x1DSYqcQHglPyLFuH6Qq+ZoNKMh/nDN2YascNO0TCK2BflQSLC3BXlisNXS0+kIY9/Yr61gRs5Nbu+/UpD8DpHjKMQLYBM8evAOIlyNEDfKFyAUm1PI2RUcnVccs3GdG95H7Nvw+iFEmBcK+/wS74XJ4cSnQJ4SQib41WqbJwOQsHnkyBG7EBDyLSCujAk3LNRwsS3i5w1AFCJBGN4M5L+4IprA1KlTVYxYnhd41BA+y8kbkx9Qfweh00cffdQsmnCTMkaSYRnWwbB13DRxI4NHCjk/EDF5SeK1BYLZ8rPE5Mhb6A5ww4QnAwLWcn84ZuSRGSO5EBJdsWKFVUgW+XEItToD1yZymSzFE/LCICqMkYeG58IRyOvBjwYMarAVtTi/Rm6RJ0A+HQZq3HTTTVKiRAm75RDIGMQBgQHhghFpENAQosZnn9Ox5QZyFy1HmMLThOvNuM6N68HwigFHxU699fwS74YeJ+JTIB8Fv2KRJ4MhwhgRg3kQU/jihCcCvxCNX7RYhtF0CHUhxIeRZvjSxSgf/Kp3pTBkQYPRO0hehihBuMcYwg3wRY4h80YCLkSS8RpJ2PBSGYUI8ascidjwhmDElzsx8kuQOI6bJ/aF0IwREkRuB+xCeAbeGhwLwhsQVrjp5qVQYmGCmz7EHvLL8Bx5TAihYrQVRKnhbcFoKwwigPcN1x7EEHLKLHOebEFyOcKXWB85VFjXGFWIUWUAQgPCF+FayzwwgM8VPyQQmsZ7YRsEHn4QILds4MCBbjkHxvUHDxq8NkjWRmI7/nZQasMREBUQzzgvsBHeXoTsEN4y8hENbx6ECURKXjw4EGsYnYnPBoIdx4zzgR8cAIn1GKCBzw2fCYQVzpOt19kbzi/xPSiciM+BIcoQQHD7QyhBEOFLHV+8GMqP1iuWgghfoBj1BI8MfoHCg4D1MJQ5p+TdwgKj+QCGcRs1Z2yT3gFybnDsxmv8wkdOEd6DGwp+TSMpF+UCEBZyJ/hlj5sSPGLwLkAUYR6EGm6W+HWPmxfsgWcGI44gOPC5QGxB9PoKGCqPGy5qiCFXB+EpCAOMsjNu9jiuyZMny1tvvaXnHtcYQpl47Qzk5qH4Jn4IYAAARDHOIUS9ESZCcjVEGmqKIRRriyFIsW/Yhps9krFxbecnP88RlqMOIYRxzBj5B8HnzNOHKt84XxAZKO0BTxwSxnFt4joFEFAI3+HY8QMIHilXgSjH9wDeAzEGjx+q7BuhOoRuUZYEQhTiBwM/0KIJkyXecH6J7+FnYvYaIYQQQohLMMeJEEIIIcRFKJwIIYQQQlyEwokQQgghxEUonAghhBBCXITCiRDiU6AqPEauoYUHRlei4CdGOXm6KbAzUPLCdvQjIaTowlF1hBCfYc+ePdp0FX3B8Ihh/ygxgeHiEE5oveKoYasnQZ0jy6a1hJCiDYUTIcRnQK0eNG5GrSsUBzVAwU3U12nQoIF8+eWXhWojIaRow1AdIcRnQFV4/NZDVWpLUIwQosqyPQ0qeaPQJlqkIKz32muvWXWrR3jN6H0I0YXq1fBirV271mrb6HOI5dgOCoqi6CLa4jgL1eW2PiHEt6FwIoT4DNdee632CUN1eLR42bdvn7kDPcSK0QZjzpw5WsEcvebQMuORRx6R2bNnazsaSyc7WqOgwvewYcO0yjUqY6NFB9rCGO1AUNl7+PDh8vXXX+s2Ue3atgK1QV7XJ4T4Hmy5QgjxGSBw0DgWogStW0BERIQmiKP/HXroQRihHQq8PXg0QFsU9IdDA10IMIBWIPAIDRgwQF+jHUj37t013IfWJ+vWrdOehhBCaGHTrl079W6hN58j8ro+IcT3oMeJEOJToLHsypUrtQceepyhXxo8TAizITl8//79mjCOMByaPxtT27Ztdd3Vq1ebt4U8qX79+plfw+PUuXNnbfpqCCk0hUbID3340OAWDXhvv/12h7bldX1CiO9B4UQI8TnQBBeCB82Dkcs0Y8YMbeSKMNnZs2fNTZAbN25sNSHX6OTJk+btoIGrZZI5wEg9YxtoBg2BBq8RmsFCqHXr1s1hQ9j8rE8I8T0YqiOE+AQJCQly0003qcdpyJAhVssaNWqktZ2QU5SVlaXznnnmGQ2VORJdBoZAsk1Ah3gygEDDlJKSIqtWrZKvvvpKnn76aWndurVERUXZvT+v6xNCfAt6nAghPoHhHfr555/l4sWLdssRoitRooTUrVtXhc/Ro0d1ZJsxQbTAG7Rz507ze9LT0zXsZ/l6xYoVctVVV+lrFNaEGAOhoaE6ag8J5gj9WXquDPK6PiHE96DHiRDiEwQEBGgiN4QJPE9IwEZ4DgneyFvCKDt4o5AsDu/Tyy+/rO/p2rWrJCcna+gMXiuE7CwZPXq0Ch6ILSSdo2TBQw89ZM5ZGjNmjIwfP15zn7Ad5C4h0Rw1o2zJ6/qEEN+DwokQ4jNgNNyvv/6qAufzzz/XcgLBwcEaqsMouB49euh6COWFhITIpEmT5JdfftGco1atWukou2rVqlltE2LsjTfe0G1hnSlTpkhMTIwuQ9mDjIwMmTp1qnq6kDwObxRCb0FBQXb25XV9QojvwcrhhJBiCYpWwhu0a9euwjaFEOJDMMeJEEIIIcRFKJwIIYQQQlyEoTpCCCGEEBehx4kQQgghxEUonAghhBBCXITCiRBCCCHERSicCCGEEEJcpNgXwEQrhHPnzmmrBn9/6khCCCGkuJGdna2tnNDL0rbxty3FXjhBNB08eLCwzSCEEEJIIYP2SJZNvh1R7IUTPE3GySpVqpR4M6gccf78eSlTpoz4+fmJN0NbPQNt9Qy0tfjaCWirZzD5kK3oeQkniqEJcqLYCycjPAfRhH5W3n4Rog8W7PT2i5C2egba6hloa/G1E9BWz2DyIVsNXEnZYVIPIYQQQoiLUDgRQgghhLgIhRMhhBBCiItQOBFCCCGEuAiFEyGEEEKIi1A4EUIIIYS4CIUTIYQQQoiLUDgRQggpspw5c0YuXLhQ2GaQIkSxL4BJCCFFkcOHD0tiYqJH91G+fHmpXr26S+vWr19f7rvvPnnqqafM844ePSrdunWTXbt2eczG3r17y/Tp07UI48svvyxVqlSRBx980C3bTkhIkDfeeEP++ecfLfRYs2ZNefjhh6V79+5SEPz+++8yY8YM+fHHH922TVwzzzzzjHz99dcyevRoiY6OlkcffTRP27j99ttl4MCBOuWF6667Tt58801p3759rn3lsN7s2bO1YOVdd90l999/vy7DuQgICJBhw4aJp6BwIoSQIiiaGjRoKGlpnvW0lCpVWuLiYl0WT99++6307NlTmjZtKgXF2bNnzc/HjRvn1m0/8cQT0qJFC1m+fLm26sAj5v3888/SqFEj8UUgSCBEvLnS948//ihbtmyRhQsXar9Z2FunTh0VXrfeeqvcdNNN0qtXLylXrpxH9k/h5GNs3LhRjh8/7vbt1qtXT9q2bev27RJCCh54DSCaOveZLGXLNfTIPs6diZUV827TfbkqnG688Ub1YsBTEhwcbLd8x44d8uqrr8revXvVezNmzBhp0qSJLps3b568++672lNswIABetP84YcfpGrVqup1gSiDBwueJXgf7rjjDhk+fLi+t1+/frr8l19+UQ8KhBsEArZhAA/Fk08+qd6i7777Tm/OCPF17dpVXnjhBQkJCXFo73PPPWfuc4p14XFKTk7W1+h99tprr0lcXJykpqZKhw4d5J133tHebfDKXH311TJz5kw5efKk3uzbtGkj48eP13UfeeQRPYa1a9fqvLp168qiRYv0XMMjhPfa4szuPXv26PP9+/dLVFSUPPDAA/pZ2HLkyBHZtGmTnufcOJjDsQEIG3itcL+6+eab1dMYGBio67711luydOlSvQbwGd17771W2z527Jj07dvXbp+tW7eWSZMmyR9//CH33HOPhIeH63TbbbfJrFmzVDgFBQXpsUO84hx6AgonH/sV2aNHT8nKynT7tnFB79u3z+UvQEKI9wPRVD6qlXgLuGE/9thjMnHiRPXMWJKSkqI3UAirPn36qEjA+hA3EBYvvviifPHFF9K8eXMNj8XHx5u/F19//XWZMmWKiotly5ZpaGnQoEHy008/aYgQN1oILAgncM0116gnKjY2Vho2bKhC7dSpU9KpUyeZM2eObgtCKzIyUp5//nl5++23ZezYsXbHc/3115v3BeEA24yQEXjppZdU4Hz55ZeSlJSkYgm2wCsC5s+fr/uC1wRCAcIPyzds2KACzFgPAu3aa69VETV16lR59tlnZcmSJVa25GQ3BA3EI4TYv//+Kw899JDabtvY3hAfrnibXsrl2BC+hHC6dOmSfua4t0CcQjQh7wyfKz4DhG8RPsVnboDXEHDOgACsVauW+TVENsSz5eeCfVI4Ef1lB9HU8ppXpUxYTbdt93zyAdm0+qU8/XIkhJD8/ECDp2fo0KEasgsLCzMvQ5grJibG7AnBjRQepRUrVuiNErlQhlccHpdp06bp80qVKmmuC262ED/Ib0G+EcSI4f2wBV4JhHIgXCCc8AgvBTwg8ADBm2F8Fz7++OPq4XrllVfsBAVEwK+//qresK+++kr33b9/f/XuIHQHTxHywNLT0zUfCt4Ry7wzbBfhJEwVKlSQwYMHq4eoY8eOegzGungfhBTOHwQKvC6IPliSk92hoaHq4alRo4YKvHXr1jlsZgvB5sgT5YjxuRzbiBEjVKzic7jzzjtV2OFzhzjD54XPBhOWwQNpKZxyA15HS9FXsmRJtcMAYhk2YYKHzd1QOPkgVWv2ceuvyMSEjSqcCCHE0yD3BzkpCHFNmDDBPB8hne3bt2u4yiAzM1Pnw+MEgWSAcBxu1ABiAuEpCAcIkGbNmul8k8mUox033HCDemUQnluwYIE+GnZA3MFbY5mMfPr0aRUKlmDf8KJgwo17zZo1Gr76+OOPNTSFEBk8UPCsQKDBq2ZpV9myZc3PIbogcIAharBfULlyZd2XAUSWbeJ/TnYjKf79999XQXf+/Hn1CsE+7NMSCA3bY3TGnlyODTYbVKxYUUUtPE0XL15UgWhpIwSWbajOkYBDqA5eR1uhhOe4JiyFMa4PCidi5sSRvxwKp0N7Z8n6Fc9IdI2e0r7rR3a/jlJTjsryuUP1eZe+UyUkNLrAbCaEFDzpF07azcPNbe2yxyT+4EJp0/ltianTP1/fJasX3pNvu+A9+fPPP+Xzzz+3EgNXXXWVem4sc24ghpC7c+DAgf+OKz3dnPQ9d+5cWbVqlXqNcLNEfhE8GLmBmzCEGd6Pm36rVpe/UyEcEOIxPCAINSEsiPCXJfD4jBw5Uj1l8FThZo5wGtbFPLwPXh+IKHiQjOO2xNUEbIgkfG5YH48QkhAECO0Z5GT3+vXr1UuHsN3WrVs1VAfvHcJylkCwGWItJy65cGwQSpZCCEIKnw9EDcJ0xvlEmA/bswTeQ9jsDITpkGOF0CzAtYFwnSVZWVkOvWrugHWcfJDYjf/9SrMEX3TJSbsldtPHmrhpy+5tkyQhfpVOeE4IKdoc2vNf3ocBvhvwHYHvig0rns33d8mZU5vzbReEBvKUELIx6NKli3qckKMEcWCEjZB7ifwc5PTgZoqb7IcffqiiB0Ao4WaMCYnHRmKzsRzz4WWxBSIEIgMeGpQsMG6y8EQhFAYPDsJlH3zwgcPh+Ehah4cIyeyGsEGuFEof4FhgJ7wr8IRgGUJlK1euNNuVFyBCELaEPfCuwfuE0XyW5GT3e++9p4IUYgIC1dbbZQAxZuvJwrk7ceKEeTp58qRLx4ZcK9gCrw+eI2wIDxfONT4jJLAjjDdq1CgrAe0KyAdDbhW8achxmzx5sh6/AezDti29lO6EHicfpHyVDg7n49chvuzKhMVISKh9rlJUdCfx87vsmo2KvvwrgRBSdClRKlJD8ZZkZlyQUiGVJC31hERUbGG3HJSr2FK/S7BeetoZu3VKlcYNCd6SnMNhOYGQ2t133232MEVERMhnn32m4SaEkfAaCchG6A0j7P73v//pDXvIkCFmsYRaQfA4IbEbN3LcmDE0HYILOT1YjtDURx99ZGcDbrbYP4SZAcJI8IJgtBduvhBI8KzYeocg/r7//nsVARB4EAIISSGPxxjNh9AYvEAQFMi7gS2wK69A7OzcuVM9cvC2QAjh2C3JyW4kz+NcwsuEc4T8I3jcbEH9JHikMMLPAN4+TJaerdWrV+d6bPg8EMKEiMGoN+McI2wI0YwEbrwXuWXwhuUF5HlBwOG8Q7gh9IscOAOcK3igXA075hU/U26B4CIOLnZjZIVljNQbwS8wxP9vGL5eyleyv+jxUeLXIURTULDjpEi42EFI6H8xZXwpzpncWrdvuKuvFLXl3Dn9VePN9UAAbfUMtLXwbMWv8PoNGkq6h+s4lSxVWnY5qePkznOKkBPCc7Vr19bXeN6yZUsNl9mODCtqnz9G0mGkIbw6nrYV1w2StRFGdUeYy1RI5xX5XAid2oYP3aUF6HHyRZxcgLgwwyNzLrpmKZgIIUUTCBkIGm+qHH4lIOQDbxPKCWCfSBCGcHKHaCL/gc8S5xUjGZGv5YtcunRJFi9erGUbPAWFEyGEFNGbYFEpLwJPO0JgCEfBM4D8HsvRY8R9IGyGCXla3uZ9cwUUvkRo0FEOl7ugcCKEEOL1oL+cu3rM+RLIOzLCdAUBEsSRu+Wr3HnnnR7fB0fVEUIIIYS4CIWTD3Pm5BbZtHqMPjoi41KKbF37puyPcx7rxbK927/xoJWEEEJI0YGhOh/FZMqWBdOuk4vpZyR28ycy9OFT4udnrYPXr3hW4rZ8ps8xrLhyNetkv+OHl5kLYhJCCCEkd+hxKs74YOIfIYQQUpjQ4+SjwLvUa8hSObR3hsTUGWjnbQJtOo+XkNBqUqZsTTtvE8C8Ln2nyMn4VRK7eWIBWU4IIYT4LhROPky5is11ckZQcKg0az86x23UanCrhEXUo3AipIiBYoZFpY5TXgplRkezByfxLBROhBBSxNDK4Q0bSPqFNI/up2TpUrIrNs4l8YS2HChYadQGQssQtOVAK5WwsLB87R89ztBAdty4cdrDbceOHfLWW2/pPPQz27Rpk7iLadOmyTfffKP92lBZGg1y0RrGk/WCLMH+0I6mXbt2bq2wjZpY9erV05Ylu3btuqKq5q6CJswzZszQz8xV0O8O9uHzNfr3od7U119/7bFmvs6gcCKEkCIGPE0QTdVe7SUlapbzyD4uHjgjR15aoPty1ev0xx9/SNWqVc3NY9ES45VXXtEbeH6wrOt09uxZ8/MqVaq4VTT9888/MmHCBO1r16BBAzlz5ow8//zz2q/tk08+EV8EDYnRZuvJJ5+Uo0cvt+LyRrKyslQcoWlx//79rfr3oY8hBO0tt9xSoDYxOZwQQoooEE2lG0R5ZLpSQVamTBnp2bOn7N69W18nJCTIqFGjtOAjvB/w7hitVBcsWCA9evRQbwsa9sKzBNDE9rnnntMWIWjDMmfOHBVTEALwcAE0rMV8g4ULF8qAAQP0+ZEjR+See+7R7aIh7cqVKx3aun37dhVMmEC5cuXk2WeflUqV0Oz4MhBVaDCMliXwDs2bN8/slcGNHZ419ALFMa9fv15Gjhyp62IZvCdG81qISLwf1dLhYYJwcBSShN1o2otGxZZ2f/jhh3LNNdfohCa8loLSkkmTJpnPQ244OzaARr0Qv4YtOFcGaAaMKt5YhsKU8ITagqa/2K7thHMEcJ4h8NDY2ZZBgwbpcWRnZ0tBQuHkizjpy4wvmbOnd0rGpfNO34omv0ajX0JI8SQr9ZKk7z9tFia2YD6WZ1245HQbmaevrIEwbv4QNEboCTf58PBwWb58ud4M0Tpj5syZKhzg3YHHByKkc+fO8u6771ptC/MeeOABvXEjfGcJ5s2fP9/8Gjf9fv366Q0f74FQww0enheE3hDmswXbX7dundqIEBMEV82aNeXFF1/U5bDrp59+ku+++04bD0PUvPHGG+b3b968WZvHQgxAFEBEQKjBkxUcHCxTpkyx8sohLAU7V61apefB6rxnZqqtsPvvv/9Wrxf6+MHurVu36vvxXoTPMjIy7N5v9HODGIVAzY3cji0hIUE9fLAFohbnCNvHOXrsscd0wjK0cIFYtBU5CLPCO2g7QTgChOMgiuFhsiUmJkab+UJYFSQUTj7ItvXvOJy/dtljMuO7xjLz+yYOxdOxQ0tk2lc1dMJzQkjR5sL2Ew5F0+5bf5TdN/8gx979y+H7MB/Ld9/yo0PxlLLusBx8Ymae7bnxxhv1hti6dWsVDrVr11YRcOjQIdm5c6fmy+BGCFFy7733yqxZsyQgIEBCQkK0we+2bdtU7EBYuEqfPn30xo3QYFpamnqnIJywLcy7//77Nd8KdnXs2FGFhy3wXv32228q7ODR6d69u+ZQrVmzRpcjZAT7KlasqEKiRIkSZi8SgP3wLCEXB8dep04d9QjhWLFfNDE2uOOOO1QQYFsQWBA4lsDu1NRUs90dOnTQXDHYjf2cPn1apk+fLidPnpTPPvtMw6G2YBvwmmHKjdyOLTIyUj8r2DJ8+HDNYYOAg3hDo2B4m7DsrrvuUu8X9p0XsN+caNy4cYELJ+Y4+SCJxy7/sdoSf3ChPp5PPiSpKYclPLKR1fKE+JViMl12+ybEr5IqMbn/2iCE+C7pu/+7wRlkJKRIxvFkfX5+zSGH70v55/J8rJdxIkUCakVaLU/dFC+Sj+jI7NmzzTlOluzZs0ciIiI0edwAXgwkYgN4oBCWg5CAOICHxdUwE268SIBesmSJ3sBxo0WIDd4T5GcZng142eANgR2OqFu3rrz22mv6HCEneGEeeugh9ezAbggqPK9cubIKQkuQQG4kxUMIhoaGmpdBTFl6/izPD+y0HRmJc4IcKwgSA3jlIOqw33feeUeF5XvvvacC7fXXX5cmTZpYbQMCyJEHxxGwO6djq1SpklVyNs43RBvE4KJFi+Svv/4yHzs8YLYePYT5HIlVeA6NzyYncBw4noKEwskHadhqlMP5bTq/LRtWPCtVavSQsuUa2i2v1/ReOX54ifk5IaRoE3ZtHbt5yE2KvKWFiqZKj3Zy+L7KozrJiY9XSpkOMQ5zmcoNaCLJy/dK+m73lDvAzTcpKUkuXLigI9YA8pTgzcA8eCqQhI0QEG7GCN8g18ZV4GFavHixihZ4iowbbo0aNdQzAuFy7tw53Rdyr2yBdwdC5b777tPXSIaHdwweMYSk4NGCoIFIgIiKjY21EgOGcHAFS28OxAea7tqWgKhWrZp6ooztYj0ISggWCE6IuuTkZD1nyCHCKDZLIHRczQtCiC6nYzt58qT5Oc4jbIENsBP5ZY8//rhZOB44cECXzZ0710o4YcovEI0FPaqOoTofpJKDYpYgpk5/GXR3nHS4boLDP9SQ0KrS59aVOoWEstYJIUWdwHL/eXAM8N0Q/XRXqT/9Til7rbX3wADzsRzrOfouCY4Klaov93CbnfBkIPdn/Pjxkp6erjdYJIcjzIYbIxK+kQCNfCB4hBDiQsjIyqbgYA29OQIJ2QjnILTWq1cvnde8eXP1gCAMhX1gn0hARr6To/d///33mnMEwYH9QJzADoTxIFJgD4QZvEEfffSRvg/bzysYog8PCiaIFuRoWQK7kedk2L1v3z4ZPHiw2g3PHUKZEHMQgBChjsolOPJkAQgkywlCMrdjO3XqlNoJUYvPDPtt2rSpJpND3CE0B0EFwYtRcRDI7gTHYSsui7THCRcG3Ii4mPHB4I8E8W48h0vUtsbDSy+9pBn6AIoX7kN8aIhLv/rqq+Z4LT4kuCkRk8ZFjosKSX8FrUoJIaQwQckAX9k2vrORKIwkYogg5EBhgnBDMjgSknEzx00f3/22wgnv++GHHzTPBgLMEoTGEPbBzd0IxWEfCAfhXoPtY3sjRozQG74t8JzgXoIwGEQJQFI7QmJ4H0KIRsI2hAoEGEKBEDV5BWE1jK6DBwz3O9y/LIHdOFcQMHiEF8jS7qFDh+qEPChsC/dYWxo1aqTbh+iAZ8jyHFoCT1Bux1a/fn3NaYI9GHUILxdEFkJ6GBWIukvwQqEwKcKtliMR3QH2beiCgsLP5GxYhYfBbpGBj8JncLviQ8TICWT5Y/ghEsmuuuoqGThwoPk9ULK4SHCicGGNHTtWPyhcGFDWyLwHUL34A8IfA5T5008/rR8+RgPYAkUN1yNGPBguYm8Fv5jwx3/DbRukfFQrt203MWGjzJncWreP4bLuwHB9W8b2vRXa6hloa+HZ6g0FMIvaOS0IcF/DPQ/D7D1tK8o44Pv+5ptvFl89rwcOHFBvpGXYMr/kRQsUmsdp//79OkQT7kVD8aKGB34pQDhBzULoOEpgmzx5sqprIznw7bfflq5du+ovAcR+IZqwLSOxDN4mqGFHwokQQooaEDIQNMWt5QpxHeRrwVnhSeHkaX799Vcd0VfQYrfQhBMEEUZKWLoJAWLHmBDGQ+KeI7Zs2WJO0jPi40g4w3y4MeEWtBxxgOGfqBmCJLbchjYSQkhRAIKGooY4A6E0OBf+/PNPLa/ga5w8eVJLWCCiVNAUmnBCiA61JwwQP4YnCTUp4G2CgkT8GTU3MMwSoTsjbOdIAGH0BeLfxogEy+WGOMNyZ8IJLsVCilq6jK19OzZ8IHFbPpMGzR+Sxq2fsFs/MWGDrFpwl4SG15YufX6SwCBr92NmxgVZPm+4JCVud/s5MLbl7ecU0FbPQFuLt62+Yqc32YpoiWFPQdiKaExu+/PW81qhQgVNSjf2c6XkZRteU44ASXdQj0joRjl9CKdatWpp0te///6rieHIcbr++ut11AU8S5bgNRL/sMx4bbkMYLkz4OXKzwiIgsRyxEh2dpb8u/wpMZmy9bFhy1Hi7x9gtf62deMlKXGbTkcPzJMa9ayTDI/snyuH98602j7i0e4AFyFixsAX8htoq/uhrcXbVl+xE9BWz2DyIVsvXrzoW8IJoglDPdHED12aUWgMOUvwNAEkgB88eFDL0kM4YRSDrQjCaySOW4okY9SFsa5lcTVbjKGb3oxlfRGIpKjoTnLi6HJ9tBVNoHL16+Tg7mkSGFRGylVsabc8MqqVLsvMOG/evrs6fRvqvbCTLV2BtnoG2lq8bfUVOwFt9QwmH7LVEHg+IZxQRgCCCOIJtTIATrAhmgzgfTLK26Nmg23SI17DdWfUc0DIzqjAaoTvcqqUin16+wdra1+PwYskOWmPhEXUdbh+g+YPSpXq3SW4ZISULGVd+ReEhdeWIfcdlISjq2Tp7AFuPwfG9rz9vALa6hloa/G21VfsBLS1eNvqlwf7CrWwEeo9TJ06VbtBG9VcAUbAoXyAJXFxcSqejAJglr1pkAyOCfMhnJAobrkczzGvqCWGBwQES0T5xvrojLCIOg5FkwGWhYRV85CFhBBCSNGi0DxOSAD/9NNPtZQ9Rr1ZlplHmO7LL7+Ur7/+WkNzqNaKLtlG4hyKe6HeBfoPoUIp6jihmSBKERjLUcPJKLSFImF33313IR0pIYQQQooKhSac0HAR5eLRvRmTJbt27VKv04QJE/QRFUchflCSH+ARFWaxHMnM6DKNkJ8B6jWhQ/QjjzyiFUxRedXWg0UIIUUZ5HaiALAnCQwMtBuoQ0TL3+C+RYomhSac4GnC5AzUlciptgQqqzqrrgqxhAaMmAghpDiKppvvGibHT//XgDXzUoacO3NWxU5YubLi5+/vcF5OXEhJlbSUVCkVGiKlQ0OkcmRF+fXbn10ST2jNgQE6lrkk+K5ev379FVfTzgu2dgQFBWlpHKMZbX5A6Zxjx47pD3q0CsPIcLQawTykoWzatEkKAqS9IBKDBsg5nW+0PoHNlp8bcoIfeughbX2GCBA6eiDqw1ZlXpgcTvJO+oUEh/NTU47K7m2TdJRdlZhudsuzszNl15bLbWnqN39A/P358RNSFIGnCaKp6biBEljqv5vj2YMJ8u/EP+RS5VJSt29b2ThpgYS2rCptHu4rgSWDXNr2vgUbZfcf66RCpyayb9523ZerXif0GDUG7RQmlnagDMvDDz+sXSsgKPID2n4YnD171vwcubUFJZr27t2r+bzoK+fK+UbzYIg7g6VLl8qjjz6qo9oxNWvWTKZNmya33HJLgdjvS1BK+iAbVj7vcP7yuUNl8z9jZdH0niqibIFoWrP0EZ0MAUUIKbpANAWVKmGeKjSsLlf9b5CcO3RS1n86V0IqhstV/xsopSLKWK2X09Rg4FXScNDVsm/RRvU+uQOkVqBNFnJVccOGlwndI2z56aefdB00nEXeqtFwFzX44G1Bk1o0fUcbLlfr8qEMS48ePcxNa7Ff2IJ9oHcqep8aw+rREw3rosEveq3CswQguND7DQWb0TN1zpw5KqaOHj2qnh+jUTDmGyxcuNDcNgzHgRQTdLyAoFm5cqV5PTQ0RjoKJqSfWAozS9CJw9hefoCXCs2QjfMADx+2ieLUxBoKJ0IIIYUKytGgBM3ixYvl77//1nnoJGFbcga1/lC+BuvAk2I0dkdIad26dTJ9+nSZPXu2tt/69ttvXc5HgqAxGpxDnMCW5cuXq3D4+eefdXAScnLR2w25tWvXrpXOnTvrICRLMO+BBx5Q8YNQmCWYN3/+fPPrefPmSb9+/dRjh/dAqOG4XnjhBfnf//6nYT40tIfXCOvCIwQxiON3FJqFqIPQyw94/++//y5paWkqXEFMTIyULFnSaoQ6uQxjNT5I605vOpzfpe/U/w/VdZSQUHv3LMJzjp4TQooHSQdOyNoPZ0lE7cpS/8b2sv7zebL2o9nS/rEbJbCka+G2PXP/lV2z1ki9fu3kxMzNedr/jTfeaJUzg/AYbvYQCihADO8GSstAuNjW6sNNHMIBjV2Rh/PKK6+YtzVjxgx5+eWXze21kKuD0dbO8mgNO+BJgscJXiqE6w4dOqQdLDCCG/urWbOmNpGdNWuW5lmFhITIL7/8os8hdvAeV4HN8B4hNIhcI3inkIe7bds2nWfYirZjyLmCYMK5gTcOghAjzDGQCjlLth0esI1y5crp5Mr5Btg++tQZ4FghTBFeNGjcuLEKJ8ver4TCyScpWdpxPaqQ0GhpefUYp+9DTlPDliM9aBkhxNtFU2iVSLNQav94f53nqngyRFP9/h2kxnXNJHnJnjzZAG+Qo5wbiCWMjEZoC90j0P4CIsUSCBx4gODJgYcJNfvQigteHvQhRX6OIRIgiHIqaGhrB9aHGNm/f79ERERYdZmAkMD2AfaPsBxGacM+CD5Xw2OoI4jEbYwoR0I6RAlK5mzcuFFFIhruGsC7BfGIRrzwxsF7hpHlderUkddee81cescA4UVHBZ6dnW8Ab5dljpMjsE1HIdPiDoUTIYQUQ9EEImpWclk8WYomJJZnpLne2ys30OEeOT4333yzvoa3KCUlxWod5PZg9B9EE0JKyHfC+xA2g6cJ3hIjzAQPTlJSUp7tgJDB+9B+w2jBBTGHJvKYBxtQuBmhrUWLFunIM+QGuQrECsKR8DgZRZ8hTmrUqKHhOEshCWGGhvYQbjjW5ORk3Tc8a7ZhSAhGT+QiQcBxVJ09PCOEEFIMRZOBIZ5Sjp1W8ZSZfilX0eRuIAoMLw88MPCU2CZ3nzlzRsUVErKxblhYmLl8APKH4AmC6IGogriwrO3nKpUrV9Y6gQhpoWH8gQMHNDkcYTaICCR8I3EbowjhmUI4z+iJaoBllg3ZLUFbMYS+0D6sV69eOg8dL3CsCAFiH0jORu3B1atXy549ezQkiORxo5+qbTsyQ/DZhjbdAbZptDEj/0HhRAghRZTEXUfln/d+19Fzre7vpSEpeIpspzKVIqT1g73l3JGT8s97MyQt6bx5WdyMfyT297+lTu82Gp4z5mem2Qus/IJ8JYyKQxcJeJswAg1hM0vQcgs5QQjJQdygXZeRnI1cI4Sx+vfvr/lBED1vvuk4FzQ3EBKDYMAIvTvuuENtGTZsmI44w/7eeOMN3T9CZshZshVOeB9KEAwfPtxu29gGQnII2UF4GUIL4UckdyO/6a677pIRI0ZI7969dSQdOmFgwrmB6MK5sqVRo0YaanS3eEJyOmwi1viZjHGWxRS4X2NjY6Vhw4Zm16y3gj8a/NHdcNsGKR/VSrKyLpmb/DrrV5ectFeCS4RLydKXkyZtSb+QKAnxq7XJL7ZvjCy5UoycAV/oik1bPQNtLTxbEUq66fZbJHZXnMvFLYFtQcy01DSrgpe25FQAs6idU2+3FeUQ8P1thDuvFHjb4GGDoMvvOTH50HnNixZgjpMPs+i3HnLi6HKpVLWL9L7lL7vlcVs+l3/+fEgCg8pI/zs2S1h4bavlyWf3yawfWkhmhmO3MiHEN4GQmf7jL2y5Uoy47777tFyCu4QTRi9iRKG3C57CgMLJR8nOzpKE+MtF0vCI1/7+AVbrHD+8VB8hjM6c3GQnnE4nbKRoIqSIAkFDUVN8wAg8RCRQYiCndmWugKR0lGVA8j2xh8LJR4FIatvlXfUqNWj+oJ1oAk3bPSfnzsRJaHhtqVqzj93yarX6SvU6AyQpcbuknN1bQJYTQgjxBO4SOiid8P3337tlW0URCicfpnHrJ3RyBvKgBozY6nR5YFBp6dZ/hiQmbJQ5k1t7yEpCCCGk6MBRdYQQQgghLkLhRAghhBDiIhROhBBCCCEuQuFECCGE5LP2Dyqak+IFk8N9kBNH/tLEb1sO7Z0l61c8I9E1ekr7rh/Z1d9ITTkqy+cO1edd+k7VpsCEkKIJimB6Sx0n1ANCgV2Aqt54HyYwduxYufHGG91u2++//y4vvPCCtkUxQE87VOW+7bbb8r1d9JiDzRj6j+08++yz0r59e63+fezYMRk3bpx4GpzDRx55RFvDoP+dUWwS7WYsizeigvntt98umzdvNp9v0LRpU6351KBBA1m6dKl+Niw94DoUTj5I7MYJ0qTNk3bzIZqSk3brhBIF4ZGNrJbv3jZJEuJXmZ+3vHpMgdlMCClY0XTzXcPk+OmTHt1PTpXDLZk0aZL5OW7kAwcOlEGDBomngbj58ccfrVqIYP8xMTHamiU/zJ071/wcTX8NUGW7oECTXwi46OhoFUdGM+Ju3bqZX1sCoWecb4hptIpBDzyIJjQpxvbQF69u3boFdgy+DIWTD1K+iuPeQfA0QTSVCYuRkNDqdsujojuJn9/lek9R0R09bichpHDAzRGiqem4gRJYyjNFMNGrbtvLM3RfV1JoEzf8W2+9VduFoPntZ599pr3hlixZIlWrVtV1cHNH7zl4dtDwFv3aIILQ3PaZZ55xWQQ1a9ZMe9rt3r1b37N8+XLtTRcfH6+98F566SVdB812sY9FixZpLzr0jIP4wHEatvz222/qYULF7rfeekub82I7aER8yy23yD///GPuYwdRddVVV6m3a86cOTJx4kQN8bVr1063GxkZqUUncSxoYow+djgnd999t90xoIHwrFmztNBlfoDnCT39vvrqK22HUq5cOfX4oZlxfvv7FTeY4+SDNG3j2KWK8NzAO3fIgBHbJSi4jN3yKjHdZMh9B3XCc0JI0QaiKahUCY9M7hRkp06dUuEEIdO8eXOn60GkwVMCAfX3339rKO5///ufCpjcwHuxfXhW2rZtK3FxcfL4449riAqCDeLh/vvvVy8SBNPevXvlr7/+Ug/Trl27ZN68eVbbe+edd6RKlSoqQPr0+a/AMLw2EHwrV17u7JCcnKwiCusgJIYmwWhojOV4P0J9AIIRobN169bpc0wQlbYsXrxYmjRpIiEh9r0DXSElJUUmT56sdkI0AXiq5s+fr55KkjsUTr6Ik95ByGlCeM6RaDIICa2qEyGEeBMQFqVKlbLKxbFl27Zt6nGBwAkKCpIOHTqo5+iPP/7IsTE6Jqz77rvvyssvv6xeJQgFeI/wfuzzhhtukOrVq6u4Cg0N1Sa3s2fP1gRweJcGDBjg8rEg7wjbB/AMQRRWqFBBPUXoJdeoUSP1Rj3xxBMqABMTE3WfEE1YH560tWvXmj1ulmzcuFEFVl4wcrIwXX/99So0P/roI/NyCChM27dvz9N2iysM1RFCCCl0ICxy4/jx4yoyIAAMEFYLDw93uH7r1q2tcpwsSUpKUo+PJcgZSkhI0FAWPFlTp05V0dGyZUsNx1WrVs1l4fTFF1/IxYsXVUAZCdywH+Lpp59+Mq8L0QYhg2RvHAsSvk+cOKFCDiIPYtIS2IewYl4YM2ZMrjllOP/YNskdepwIIYQUOpajgPEcIsIYLYZcHOPmXqNGDVm/fr15Qgjtsccey/P+oqKi7EJ8CI3B84I8KniJpk+fLitWrNDebW+//bbL24Ygg1cIoglerx49ephH9UEgWdo/Y8YM9UAhHIicJnicZs6cqTlc8HQ5Ok84J+4G59vfn5LAFXiWCCGEeBUY9QbRAYHw888/S2pqqs5H/lNGRob88ssveqNHQvbgwYNl9erVed5H7969dVQZco2Q/4SkbWyvS5cumpP05JNPyunTp6Vs2bIaVsOjLQgXInToCHiZPvjgA7n66qs1DAeQRzVlyhTdT3Z2tjbSHT58uB7Td999p6FE5BlBYEHEONonwniwy93Ak4dtk9yhcPJhzpzcIptWj9FHR2RcSpGta9+U/XFTnW4Dy/Zu/8aDVhJCCguMfMtIu+iRCdv2FKgxBK8LkrjhiYH3B2BUG+olLViwQHOW7rrrLh2pBhGUVxDuQpI2PEkY3QbvEhK94dW66aabNByIIf9IREfCOISULUZID0LOll69eqnAMcJ0ACPrRo4cKQ8//LBuH7lZCOkhHPfcc8+peIHQ6tmzpz5avtcAtu7cuVPcCZLzIQDh+SK542fyhM/Ph0DiX2xsrDRs2NCqcJg3YiQ63nDbBoms2EKmfFpBLqafkRIly8nQh0+Jn5+1Dv7nz4clbstn+rzXzcukcrVrrZYfP7xMFky7zmr7xhfUlWK41/GLybYQp7dBWz0DbS08W72hjlNRO6feAkbFIfSHkX+GJ+tKgfBDaPD111+X4npeL+RBCzA5vDjj5RcyISR/QMhA0HhL5XDiPsqUKaOJ40gyv5IK6JbA24bkd+IaFE4+CrxLvYYslUN7Z0hMnYF23ibQpvN4CQmtJmXK1rTzNgHM69J3ipyMXyWxmycWkOWEkIIAgoaipmiCECVChMjvsmwpkx+QjI5IRl5H6hVnKJx8mHIVm+vkjKDgUGnWfnSO26jV4FYJi6hH4UQIIT4CcqJQ0sAd4a/u3bvrRFyHyeGEEEIIIS5C4UQIIYQQ4iIUToQQQgghLkLh5Is4qSCBoZ9nT++UjEuOC7KB1JSjOhFCCCEk71A4+SDb1r/jcP7aZY/JjO8ay8zvmzgUT8cOLZFpX9XQCc8JIYQQkjc4qs4HSTy2xuH8+IML9fF88iFJTTks4ZHWVWAT4leKyXS5/1NC/CqpEtOtAKwlhBQGKILJOk7ew5kzZ7R0gLcXWia5Q+HkgzRsNcrh/Dad35YNK56VKjV6SNlyDe2W12t6rxw/vMT8nBBSdEXTsOH3yomEJKv5puxsOXfutGRmZkhQcAm5dDFdQkLCpHSI6xWoMzMuydmziRIQECjVqlaW2bN/dUk81a9fX4fRWw6hDwgI0Ea3OXH77bfLwIEDZdCgQS7bmJsd9913nzz11FNWzX0xJD8uLk48BdrCoNAkhNPLL7+sjYAffPBB8TRo4/LMM8/I119/LZ988om2rLH9vNACBufE2bnp1q2btr5JT0+Xe+65RyZNmqSfZXGFwskHqeSgmCWIqdNfJ2eEhFaVPreu9KBlhBBvAJ4miKbeg76V4ODLHo5LGWmy+I/XJODCYekz6GWpEFVXNm/4TTatmyoNWwyRFq0H57rdUwl7ZOGccVKpaiO5tseTsnjWg7ovV71O6M1WtWpVKWy+/fZb7QfXtGnTAtsn+t0ZjBs3rsD2++abb2rBTEOwoup4TlXCczo38Jj1799fPvvsM4e9+4oLhZrjlJCQIKNGjdKmhZ06ddIP+OLFi7rsyJEjcuedd0qLFi2kT58+smrVKqv3/v3339oAEd2y77jjDl3fEnSaxjZbtmypDSPT0tIK9NgIIaSwgWgKLlFa2ystnT9ezp09Jv1uelOiqzfX+e2uvkPaXj1CtqyfJtu3zNF5zqazSUdl8bw3pHzF2tJ30BsSEhIpfv7uuYWgGS7uBddee600a9ZMvUy4P9iCoo9YB4137777bvP3fkZGhjbs7dKli3Ts2FEb92KeM2688UYZPXq0euYcsWPHDrn11lu1ovaQIUNk+/bt5mXz5s2T6667Thv2jh8/Xp/DKwNmzJih20bPT9jxww8/6Pzhw4frI+5ZmzZt0oa+H3/8sfz1118qUiyBsEE1b+M+Bm8P9oX7WGpqqs7fv3+/3HLLLeZGxLNnz3Z4HDg/2B9scZXczk3fvn3lt99+06bAxZVCE04YAYY/FAga/DF88MEHsmzZMvnwww91GTpIly9fXl2bULiPPPKIHDt2TN+LRyyH6xYfYLly5dTVaPQrXrhwobokoeq///572bJli7zzjuOEakIIKcpcupQmC2aNkTOnD0mfAa9KxUr1rJa3aneLtO5wm2xYM1k2rvvF4TZOntgt82a+JOUiY6RX/7ESHOzeMA2+n8PDw2Xx4sX6oxhMnjzZLuSE+8SUKVN0HXiuvvjiC12GMNS6dev0fgERge98eE6c8cADD2iYcOLEiQ6b6N57770ybNgwWbNmjXprsD6EAgTLiy++qIJp+fLlev+Kj4/X9x0+fFib5L733nuyceNGefXVV1XA4X24xxkeN/yYN7jmmmvUE4XmsmDv3r0qGDt37ixz5szRY8VxQEhBNGF7AKILAgZhzldeeUXvdY6cA+hnB2GXlwrjOZ0bEBISouLWEHfFkUITTrgAN2/erF6munXrqnKGkMKFhYsVShkXQ+3atfWDhOcJfxRg2rRp0qRJE/3FgfdiG7h48YcDoPJHjBghXbt21Q947Nix+l56nQghxQmE53ISTa6IJ3eKJngz8F1vTEuWXM65RN+1Z599VrKzs+X48eMqoiCUbMNE8CL9+uuvev+AYHjttdfMnp5HH31Uf2zjh/RDDz2k83JKasd9Ax6dnTt3Wi2DIIqJiVFbsR4iHtWqVZMVK1aotwkeoLZt22p4ErlDWAdUqlRJRRvuSadOnVLxAXvPnTvn1I6goCDp1auXzJ8/X1/jsUePHrrtmTNnaj5R9erVVaw8/vjjOg8OAjT6haMBNiHqgnufo5yjDRs2SOPGja3m4R5r+RnAs+bquTFo3Lixbru4Umg5ThUqVNAEM1zolkCd49dCo0aNrEYftG7dWoUWwHJ84Aa4YPBBYjnmb9u2TT1UBhBduICR+Gep9gkhpKiCRHDkNCE8l5NoshRPAOLJeO1uTxOEhaMcJ4gleGgQ8qpXr56mbEAsWAKxgHsGkpvhYYqKipKXXnpJvTMnTpxQ4eT//6FDiIvcvCy4x8CbhLDZRx99ZGULQnOW9xjkcWH+yZMnVSAZ4B4FkWcIjh9//FHFDcQbfrQbtuQEQnMIwyFnCMIJieOGHRAwhpcJQFgirPn000/rOXjhhRf0ngnxg4RuiDVL4L2yvcciXJhTjpPtuZkwYYLD+/e2bdukuFJowiksLExzkCwvCLhmO3TooGq9YsWKVutHRkbqHwfIaXlycrL+0VkuxwWNi9t4vyNwced2gRc2tvbt2PCBxG35TBo0f0gat37Cbv3EhA2yasFdEhpeW7r0+UkCg6yHwWZmXJDl84ZLUuJ2t58DY1vefk4BbfUMtLXwbMWypLOnJOhCSel30xtSsVJdzM11263a3azrQTwlntwtx45ul3KR1aVX/1ckOLikzTYuP3dmiyM7na2Lmz68KzffjP2LvPHGG/pdbrmNpKQkFQYQT4ge/Pzzz/q+tWvXqjhAjpMhViAmEAJzdo6MbcIzhZATxJgxH9tCTtGXX35pXh8REIghpH4cOHDAvF2MMjP2A0/OypUr1SuF+w3s//33362O2fJ4jAn5UPhhj/cjTAhvlmEHHAAYjQeQc4TICuyAVwzHDq/b1q1bNVUFQg9hOUsgJHFvdbR/Z9ieGySCG/MNsrKyVJjm9vfia39XPjeqDjFuuAWRswQXoe0oDbw2ktXwR+NsOS5k47Wz9zsCf2g5JRN6A5bJeNnZWfLv8qfEZMrWx4YtR4m/v/WvjW3rxktS4jadjh6YJzXqWY+aObJ/rhzeO9Nq+zm5lfN6EV64cEGfu6ODtyehrZ6BthaerViecemSdOv3hESUryUZeajn1LTVTZJwYpcc2He5Xlz3vi+Jn3+Q3TYysjL1BorvDEffnY7shDBw9B0DkQGwDEIAuTn4EY3X2Ae+85FDBHGFG3mDBg30B3FoaKiuc/3112v+E9IySpQooSE85ARhniMs7YC3BzlNxv4hZJDDNHfuXM1Bgj2PPfaY5vzAuwXhBuGCKMenn36q3ihsD94oCBXYisnwYkHwwU6E5fDjHc9xvvAD37ABpRCwT4QBsS1jHnK4kK4CxwD2jzQW5EshhxeDqlA6ACFMiCOcD9tzi/fhvBnzsc/cwoc5nRuDo0ePqoDL7X7hS39XxsA0nxFOEE1Q8rjI4abFhW85dBNA9OACAVhuK4LwGl4sLDNe2y7Pqe4E3MDeXpgMNhpAJEVFd5ITR5fro61oApWrXycHd0+TwKAyUq6ifYgyMqqVLsvMOG/eftmyZd2q3rE9b/+Doa2egbYWnq24SeMmvnndFKlUuYEEB7keYkPJgeNHtppbO23fPMNhqQJT1iX1AMEOR9+djuyEaHD0HQPPCYQDwlI1atSQwYMHyz///KPrYh/47oY3CaO9MOH+gPVwz8A6TzzxhD7HaDzcqCEqcF9x9n1maQe8SwhLQRBhHrxFEGcIk40ZM0YiIiI0JHj11Vfr+piHCTda2IlzDRExdOhQzftBKAznA56iOnXqaIQEQ/sHDBigQgeCCu/Bvcqw4aabbtLcXAx4MubddtttKsDg+YFAQV4vxBPsgz04PghG7Av2Q9TZApuRcG5sE/vEvnP6nrc9N8gl/uqrr6zes3v3bj323O4XvvR3ZQg8V/AzFbIPDXFtjBzARYBRAgBu09WrV2u82ABxVuQ2Ia6LDxK5SohpG+AiQ+gPFyZymvBBY8gqwC8C/NFBqdvmOOFkYURDw4YNvV444Y8S7tgbbtsg5aNaSVbWJUlO2iNhEXUlIMBxHZXkpL0SXDJCSpaKdLg8Pe20JBxdJUtnD9Dt49eWO8BlhT92X/iDoa2egbYWnq34oXjzLXdKXNwuCQzEjdK10gFGcUvjPWlpqZKamuy0SGalqAj5+adJDus4FbVzChAqQ1QDXiCA57inYBRdQRWEzMt5hbcJZX0QcjPyv66UlJQUFYUYvW6bh3YlthY2edEChepxgrtx6tSpGpvGyAIDjBJAfBkXpeFlwk0dCeLGcsuMfqhyhPkQD8bFAXWP5YZwQtI43Jhw7xYlIJYiyluPmLAlLKJOjsshqELCqrnZMkJIYQIh8+sv37HliptBwjZGAP7yyy+ag4RQGoSTt1bRxog82IfRd6h/5Q5mzZql3qbcRFNRptCE0759+zQ+fP/996sggjvTAG7WypUrq0sWSW8Ydok4M1ynhlsTnieIK5QcgPsSIzUMoYT6GxiZgLAfksThBkbSobde3IQQ4m4gaIqTqCkI4PFHSA7CAR4KRDcsR715IyiZgAnFQa/U6wNnxh9//CHffPONFGcKTTihfgeS/hBLNrL2DdATB6IKQy0R80VNDYgj9PYBEEkoAIaRF5gPRY1H46JAyA8uVYgnuKxRFwPDNwkhhJArAf3lCqLHnLtA2QbkELsDRICmTp0qxZ1CE07wNGFyBsSSbeVYS6CeMeV3+4QQQgghPtWrjuSP9Av2PZxAaspR2fT3K3Ls0OVqvLZkZ2dK7KaJOuE5IYQQQvKGV5QjIHljw8rnpWrNy0XRLFk+d6gkxK8SP78AGXLfQQkJta7Qu2vLF7Jm6X8V1Ru2HFkg9hJCCCFFBXqcCCGEEEJchB4nH6R1p8ujC23p0neq7N42SaKiO9p5m0D95g84fE4IIYQQ16Bw8kFKlrbu02cQEhotLa8e4/R9/v6BDM8RUkzAiGLWcSoc0JLEUTNjUjSgcCKEkCIomoYNv1dOJCR5dD85VQ63BP3OjKLFqAUEwYUJoL/cjTfe6Hbb0GAXJWnQ/9Sy+DFK2aBczVtvvSWeKrWDfqtG5wuUy0HfO6OcjidBYU589nv27JE5c+boPLxGqR60WgEPPPCA2nTHHXdohw3LVi04ZzNmzFDb4+LidPl7773ncbt9DQonQggpYsDTBNHUe9C3EhzsmVZSly5dkPm/36X7yk04oQ+cAfrJDRw4UGv0eRo0tEWj2l9//dUs1DyNbePbTZs2Fch+z5w5oyV8IH4gksaNG6fzn3vuOYmOjrZqUbZ27Vp9hLBEQUvLPqgGhthctWqVdOzYsUCOwVdgcjghhBRRIJqCS3hocpMgQ1gLN+ZRo0Zp1wh4purXr6/zDa677jrzzf7IkSNyzz33SNu2beWGG26QlStXOt02KnvDwwXPiTPgHerevbu2/ULR5dTUVLOnBs10US0cvdngqYLoA6gaDkEGu9AHFSIQhZvREQMNgNevX2/2ohnHguNDH1aD7du3axNdCM/Tp0/LY489pt0vULB55syZ5vXQYxXtUrAMfVotz4slWA/2GJ6l3IAHDPUSc/K8oUsH2soQayicfBg0+U1K3KGPzkCT3/QLiU6XY1lq8hEPWUgIIbmDlltoML58+XLtReoMiAyEmiAi/v77bxU66B137Ngxh+vDE4YOExAsCF/ZgnAWmsyjhQg8NRBNRgsVdK/Yv3+/LF68WNt7GaEvgJZf8PAgBPfvv/9KzZo1VWCg+S9CjxBbs2fPttoXRN78+fPNr+fNm6diDZ4wdLYoV66cikA0tH/33Xe1qX1iYqJ88MEHaiOOF3lTzoQMQmwQXa6C8N1rr72mx7B69WqH60DIImTn7PwWVyicfJhFv/WQmd830UdHxG35XKZ/U1emTaopyWf32S3HPCxbOntAAVhLCCHO6dOnj/YTzSmktm3bNjl//rx2hYBnpUOHDtKpUycNN+XkdUL/UniI0ObLEnh24L1CM9zSpUur1wfzTCaTCiU0jo+IiJBq1aqpt8fgtttuk/Hjx6utEBVhYWFW/VYdgU4XWPfAgQP6esGCBdKvXz85efKketPQTw5CDyEyeLAg5NDiBOFGhBoh4tB39dVXX7XbdkJCgm4H3q28gOOC8IRnzfC0WYLjgz1Gfhq5DHOcfJTs7CxJiL/sosYjXvv7B1itc/zwUn3MzDgvZ05ukrDw2lbLTyds1GWEEFLYVKhQIdd1jh8/rl4YeHQMIIbCw8NzfB8EUf/+/dVTZLs9NI+HlwliCV6Y7OxsDZ1BjKDPm4FlcndycrKG5GJjY6VWrVouNZCHKIJHCF4nI2cIXjaIQRwDBKDlMcGrhtwj5IfBYwbbYQ9EDsKDlsBWnIP85HENHz5cRRzOgSNvHz4XbJ/8B4WTjwKR1LbLu+pVatD8QTvRBJq2e07OnYmT0PDaUrVmH7vl1Wr1lep1BkhS4nZJObu3gCwnhBB7jCbtxnPDOwRBYyRc4yZeo0YNDXNZip+QkJActw3Pzeuvv66j+7p27SolSpTQ+eXLl1evEnKYsA8IIHiFIiMjpVKlSnLixAkVRsBSPCAcB08WQnz+/v6aJ4XRdLkBDxMECrxm8LDhOGED9rtu3TrdFoD3KiAgQM6ePatiCKIpLS1N85ieeuopWbRokd25g+DLD3gvzs2AAQM0H8wWfA6GXeQyPBs+TOPWT8hNd+/SR0eUj2olA0ZslW79Z0hgkH0iJ+Zh2bX9fikAawkhxDWQtAzPDETTzz//bA4jwSOC0BWG3eOGjmTswYMHO83RsQReKqxrKbqQdwSPDsQX8qeQT2SMPkNy92effabiBcu//fZbK48TxA4Exd69e1XQwC7DswRh5Ah4keDNQhgQIsrwZDVq1Ehzm5CQDoE2YsQIDdUhjwqhxB07duj+EBJ05F2DyIPwM2zIz/k2wpS2wMOH7ZP/oHAihJAiCkoGXLrooenSBY/ZjXwk3MQxcg6j1RDSMkQJwlYILSG/6a677lKRAY+RKzz55JOa12MAIYUEbeQsIYyG0BtGz8ELgzyqypUrq4cK+4HwMkasYYg/krFRD8kIAx46dEjFF2yGcML7bIHQgqepbNmyVrWl3n//fRWBCNfB84PaStgnvF2jR49WMYd9TZ06VRPHbYEnDse1c+dOyS+o64R9WAJxinOCJHHyH34mSPpiDIaV4sJo2LChJgd6M0jQwx/vDbdtUG+Su0hM2ChzJrfW7RtfUFeK4V7HF4SlC94boa2egbYWnq3eUADT18/p5s2bdZRcaGiovsbINoTT4JXyNlsBBB+E2xNPOI5A5AfUcIJHDqFId9rq61qAOU6EEFLEgJCBoGHLlfyDkWzIM0KRSNz8ER5EIrW3Aq8ZRg+OHDnSbZ8JzgHKPxBrKJwIIaQIgptnURU1BQHCeqgThSKVSCZHWA8FIb0VlE1AgU54xhC+vFIQ9oNwxPETayicfJATR/5yGKo7tHeWrF/xjETX6Cntu35k5xpNTTkqy+cO1edd+k7VpsCEEELswWg3X6uaDY+Tu0DCemGHJb0VJof7ILEbJzicD9GUnLRbYjd9LOfOxNot371tkiTEr9IJzwkhhBCSNyicfJDyVTo4nA9PEygTFiMhodXtlkdFdxI/vwCdoqLZtJEQQgjJKwzV+SBN2zztcD7CcyiGCdEUFGzf7bpKTDcZct9BfR4SWtXjdhJCCCFFDQonX8TJsE7kNIVHNsrxrRRMhBBCSP5hqI4QQgghxEUonAghhBBCXITCiRBCCCHERSicfJgzJ7fIptVj9NERGZdSZOvaN2V/3FSn28Cyvdu/8aCVhBBCSNGByeE+ismULQumXScX089I7OZPZOjDp8TPz1oHr1/xrMRt+UyflwqpJJWrXWu1/PjhZeaCmIQQQgjJHXqcijNe3nSREEII8TbocfJR4F3qNWSpHNo7Q2LqDLTzNoE2ncdLSGg1KVO2pp23CWBel75T5GT8KondPLGALCeEEEJ8F7cLpzNnzki5cuXcvVnigHIVm+vkjKDgUGnWfnSO26jV4FYJi6hH4UQIIYR4KlTXsGFDFUi2xMfHS7du3fKzSUIIIYSQouNxmjlzpvz+++/63GQyyciRIyUoKMhqnZMnT0qFChXcbyUhhBBCiC8Jp+uvv16OHj2qz9etWyctWrSQkJAQq3VKly6t6xFCCCGEFGvhBJH0yCOP6PPo6Gjp06ePlChRwpO2EWeYTE5mm+TcmVinTX5Baspl8cuedYQQQkgBJYcPHDhQDh06JNu3b5eMjAy75QMGDMjPZomLbFv/jnTtZ1/Ucu2yxyR208dSJixGBozYbieejh1aIoum99TnPW5aKFVimI9GCCGEeFw4TZo0Sd59910pW7asXbjOz8+PwsnDJB5b43B+/MGF+ng++ZCkphyW8MhGVssT4leKyZT1/89XUTgRQgghBSGcvvnmG3n66aflnnvuyc/byRXSsNUoh/PbdH5bNqx4VqrU6CFlyzW0W16v6b1y/PAS83NCCCGEFIBwunjxovTo0SM/byVuoJKDYpYgpk5/nZyBvKY+t670oGWEEEJI0SZfdZxuuOEG+fnnnzUZ2R1cunRJ+vXrJ2vXrjXPe+2116R+/fpW0+TJk83L//jjD+nevbs0b95cSyNY1pWCXQgldujQQdq1aydvv/22ZGdnu8VWQgghhBRf8uVxOn/+vPz2228qXqpWrWpXz+mHH37Ik/fqf//7n+zZs8dq/r59+3Q+EtENypS5nOy8detWeeGFF2Ts2LHSoEEDef3112X06NHyxRdf6PJvv/1Wbfvkk08kMzNTw4qRkZEMLRJCCCGk4IVTjRo15MEHH7yyPYvI3r17VRw58lxBOEHoOCqoCc9T7969zUno8Ch17dpVjhw5ItWqVVPhNmrUKGnTpo0uf+qpp+Sjjz6icCKEEEJIwQsno57TlYJCmu3bt5cnnnhCC2paerQSEhJUoDliy5Ytct9995lfV65cWapUqaLzg4OD5fjx49K2bVvz8tatW2s7GFQ2r1ixoltsJ4QQQkjxI1/CCWGxnHjzzTdd2s6wYcMczoe3CWUNPv/8c1mxYoWEh4fLXXfdZQ7bORJACMWdOHFCTp06pa8tl5cvX14fsdyZcILXy105W57C1r4dGz6QuC2fSYPmD0nj1k/YrZ+YsEFWLbhLQsNrS5c+P0lgUGmr5ZkZF2T5vOGSlLjd7efA2Ja3n1NAWz0DbS3etvqKnYC2egaTj9nqUeFkC/KIECaLjY2V22677Yq3t3//fhVOtWrV0u39+++/8tJLL2mOE1q6pKenq2fJErxGkjmWGa8tlwEsdwa8XI6KeXoTsNEgOztL/l3+lJhM2frYsOUo8fcPsFp/27rxkpS4TaejB+ZJjXqDrZYf2T9XDu+dabX9c+fOue0ivHDhgj7HZ+nN0FbPQFuLt62+YiegrZ7B5EO2It/ao8LJmUcJhTF3794tVwpyl5CzBE8TQAL4wYMHZcqUKSqc0OrFVgThdalSpaxEktESxlgXy50BUYZee96MkRwPIJKiojvJiaPL9dFWNIHK1a+Tg7unSWBQGSlXsaXd8sioVrosM+O8efsoaupO9Y7tefsfDG31DLS1eNvqK3YC2uoZTD5kqyHwCszjZNCrVy+ZOHHiFW8HJ9gQTQbwPq1Zc7lidlRUlCQmJlotx2skkmMZQMgOI/6M58BRornlPr39g7W1r8fgRZKctEfCIuo6XL9B8welSvXuElwyQkqWirRbHhZeW4bcd1ASjq6SpbMHuP0cGNvz9vMKaKtnoK3F21ZfsRPQ1uJtq18e7MtXHSdnau3XX3+ViIiIK94WRsDdeeedVvPi4uJUPAHUbtqwYYN5GZLBMWE+hBMSxS2X4znmFbXE8ICAYIko31gfnREWUcehaDLAspCwah6ykBBCCCla5MvjhNCZI3WG0BgKV14pCNN9+eWX8vXXX2tobtWqVTJz5kxzfaihQ4fK7bffriPxmjZtqnWcrr32Wi1FYCxHAcxKlSrp6/fee0/uvvvuK7aLEEIIIcWbfAkn2wKXEFEoglmnTh2rPJz80qxZM/U6TZgwQR+jo6NV/LRseTlPB4/jxo3T5Uhmvuaaa+TVV181vx/1mk6fPq1lEwICAmTw4MF2HixCCCGEkAIRTmhjApCwjdIBaGdSs2bNKxJNu3btsnqNdiqYnDFo0CCdHAGxhJIJuZVNIIQQQgjxuHBKTk5WUbJkyRLNls/KypLU1FQtOonk8NDQ0PxslrhI+oUEh/NTU47K7m2TdJRdlZhudsuzszNl15bLbWnqN39A/P3dOjaAEEIIKfLkKzkceUwoJjlv3jxtzLt+/XqZM2eOJoi7WvyS5J8NK593OH/53KGy+Z+xsmh6TxVRtkA0rVn6iE6GgCKEEEKIh4XT0qVL5ZVXXjGPcgPIb3r55ZfVC0UIIYQQUhTJV6wGo+f8/e01F5LEEbYjnqV1J8devS59p/5/qK6jhIRermFlCcJzjp4TQgghxIMep+uuu07Gjh0rhw8fNs9DojhCeF26dMnPJkkeKFnacT2qkNBoaXn1GIf5TQA5TQ1bjtSJ+U2EEEJI3snX3fPpp5+WkSNHSs+ePSUsLEznoSxA586dtaccIYQQQkhRJM/C6dChQ1qF+8cff9QSAihHgNBdjRo1pHbt2p6xkvgkx44d0+bP7i61j+r0qO1FCCGEeK1wQrM+VOj++eef5bvvvtNaTvXr19fp4YcflmXLlsmIESPk2Wef9fqeNMTzxMfHS/fuPSX9onUzZndQulRJWbv2b4onQggh3iucUC0c5QdQp8kogGnw6aef6kg71HaqXr26DBs2zBO2Ehuysi6Zm/w661eXnLRXgkuES8nS5R0uT7+QKKnJR9xuW1JSkqSlX5RBw76UChXquG27p07tkxlT7tftUzgRQgjxWuGEBr7IX0IfOWcJ40899ZQKLAqngmHRbz3kxNHlUqlqF+l9y192y+O2fC7//PmQBAaVkf53bJawcOtQavLZfTLrhxaSmXHeYzZWqFBbKldt4rHtE0IIIV45qg6hF/SQy4kOHTpoTgvxPNnZWZIQv1Kf4xGvbTl+eKk+QhidObnJbvnphI0eFU2EEEJIsRVOkZGRKp5yAtXEw8PD3WEXyQV//wBp2+VdCYuop494bUvTds9JRPmmUr3OAKlas4/d8mq1+uqy0HD3hdIIIYSQoozLobrrr79ePv74Y/nmm28kKCjIbnlmZqZ88skn0rFjR3fbSJzQuPUTOjmjfFQrGTBiq9PlgUGlpVv/GZKYsFHmTG7tISsJIYSQYiicMHJu8ODBMmjQILn99tulSZMm2swX9Zt27NghkydP1ka/b7/9tmctJoQQQgjxduGEQpdIEH/33XflrbfekrS0NHOZAgioPn36yKOPPirlyzsevUUIIYQQUqwKYCJ/CW1V0MwXSeDJyck6DyUIAgLsc2wIIYQQQqS4t1wJDg5mlXBCCCGEFDvy1eSXFC4njtjXbAKH9s6S6d/UlzVLR2kI1ZbUlKMyb2onnVJTch4hSQghhBB7KJx8kNiNExzOX7/iGUlO2i2xmz6Wc2di7Zbv3jZJEuJX6YTnhBBCCMkbFE4+SPkqHRzOj67RUx/LhMVISGh1u+VR0Z3Ezy9Ap6holo0ghBBCCiTHiRQuTds87XB++64fSYPmD6poCgouY7e8Skw3GXLfQX0eElrV43YSQgghRQ0KJ1/Ez8/JbD8Jj2yU41spmAghhJD8w1AdIYQQQoiLUDgRQgghhLgIhRMhhBBCiItQOPkwZ05ukU2rx+ijIzIupcjWtW/K/ripTreBZXu3f+NBKwkhhJCiA5PDfRSTKVsWTLtOLqafkdjNn8jQh0+Jn5+1Dl6/4lmJ2/KZPi8VUkkqV7vWavnxw8tk+dyhBWo3IYQQ4svQ41SccTI6jxBCCCGOocfJR4F3qdeQpXJo7wyJqTPQztsE2nQeLyGh1aRM2Zp23iaAeV36TpGT8askdvPEArKcEEII8V0onHyYchWb6+SMoOBQadZ+dI7bqNXgVgmLqEfhRAghhLgAQ3WEEEIIIS5C4UQIIYQQ4iIUToQQQgghLkLh5IuYTE5mm+Ts6Z2Scem807emphzViRBCCCF5h8LJB9m2/h2H89cue0xmfNdYZn7fxKF4OnZoiUz7qoZOeE4IIYSQvEHh5IMkHlvjcH78wYX6eD75kKSmHLZbnhC/UkymLJ0S4ld53E5CCCGkqMFyBD5Iw1ajHM5v0/lt2bDiWalSo4eULdfQbnm9pvfK8cNLzM8JIYQQkjconHyQSg6KWYKYOv11ckZIaFXpc+tKD1pGCCGEFG28IlR36dIl6devn6xdu9Y878iRI3LnnXdKixYtpE+fPrJqlXVo6e+//9b3NG/eXO644w5d35LvvvtOOnXqJC1btpTnn39e0tLSCux4CCGEEFI0KXThdPHiRXnyySdlz549VqPDRo4cKeXLl5fp06dL//795ZFHHpFjx47pcjxi+aBBg+S3336TcuXKycMPP6zvAwsXLpRPPvlExo0bJ99//71s2bJF3nnHcUI1IYQQQohPCKe9e/fKzTffLIcPWycyr1mzRj1IED61a9eWBx54QD1PEFFg2rRp0qRJE7n77rulbt268uabb0p8fLysW7dOl//www8yYsQI6dq1qzRr1kzGjh2r76XXiRBCCCE+K5wgdNq3by+//PKL1Xx4iBo1aiSlS5c2z2vdurVs3rzZvLxNmzbmZaVKlZLGjRvr8qysLNm2bZvVcoiujIwMiYuLK5DjIoQQQkjRpFCTw4cNG+Zw/qlTp6RixYpW8yIjI+XEiRO5Lk9OTtbwn+XywMBACQ8PN7/fEQjzGaE+b8XWvh0bPpC4LZ9Jg+YPSePWT9itn5iwQVYtuEtCw2tLlz4/SWDQf0IUZGZckOXzhktS4na3nwNjO5b/uweTR2z1hc8f0FbPQFuLr52AtnoGk4/Z6tOj6hBSCw4OtpqH10giz215enq6+bWz9zvi/Pnz6pXyZmCjQXZ2lvy7/CkxmbL1sWHLUeLvH2C1/rZ14yUpcZtORw/Mkxr1BlstP7J/rhzeO9Nq++fOnXOLrSkpKapxMrMyJSMzU9xFRhbqUJl0++6yFdu7cOGCPvfz8xNvhrZ6BtpafO0EtNUzmHzIVjhcfFo4lShRQs6ePWs1D6KnZMmS5uW2Igivw8LCdJnx2nY5QnrOKFOmjFVo0BuBjQYQSVHRneTE0eX6aCuaQOXq18nB3dMkMKiMlKvY0m55ZFQrXZaZcd68/bJly7rF1tDQUBE/kcCAQAkKdN9lFhQQoH+A2L67bDV+aWB73v7HTVs9A20tvnYC2uoZTD5kqyHwfFY4RUVFaeK4JYmJiebwG5bjte3yhg0bakgO4gmvkVgOMjMzVYhVqFDB6T7xoXr7B2trX4/BiyQ5aY+ERdR1uH6D5g9KlerdJbhkhJQsFWm3PCy8tgy576AkHF0lS2cPcOs5MLZj+b978PPI52Vsz9uvAUBbPQNtLb52AtpavG31y4N9hV6OwBGozbRjxw5z2A1s2LBB5xvL8doAobudO3fqfH9/f2natKnVciSNI8+pQYMGUpQICAiWiPKN9dEZYRF1HIomAywLCavmIQsJIYSQooVXCqd27dpJ5cqVZfTo0Vrf6csvv5StW7fK4MGXc3Ruuukm2bhxo87HcqxXtWpVHaFnJJ1//fXX8ueff+r7XnnlFS17kFOojhBCCCHEJ4VTQECAfPrppzp6DkUuZ8+eLRMnTpQqVarocoikjz/+WGszQUwhDIflhqutb9++Wvvp5Zdf1lpPqOX09NNPF/JREUIIIcTX8Zocp127dlm9jomJkcmTJztdv0uXLjo54/7779eJEEIIIaRIe5xIzqRfSHA4PzXlqGz6+xU5dmiJw+XZ2ZkSu2miTnhOCCGEEB/1OBHX2bDyealas7fd/OVzh0pC/Crx8wvQ0XIhoVWtlu/a8oWsWfqI+XXDliMLxF5CCCGkqECPEyGEEEKIi9Dj5IO07vSmw/ld+k6V3dsmSVR0RztvE6jf/AGHzwkhhBDiGhROPkjJ0tZ9+gxCQqOl5dVjnL7P3z+Q4TlCCCHkCmCojhBCCCHERSicCCGEEEJchMKJEEIIIcRFKJx8mKysS5KUuEMfnZGctFfSL1g3RLYEy1KTj3jIQkIIIaRoweRwH2bRbz3kxNHlUqlqF+l9y192y+O2fC7//PmQBAaVkf53bJaw8NpWy5PP7pNZP7SQzIzzBWg1IYQQ4rvQ4+SjZGdnSUL8Sn2OR7y25fjhpfoIYXTm5Ca75acTNlI0EUIIIXmAwslH8fcPkLZd3pWwiHr6iNe2NG33nESUbyrV6wyQqjX72C2vVquvLgsNr1NAVhNCCCG+DUN1Pkzj1k/o5IzyUa1kwIitTpcHBpWWbv1nSGLCRpkzubWHrCSEEEKKDvQ4EUIIIYS4CIUTIYQQQoiLUDgRQgghhLgIhRMhhBBCiItQOPkgJ47Y12wCh/bOkunf1Jc1S0eJyWSyW56aclTmTe2kU2pKfAFYSgghhBQtKJx8kNiNExzOX7/iGUlO2i2xmz6Wc2di7Zbv3jZJEuJX6YTnhBBCCMkbFE4+SPkqHRzOj67RUx/LhMVISGh1u+VR0Z3Ezy9Ap6jojh63kxBCCClqsI6TD9K0zdMO57fv+pE0aP6giqag4DJ2y6vEdJMh9x3U5yGhVT1uJyGEEFLUoHDyRfz8nMz2k/DIRjm+lYKJEEIIyT8M1RFCCCGEuAiFEyGEEEKIi1A4EUIIIYS4CIWTD3Pm5BbZtHqMPjoi41KKbF37puyPm+p0G1i2d/s3HrSSEEIIKTowOdxHMZmyZcG06+Ri+hmJ3fyJDH34lPj5Wevg9Suelbgtn+nzUiGVpHK1a62WHz+8TJbPHVqgdhNCCCG+DD1OxRkno/MIIYQQ4hh6nHwUeJd6DVkqh/bOkJg6A+28TaBN5/ESElpNypStaedtApjXpe8UORm/SmI3TywgywkhhBDfhcLJhylXsblOzggKDpVm7UfnuI1aDW6VsIh6FE6EEEKICzBURwghhBDiIvQ4EUIIKfYcO3ZMjhw5oh0Y3ElERIRER0e7dZukcKFwIoQQUqyJj4+Xbj26S9rFi24fM1OqZCn595+1FE9FCAonX8RkcjLbJOfOxDpt8gtSU47qI3vWEULIZZKSkuTCxXTpOHaohNWo4LbtJh86JX+Pmarbp3AqOlA4+SDb1r8jXfvZF7Vcu+wxid30sZQJi5EBI7bbiadjh5bIouk99XmPmxZKlZhuBWYzIYR4O2ExFaR8Pf6oJDnD5HAfJPHYGofz4w8u1MfzyYckNeWw3fKE+JViMmXplBC/yuN2EkIIIUUNepx8kIatRjmc36bz27JhxbNSpUYPKVuuod3yek3vleOHl5ifE0IIISRvUDj5IJUcFLMEMXX66+QM5DX1uXWlBy0jhBAfxWSSSxcuSvr5NLdtEttD7ikpWni1cFq8eLE88sgjVvN69uwpEyZMkJ07d8qYMWNk9+7dUqdOHRk7dqw0adLEvN4ff/whH374oZw6dUo6duwor776qpQrV64QjoIQQog3k52dLRfT02XB41+IX6C/BAQEiJ+/8+F12VnZ+h5/f3/xD/gv48WUbZKsrCwtaeAfECDZmZmSkZau65Kig1cLp71790rXrl1V9BiUKFFCLly4IPfff7/ccMMN8tZbb8mUKVPkgQceUKFVunRp2bp1q7zwwgsqpho0aCCvv/66jB49Wr744otCPR5CCCHeBwRQiZIl5drX75QDSzZLyokz0vqB3lK2ekW7dQ8s3ix75q+Xur3bSM3rW9gtP3f4pGz4Yr6EVionNbu3kOVPfafbJ0UHr/409+3bJ/Xq1ZMKFSqYp7CwMJk3b54KqGeeeUZq166tIikkJEQWLFig75s8ebL07t1bBgwYoMLp7bffluXLl2txM0IIIcQOPz8pXSFMrnl2sETUqCRbvv1TLp5LldLlQs1T/D9xKqwaD+kojW/pZLXMmCq3qC3XPDNY0s6kyO7Zawv7qEhxFE41atSwm79lyxZp3bq1ucIrHlu1aiWbN282L2/Tpo15/cqVK0uVKlV0PiGEEOKMwJLB0v6xGyW0SqSs/XCWJB04ofP3zP1Xds1aI/X7d5C6fdvmuI2ImpWk/eP9JfXUWcnMyCwgy4kUd+GEhLoDBw7IqlWrNK+pe/fu8u6778qlS5c0b6liRWsXamRkpJw4cfkCP3nyZI7Liwo7Nnwg07+pp4+OSEzYIDO/byZLZg2UzIwLdssxD8v++uOWArCWEEJ8Uzz9O/EPl0WTpXhqdltXMZmY31TUCPTmvkFpaWkSHBysSd5Hjx6V1157TdLT083zLcFriCqAdXJa7kyoefvoB0v7srOz5N/lT+kfJR4bthwl/v4BVutvWzdekhK36XT0wDypUW+w1fIj++fK4b0zPXIOjO1Y/u8eTB6x1Rc+f0BbPQNtLb52gv9sNJm/rgJLBEv7UTfKgse+kIQtBySqeU2p26dtnr7OQqPLS2BgEL+vTL5hq88LJ5SnX7t2rZQtW1ZDcQ0bNtSRCU8//bS0a9fOTgThdcmSJfU58p8cLS9VqpTT/Z0/f14yMjLEm4GNBhBJUdGd5MTR5fpoK5pA5erXycHd0yQwqIyUq9jSbnlkVCtdlplx3rz9c+fOucXWlJQU/YLJzMqUjEz3uaozslDA06Tbd5et2B4GHAB3N/h0N7TVM9DW4mvnf99XJsnMzJaMzP/uA3sXb5Ds//cYnYo7Iqf2HpXwGlEub/diarpkZWby+0q839aLFy/6vnAC4eHhVq+RCI6DQ5J4YmKi1TK8NsJzUVFRDpfjfc4oU6aMjsjzZmCjJT0GL5LkpD0SFlHX4foNmj8oVap3l+CSEVKyVKTd8rDw2jLkvoOScHSVLJ09QLcPoeoOQkNDRfxEAgMCJSjQfZdZEIYJ+/np9t1lq/FLwxDp3gxt9Qy0tfja+d/3lZ8EBvpLUGCQOadp3x/rpWH/q6Vmt+aydsJs2fDxXM1dQhguNzLTL0nsLyvFJCZ+X5X1flsNgefTOU4rV66U9u3ba1jOIDY2VsUUEsM3bdr0XzjIZJKNGzdK8+bN9TUeN2zYYH7f8ePHdTKWOwIfqi9MlgQEBEtE+cb66IywiDoORZMBloWEVfPIOdBtmv935+Q7nxcnTpx8Y/r/O4H+2zPvX9k1+/9zmvq1lcBS/5/zFB0paz+aJUkHT+T4FZV58ZIKLSSHBwYFFfqxcfLLwzXgw8KpZcuWGnJ78cUXZf/+/VpOAGUF7r33XunVq5ckJydrfSbUesIjBBZKEIChQ4fKrFmzZNq0aRIXF6dlC6699lqpVu2yQCCEEEIc4Wz0nLPRdo48TWs/mi0px05rcjhrOBU9vPYTRdjo66+/ljNnzshNN92ktZpuueUWFU5YhmKW8CoNGjRIywx8+eWX5lAbRNe4ceNk4sSJKqLgJnzzzTcL+5AIIYR4MYdX7Mhx9Fxu4slSNCGkF1q1fAFaTwoKr85xqlu3rnz77bcOlzVr1kxmzJjh9L0QVJgIIYSQ3MjOzJIDy7ZIs+Fdcyw5YIgnCCSIJyPnyVY0YV7i7qMFegykmHuciHPSLyQ4nJ+aclQ2/f2KHDu0xOHy7OxMid00USc8J4QQcpmszCyp2bW5S3WabD1PibFH7EQTKbp4tceJOGbDyuelas3L+VyWLJ87VBLiV4mfX4COlgsJrWq1fNeWL2TN0v+aJjdsObJA7CWEEG8nIDBAqndu7PL6hnha/fZvsuaDy/Xwrhk9hKKpGECPEyGEEEKIi9Dj5IO07uQ40b1L36mye9skiYruaOdtAvWbP+DwOSGEFHcQqkNyePn69t+djjBymtJOp0iHJwbIrtlrrXKeSNGFwskHKVnaug+fQUhotLS8eozT9/n7BzI8RwghTkJ1SA4PrVIu1zwnR4ng4TWj7BLGSdGEoTpCCCHFHv/AAE0ORzkC1HLKi2jKS50n4vtQOBFCCCEimhyOGk7OxJMz0WRgK55Sjlq3/iJFAwonQggh5P9BmM6ReMpNNDkST1snL9Pm9KRoQeHkw2RlXZKkxB366IzkpL2SfsH5rx4sS00+4iELCSHE98WTq6LJVjyFVAiXzIyMArObFAxMDvdhFv3WQ04cXS6VqnaR3rf8Zbc8bsvn8s+fD0lgUBnpf8dmCQuvbbU8+ew+mfVDC8nMOF+AVhNCiPdjJIhDPGHSRr95SPqGeGp6W1c5smSbhy0lBQ09Tj5KdnaWJMSv1Od4xGtbjh9eqo8QRmdObrJbfjphI0UTIYQ4oWa35ubnkfWi8zxSLqBEoI7WI0ULCicfxd8/QNp2eVfCIurpI17b0rTdcxJRvqlUrzNAqtbsY7e8Wq2+uiw0vE4BWU0IIb6BEZ6DpymqeU1J2HIgx9F2jkByOEN1RQ+G6nyYxq2f0MkZ5aNayYARW50uDwwqLd36z5DEhI0yZ3JrD1lJCCG+haOcJogmhOyAK/3sUI4AyeF+fvRPFDUonAghhPgU8fHxkpSU5Lbt7du3T8Rk0ufOEsEtc54sXzsTTShHgOTw5KDjbrOTeAcUToQQQnxKNLW9qr2kpae5bZsmk0nS0tJETJLj6DlXxJMhmlCOoE6fNnJiZZzb7CTeAYUTIYQQnwGepgtpF6TdCzdJaNXybtlmxoWLsuylH2XHLysk7UxKjqPnchJPlqIJ5QjOHj7pFvuId0HhRAghxGdAQcm0C2my6u3fJKhksPj5+0l2VrbO9/f3F/+A3HOKTNkmycrKEj8/P/EPwMAak1y6kC4pJ87INc8MznX0nCPxZCuaUI6AFE0onHyQE0f+0sRvWw7tnSXrVzwj0TV6SvuuH+mXgiWpKUdl+dyh+rxL36naFJgQQnwJiKNSpUtJxVZ1JOPiJYmoVVlO7TgsdXu3kZrXt3B5O+cOn5QNX8yXUhFlJDPtkhz6e6e0fbifyyUHLMXT2YMJcnp3PEVTMYHp/j5I7MYJDudDNCUn7ZbYTR/LuTOxdst3b5skCfGrdMJzQgjxRfCjsMU9PUSyTJK055hEt60rjW/pJKXLhbo8VW5RWzqM6i9piSmSlpQqwSElpWyNqDzZAfFklCqA+KJoKh5QOPkg5at0cDgfniZQJixGQkKr2y2Piu4kfn4BOkVFd/S4nYQQ4ini1+4yP4e3B6GyvIDRc7tmr/3v9cUMyUp33r7KEdgn9m1wYMmWPL2f+CYM1fkgTds87XA+wnMNmj+ooikouIzd8iox3WTIfQf1eUhoVY/bSQghniArM1MOLN0izYZ31ereGAmH/CJXW6JYlhy4ZvQQST+bKn889Ils+HyeXP30TS55jWxzmiCa8lLn6Uo4duyYHDlyxC4d40qJiIiQ6GimcOQGhZMv4uSPBX9E4ZGNcnwrBRMhxNfJysySmtc1NwsUCBdXxZOjOk0XTqdIUEhJSTmepMtyC7k5SgTPS52nKy3H0K1Hd0m7eNHZrSDflCpZSv79Zy3FUy5QOBFCCPEp0P+teufG5tcQLq6IJ2fFLYF/YIC0eaiPbJq0MEfxlNPoOVvxFFG3smfKMVxMl45jh0pYjQpu227yoVPy95ipun0Kp5yhcCKEEOJTBATa37pyE085iSYDJIdjGd7vSDy5UnLAUjxVaVdPPILJJCUrhEmZKpFu2+SlCxe1ECjJHQonQgghRQJn4skV0WSAZY7EU17qNBniaetPyzQfy52gXlV6WposevJLCSgRlKd6VQjtOZoHsjIyJSMtXbdPcobCyYc5c3KLHNrzu8TUHSTlKja3W55xKUViN30iZcrWlFoNbnW4jf1xU+Vk/KoCsLZ44u6eWvhFGBAQIGXLlnXbNgkpyuKpzYN9dPScK6LJmXiqf2N7Wf/5vDzVaYJ4Sjl+RjbHzRd317EqUaKkdB9/j0TUqexyvarQSuWkdq/Wsvm7xfq81f29rIRX0r7jsnTUJN0+yRkKJx/FZMqWBdOuk4vpZyR28ycy9OFTdl241694VuK2fKbPS4VUksrVrrVafvzwMnNBzOKOJ0apnD59WoYNu13S0i+KOylZIljWrftHqlZloj8hOYmn1W//Jms+mKnzMHrO1eKWluJp9ZvTdBuhVfNe3BJ5WNu+XCTuxi/AX0qULa31qHID66AaOo5j89eL9Djw2vY4LiSec/sovaIKhVNxhn8kZq9Q9+49Jf1i3mq4uOIdSk+/KHc+NF3Khrn+hZ0Tp07tld9/vl+9WBROhBBS8FA4+SjwLvUaslQO7Z0hMXUG2nmbQJvO4yUktJqG6my9TQDzuvSdoqG62M0TpbgCEQKv0KBhX0qFCnXctt3UC0ky5dt7JKZmeylVKvdfhq7B5E1CcsPIaUo7nSIdnhigobq81HkCRk5TRO3K5lCdK6UKLDm8YoeWTnA7echDystxIL9p586dcunSJbf9eAwODi5yqQUUTj4M8poc5TYZBAWHSrP2o3PcBnKfwiLqFWvhZFChQm2pXLWJ27Z3PiVR/P35J0ZIQeIoETy8ZlSeimQ6SgTPabSdI/bM/VeLdKJ0grvJyMiUlKOJUr5+Vbcdx8X0i5KSkiK33HKLW20tWaqkxMXGSUxMjBQV+K1OCCGkSOBs9JyrdZ6As9FzzkbbORNNKEeAIp07Dy51+3H6+/nJ1snLJLxWJbcdR0Zmhi6PGnmNhF7lHpFz8cAZOfLSAklMTCxSwonp84QQQnwKR0P8cys5YIgnCAmIBke97c4dTMix5IAhOrAP7Av7dCaa6vfvYFWk050EBAVKSMVwp8eRW+mEnI4juGpZKd0gyi1TiZrlpChC4UQIIcSnQN4Q8ocMXK3TlJN4ys7MkvWf5V5yICfRYSmaPNqvzs9Pmg7v6vA4XK03ZXscWRfdW2+qKEPh5Is4qe6KRLyzp3dKxqXzTt+amnJUJ0II8VWQN4T8IQiVvBS3dCaeUOsoIzVdQitHuJS/5Eg8FZho+n8CSgTaHUdeinTaHseuX1fr2JPsdOcC6lJCik7OyEq9JOn7Txf5CuTMcfJBtq1/R7r2m2o3f+2yxyR208dSJixGBozYLkHBZayWHzu0RBZN76nPe9y0UKrEdLNavnfvXh0B4Q727dvnlu0QQoijlivIH4JQwRRYKjhPI+Ysc55Q3yjzUqbWRmr9YB+XR8xZ5gotGPWFziso0eTsONSu2pXzNPLPOI6lL/+oVcWPf7RCwrvVlYDS1u9PWXdYDjz6uz6v+fEgCW1X3U407b71R8k4niyRt7SQ6Ke7SlGFwskHSTx2uYGkLfEHF+rj+eRDkppyWMIjG1ktT4hfKSbT5aGxCfGrzMIpLfWk+PkHyX33P6xVqd1Wwyjtop14I4QQdxDdvr4cW7dbn0fWi85TcUsAYYHh+UaBzMASQRKQh+KWAPvEvhO2HNDXNbs5H+XsKWyPA8/zUqTTOI7QahXk+L97JftsumScSJGAWtZ98FI3xYtkXfYkXdgcbyecMhJSVDSB82sOSVGGwskHadhqlMP5bTq/LRtWPCtVavSQsuUa2i2v1/ReOX54ifm5waVLyVoHqs/ACRJTo5lbbEy9cEZ+/vZeCQl1XxNKQggxfphtm7xMPU2GcEGoLC/eHoS1tI1K1UjJTLskp+IOa3J4yaY1XN4G9ol9RzWvKad3x+e5zpM7sDwOgOd58b4Zx5G075iIn0iZDjEOk7rLDWgi5/89/P/Pm9otx3vgaYJoqvRoJynKUDj5IJUcFLMEMXX66+SMkNCq0ufWlU6Xlytf0211jM6nnGINI0KIR8jMyJTUU2el80tDVSAY+UXAFfFkmwuUdua8HFixTZPDr356kEuiwzanydhmQYon2+MAealXZXkc1To2ksTthyWif2OHrVeCo0KlziTnNZ7wnqIcnisWyeEXL16U559/Xtq0aSMdO3aUb775prBNIoQQ4qZenc1u62oWBhAuEDAQABACOeEogRrNboNCSmpyuLMh/pY4SgR3pVSBO0EBTNvjcKXkgrPjqHJNA4/aW5QossLp7bfflu3bt8v3338vY8aMkU8++UQWLFhQ2GYVM5DnlCJpbpzSL6ay6wghxZzAoCAJrVreap4r4imnUWfwmCA5PDfRkdPouQIb4p+drQUwHR2Hq+KpoEcBFiWKZCzlwoULMm3aNPnqq6+kcePGOu3Zs0d++ukn6dWrV2GbV0zwl4vpqTLxvesRNpesrEzNSwgICLRyA2dnZ2l/JH9/f/H3d56YjvdiG9nZGXIx/YK+hxBSPMH3hSMMAeAobOfKUP2AXCqMuyI2LEfbIQ/LE0Pz0XIFBTCdHUduldIpmq6MIimc4uLiJDMzU1q2bGme17p1a/n888/NN2niWQICgyS4RIjc98jvElKmvFzKSJOl88fL2TNHpHuf0VK+Yh3ZummGbFn/mzRvM1iatRyY6zYTT+6VP6aPlhPHzvIzJIS4LJ7yUt/ImejIi9gwxNOKV6doPpYnWq6gAKanj4MUI+F06tQpiYiIsKpJVL58ec17Onv2rJQrVzTKwO/Y8IHEbflMGjR/SBq3fsJueWLCBlm14C4JDa8tXfr8JIFBpa2WZ2ZckOXzhkviiQ0esQ+epZAykVIm9LJL/cYh78iCWWPkr8UfSJWqTeXQ/rXSvuPd0qqda00lsZ1re/xPpnw73CP2IgyIcKC7SEu/vC2EK92FhioJIS6Lp7MHE3TEm6tFIR2JDmPkXl7EBkQK8rCWPvWd7NixQ9LS0sRdNfJQABQFMD15HBdiE+To2EXagqX6a73Fv2SQ1fLs9Aw5/OJ8uXT0nFR9pYe2WLHl7Lw4KYoUSeGEC9S2kKPx+tIl64Q9I+SD93h7tVPYV79+fcm6sEhSjm+Rc8e/kMoV/fUx5Xi4XcZawp6ZUjESxxsrJ/aMk7KR9a2WnzsdJ6UCYqVadGnxD6gnpswEOX1ym1tshYepZo2qknxuj1y6eNI8v0OnW+Xvv96TC+djpUHj1lKjVhM5k/hf64TcKB3iL3Xq1pUff/xRxbE7OHPmjERHV5FVf44W/wDrLwenoMJu9uWaWH7iL34B9qNQUEyuSuVyMm/6nTrM1265ySSm/7/+/Pz9HY5ksSU7K0Oiq1TR4/f2HwA4Pnh+AwOtw7PeCG31HTuTkpIkplp1yT6cLOcvHXe6XuWYqpLVpJ6cP3BaygeFSr2e7SV972mH62ampklMdDVJ331SMkv8d+9o2rO97J68UuRAstRpUk+3eX67833aEupfSqpXqy6vjH1FX+f3PFy+NZnM26hSOVrk5AU5n+GaLa4cR2BCutSrW1dCD5ikxOIEyV62T2ICIkWOi5T6YZ8E17T+vr10IEkqHw8UCYiUoB/2SajtgLpsk0RuSJXI+vX1WkhN9e4ffenp6froShqIn8nb1UI+mD9/vrz22muyevVqK5Xep08fWbt2rYSHh5vnnz59Wg4ePFhIlhJCCCHEW6hRo4ZERkYWP49TVFSU/ioxfu0Y4buSJUtKWFiY1bply5bVE1WiRAnmzRBCCCHFkOzsbE3ngSbIjSIpnBo2bKiCafPmzVrHCWzYsEGaNm1qJ46wXm7qkhBCCCFFmzJlXGsRViRdLKVKlZIBAwbIK6+8Ilu3bpU///xTC2DecccdhW0aIYQQQnyYIimcwOjRo7V+04gRI2Ts2LHy6KOPSo8ePaQoVTzfuXOnDBkyRJo3by433XSTFvz0VlsN1q9fL926XW4u7K22/vXXX9K/f38tZ3HDDTfIkiVLvNbW2bNnS8+ePaVZs2Zy66236g8Fb7XV4OjRo3pukW/orbY+9NBDOhDDclq2bJlX2rpr1y4ZOnSoXgO4XtesWeN1dt5+++125xMTvqe9zVawePFi6d27t16nOLcYFVeQ5MXWVatWyY033qi23nnnnbJ///4CtdUAA6/69euX4991Yd+z3AaSw4n3MG7cONMNN9xg2r59u2nRokWmli1bmubPn2+3Xmpqqumaa64xvfXWW6a9e/eaXn31VdPVV1+t873NVoO4uDi1sWvXrqaCxlVbY2NjTY0bNzZ9//33poMHD5omT56srzHf22z9999/TU2aNDHNnDnTdPjwYb0W2rVrZzp//rzX2WrJPffcY6pXr55pzZo1poIkL7Zef/31plmzZplOnjxpni5evOh1tiYnJ+vf1IsvvqjX60cffWRq3bq1KTEx0avsTEpKsjqXixcv1r+rrVu3FoidebF19+7dpqZNm5pmzJhhOnTokGns2LH6XXvhwgWvtLVRo0amDz/80LRv3z7T+PHjTR07dizQ7wCQnp5uGjlyZI5/195wz3IXFE5eBC4g/MFaXngTJ0403XbbbXbrTps2zXTdddeZsrOz9TUe8WU/ffp0r7MVTJkyxdSiRQv9Miho4ZQXW9955x29sVty9913m95//32vs3XevHmmTz/91Pw6JSVFv7i2bNnidbYaQIzceuutBS6c8mIrBFLDhg1N+/fvNxUGebEVAr979+6mzMxM87xBgwaZ/vrrL6+y0xLY2qdPH9MHH3xgKijyYuu3335rGjhwoN3fVUGJvLzYClE3fPhw82vcB3r37q3ftwXFnj17TDfeeKN+t+f0d13Y9yx3UmRDdUWp4vmWLVvsaktgHpYZdUHw2KpVK02I9zZbwYoVK2T8+PHqSi5o8mLrwIED5amnnrLbRkpKitfZilACQkpGDZLvvvtOBzrUrl3b62wFGOn6zjvvyLhx46SgyYutCHXg76latWpSGOTF1nXr1mnoOyDgv3ZF06dPly5duniVnZb8/vvvcu7cObnvvvukoMiLrShXs3fvXh1QhGWwF0nD1atX9zpbjxw5oiFaA1y39erVK7D7gHENtm/fXn755RfJicK+Z7kTCicfqnhuu27FihWt5uGmeeLECa+zFXz66aeFlmOWF1shOho0+K9LOHoc/vPPP3LVVVd5na0GsA9fsmhkjbyIkJAQr7T1rbfeUmFat25dKWjyYiuEE26UzzzzjOaXDB48WJYvX+6VtuLGiUKoL730klxzzTVy88036w3f2+w0QJRj0qRJOlCnoK7TvNqKen/XXnutDBs2TJo0aaIN4ydMmODSMPWCthXzExISrObhHoAfKQXFsGHD9HsHg7JyorDvWe6EwslHK547W9d2PW+wtbDJr62oKI5BBfhVVFAJ7fmxFUIEv4pHjRolzz33XIH9gsuLrX///bfe0B9++GEpDPJiK4QTPHgQTbjJw3sDz962bdu8zlY0NP/yyy+lQoUK2tS8bdu2cs8998jx48e9yk4DJA7jRgmBV5DkxVaIDtzkX375Zfn11191oAiS2FEs2dtshdd54cKFOnABXqoZM2bodZqRkSHeRloh37PcSZGs4+SroAin7UVkvEbxTlfWtV3PG2wtbPJja2Jiotx11136Cxm/NguqOGp+bMWvTkyoXwZ3+NSpU6VFixZeYytECG5CY8aMKbRrIy/nFeIOo8AMDwM8kBhVhZsoasF5k60I0eFzh2gGjRo10o4Js2bNkgcffNBr7DTATb5z585W3RsKgrzY+u6772q4a/jwyz0xX331VRUoCIHef//9XmUrzuXIkSP1B15WVpaGzCD0zp8/L95GiUK+Z7kTepy8tOK5gbOK51gXN3dL8NrWFeoNthY2ebUVrm98aeKP+ocffijQnnB5sRWlB2yHSSPUWFBueldthZ0IKeHmjpCikbuBHBcIKm+yFUAk24ZlatWqZRcS8QZb4WmCbZagE0JBeJzy8x2wcuXKQilHkhdb8TdlGa7H9YDXx44d8zpbAbyhGzdu1LIEyHNET7jo6GjxNqIK+Z7lTiicvLTiuYGziueog7Fp0yZzY2I84o8H873N1sImL7Yi9HHvvffq/MmTJ+sfu7fa+ttvv8n7779v96VveyMtbFuRvLpo0SKZOXOmeQLoJ/nYY495la0A4U7b+kJI2PW28wrgWUQdJ9tQY0HcOPP6HYDQNwQ0EoQLmrzYihs5eptacuDAAalatarX2frHH3/I66+/riEv5AvBu4twKDxP3kbzQr5nuZXCHtZHrHnppZdMffv21SHlqHXSqlUr08KFC3UZ6p+kpaWZh8h26NBBa2FgOCgeUSOjIGtiuGqrJRh6Whh1nFy1FWUHmjVrputZ1p1BvRxvsxU1XlDD5bvvvjMdOHBAa/ig5MOJEye8zlZbCqOOk6u2Yh5qDKGOD2ojffzxx3pNHDlyxOtsPXr0qH7mEyZMUFtRz6cgr4G8fP74vDHM3hiOXtC4auvcuXPNdZxwTlGipCBrY+XF1m3btmktNyzDd8DDDz9sGjBggCkrK8tUGNSz+bv2tnuWu6Bw8jJQZO2ZZ57RLz8UMkNNEcuL0rLmBf6o8EeCP/LBgwebduzY4bW2FrZwctXWnj176mvb6dlnn/U6W8HSpUtN/fr102sA9Xs2bNhQYHbm1dbCFk55sfXXX3819ejRQ29KqOmzbt06r7V1/fr1aiNs7d+/f4Hamhc7IUhwoyws8vr59+rVS9cdOnSo/kjxVlt/++03/U5FkUwIp4SEBFNhUc/m79rb7lnuwg//FbbXixBCCCHEF/CuZBRCCCGEEC+GwokQQgghxEUonAghhBBCXITCiRBCCCHERSicCCGEEEJchMKJEEIIIcRFKJwIIYQQQlyEwokQQgghxEUonAghZq677jqpX7++eWrcuLH06tVLm4e6k9tvv10+/vhjc284TLmBpsu//vprvvf5+++/6/E54ujRo1bHjQk99oYOHSrLly/P9z5dPbacbMJjbseD/mRY19H70B/uSo6BEGJNoM1rQkgx5/nnn5c+ffroc3RoX7NmjbzwwgsSHh4uAwYMcPv+sG1XmDt3rnz++edy8803i6eYNm2aVK5cWZ+jYer3338vI0eOlHnz5kn16tXFm8BndO2119rNh/2rVq2ScuXKmT/Pdu3aSZcuXQrBSkKKHvQ4EUKsCA0NlQoVKuiEm/DAgQPlqquukkWLFnlsf5hyoyC6Q0FsGMderVo1efbZZ7Xz/NKlS8XbKFmypFkcWRIQEKD245EQ4n4onAghuRIYGChBQUHmMNurr74q3bp1U4/H+fPn5fjx4/Lggw9K8+bNNXz0ySefSFZWlvn9ixcvlp49e0qLFi1k3LhxVstsw1mzZs3S8CC2deutt8rOnTs1FDV69GiJj483h6EgpCZOnCgdO3aUNm3a6P6PHTtm3k5CQoLce++9uk+Iv8OHD+fruIFx7Nj3Rx99JO3bt9f9gU2bNmlID/vBsU+ZMsVqGzg/Dz/8sDRt2lRuuOEG9eBZ2jhq1Chp27atNGnSRO3csGGD1fsXLFggnTt3llatWsnLL7+sIcucQo+WoTqc13Xr1unngc/txRdfNNttgM/y6aefzvO5IaS4QuFECHFKRkaGeppWr16tQskAN+133nlHb8ghISHyyCOPSGRkpMyYMUPefPNNmTNnjobVwN69e+Xxxx9XcTF9+nQN/9mKA4OVK1dq6G7EiBEye/ZsFRMPPPCAtGzZUkNOlSpV0jAUPGGTJ0/W/bz33nvyyy+/6P7vvvtutRk89thjkp2dreG3++67T8NueSE1NVU++OAD3V6nTp3M85ctW6bi6KmnnpJ9+/aprRA+OCePPvqojB8/XoWiAZ7Xq1dPZs6cKddcc42eq5SUFF2GbUBETp06VZdHRUXJK6+8YmUH8rpgB87nihUr5IsvvnD5GHAuce5wXpBT1rdvX/0sIeYAzs/ChQt1PiHENZjjRAixYsyYMeqFMPJ8EBKCOLjxxhvN68DTBA8I+Oeff9TTA4Hi7+8vtWrV0hAXPETID4JYgkfozjvv1PVfeuklFR+OgADq16+fiizwzDPPqLfn3LlzGs4zwlBg0qRJaiu8PwCeLHifIL4QZoMnCPupUqWK1K1bV7Zv367em5zAvv38/NSblZaWpkIGQtAyv+mWW27RYwRY1qhRI3nyySf1NeZDTMG266+/XudB/EE4Gsfz559/yh9//KHetO7du6snDoIQDB8+XO6//34rmyAYW7dubRaD7777rgo0V8A5w/krXbq05qjhXJUtW1ZDj/g8169fr8IQgo4Q4hoUToQQKxA66tGjhz4vUaKEw3yZ6Oho83MIhbNnz5pv7oYnA6IrKSlJlzds2NC8DDdyy9eWHDhwQAWFAfKLIMIceYNOnDghTzzxhIo1A+zz4MGDcvHiRRUKEE0GCJXlJpy+/PJLFUsQTxAb5cuXt1vH9tgx+s4SeHjgQTKwXA5bcex4H/YBgYjE840bN+qxQ9zh3Fli+X6ItMTERBWS+QH77927t54HCKf58+erwDNCkYSQ3KFwIoRYgZBXTExMjutAUBkg9AZPy6effmq3npH0bZvY7exGbeQU5YaRI4V8o5o1a1otg0cFXjBX92kJhFbVqlVdPnbL5wYQPpY5XLaiE8thCx4RQktOTtYRcshXgvcHoTxLLIWhcUxXInTgVUO+E8J1CCMi5EoIcR3mOBFCrggIF4TqMMILggsTEpMnTJigXhWEybZt22ZeH4IhLi7O4bbwXstlECAQFMiJwrYMwsLCVOCdOnXKvE/kPUEEwHODnCJ4ZQ4dOmR+T2xsrEeOfcuWLVbzECK0FHO7du2yEplIdofQRO7Xv//+qzWykLCN8OfJkyd1PUvRt3v3bvPzrVu3algP3rD8gqR7eNW++uor3Q9KFRBCXIfCiRByRSCvCOErjMyCSEDeDPKYSpUqpd4W1F1CCOqzzz6T/fv3a/K05eg3S+AJQVI4kswhepBDhJs7CnFiexBDCMVBgCBn6sMPP9R8HczDiDGEvCBKateurSUUkB8EIYa8IiSTu5thw4apIHv//fdVsMHun3/+WXOVDHA+cOwIz7322mvqVYLXB+IP3iTUp8JoQYTPjKKgxsg5gHwziDMkdUOMGrlirgKRhfNz+vRp8zx4uL799lsdvciyBYTkDQonQsgVgRsvhAE8SRBJSFxGsUUIGQBvEJZDIKCAJrxEzooxYnQaEr5RZgA5OBAlGE2GBPUOHTrotjCkH/PvueceGTx4sA7Rx3Yhxr7++msN1QGMRIuIiNCcKQgbiDJ3g9AeRrkhIR124ThRAuCmm24yrwPbIJ769++vHiOsDxEIzxFG0MHzAyGF/CqcM4Qr4ZUyQB7UQw89pAnm2AYS9fPCkCFD1D6UZrAUTsgDMwqdEkJcx89UEFXlCCGEeA3wXsEruGTJEqsQKCEkd5gcTgghxQTkUCFfDF4veOsomgjJOwzVEUJIMQGFN5H3hRDmXXfdVdjmEOKTMFRHCCGEEOIi9DgRQgghhLgIhRMhhBBCiItQOBFCCCGEuAiFEyGEEEKIi1A4EUIIIYS4CIUTIYQQQoiLUDgRQgghhLgIhRMhhBBCiItQOBFCCCGEiGv8H9AzF0xkNKeYAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Prediction Distribution Statistics ---\n",
      "Total Records: 2950\n",
      "Ground Truth Positive Samples: 693\n",
      "Ground Truth Negative Samples: 2257\n",
      "Mean Predicted Probability (Average of All Predictions): 0.261\n",
      "Std Predicted Probability: 0.331\n",
      "Calibration Error (|Mean Pred. Prob. - Ground Truth Pos. Rate|): 0.026\n",
      "True Positives: 260\n",
      "True Negatives: 1897\n",
      "False Positives: 360\n",
      "False Negatives: 433\n",
      "Accuracy (at 0.5 threshold): 0.731\n",
      "AUPRC: 0.448\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Distribution of predictions\n",
    "LLMAnalyzer.plot_prediction_distribution(\n",
    "    df_mdata,\n",
    "    title_prefix=\"Gemini 2.5 Flash - Prediction Distribution\",\n",
    "    data_filter={\"task\": [\"mortality\"]},\n",
    "    show_stats=True,\n",
    "    color_neg=\"#6173FF\", \n",
    "    color_pos=\"#2ECC71\"  \n",
    ")\n",
    "LLMAnalyzer.plot_prediction_distribution(\n",
    "    df_mdata,\n",
    "    title_prefix=\"Gemini 2.5 Flash - Prediction Distribution\",\n",
    "    data_filter={\"task\": [\"sepsis\"]},\n",
    "    show_stats=True,\n",
    "    color_neg=\"#6173FF\",\n",
    "    color_pos=\"#2ECC71\",\n",
    ")\n",
    "LLMAnalyzer.plot_prediction_distribution(\n",
    "    df_mdata,\n",
    "    title_prefix=\"Gemini 2.5 Flash - Prediction Distribution\",\n",
    "    data_filter={\"task\": [\"aki\"]},\n",
    "    show_stats=True,\n",
    "    color_neg=\"#6173FF\",\n",
    "    color_pos=\"#2ECC71\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b2c1449d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "b7f6e3f9",
   "metadata": {},
   "source": [
    "---"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
